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Abstract 
 
Predicting the Effects of Intracellular Protein Variation on Base Excision Repair Capacity 
in Human Cells 
 
Andrew James Atkins 
 
 
 
 Base excision repair (BER) is one of the primary means by which cells cope with 
genotoxic stress and DNA damage. BER is carried out by a series of enzymes which excise a 
damaged base from a DNA strand and replace it with an undamaged base. The importance of 
BER to the maintenance of genomic integrity, cellular health, and the health of an individual 
cannot be overstated. Numerous diseases, particularly cancer, have been correlated to BER 
deficiencies in several ways. 1)  Increased disease risk has been correlated to elevated levels of 
highly mutagenic lesions repaired exclusively by the BER pathway. Elevated tissue levels of 
reactive oxygen species (ROS) which generate such lesions has likewise been correlated to 
increased disease risk. 2) Some functional variants of BER enzymes have been shown to be 
correlated with elevated disease risk. 3) Tumor cells have been shown to express BER enzymes at 
altered levels compared to surrounding healthy tissue. 
 Although the correlation between BER deficiency and disease risk has been thoroughly 
demonstrated it has not been well characterized. An unrepaired DNA lesion can lead to 
mutagenesis. Yet all cells cope with thousands of potentially mutagenic lesions each day, the 
majority of which are repaired without incident. Simply stated, mutagenesis can occur when a cell 
faces a damage load which exceeds its repair capacity. Therefore the need to characterize the 
quantitative relationships that govern repair capacity is central to understanding the development 
of diseases triggered by mutagenesis. 
 To this end I have created a formal model of the BER pathway. To test the model, I 
established protocols for DNA damage measurement in cultured human cells using single cell gel 
xx 
 
electrophoresis (SCGE). I developed novel software for the quantitation of SCGE data. In order 
to measure the system response following a perturbation, I created three cell lines deficient in the 
critical BER enzyme polymerase β (polβ) using RNA interference (RNAi) on HEK 293t cells. 
Polβ knockdown was confirmed and quantified with Western blotting. Repair curves were 
generated for wild type and knockdown cell lines using SCGE. Model validity was tested by 
comparing model predictions and experimental results.             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter 1: Introduction and Background 
 
1.1 Introduction 
 
 Base excision repair (BER) is one of the primary means by which cells cope with 
genotoxic stress and resulting DNA damage [1-8]. BER is carried out by a series of enzymes 
which excise a damaged base from a DNA strand and replace it with the appropriate undamaged 
base [1, 2, 9]. The importance of the BER pathway to the maintenance of genomic integrity, 
cellular health, and the health of an individual cannot be overstated [10]. Numerous diseases, 
particularly cancer, have been correlated to BER deficiencies in several ways [11]. 1)  Increased 
risk for disease has been correlated to elevated levels of highly mutagenic lesions repaired 
exclusively by the BER pathway [12-14]. Elevated tissue levels of reactive oxygen species (ROS) 
which generate such lesions has likewise been correlated to increased risk for disease [15-19]. 2) 
Functional variants of BER enzymes have been shown to be correlated to changes in cancer risk 
and BER capacity [14, 20-27]. 3) Imbalances in BER pathway enzymes have been shown to have 
potentially mutagenic consequences [28, 29]. And tumor cells have been shown to express BER 
enzymes at altered levels compared to surrounding healthy tissue [30-32]. 
Although the correlation between BER deficiency and disease risk has been thoroughly 
demonstrated it has not been well characterized [10, 11, 15, 33]. An unrepaired DNA lesion can 
lead to mutagenesis [1, 12]. Yet all cells cope with thousands of potentially mutagenic lesions 
each day, the majority of which are repaired without incident [1, 34, 35]. Simply stated, 
mutagenesis can occur when a cell faces a damage load which exceeds its repair capacity [36-38]. 
Therefore the need to characterize the quantitative relationships that govern repair capacity is 
central to understanding the development of diseases triggered by mutagenesis [12]. To this end I 
have created a formal model of the BER pathway.  
2 
 
The utility of mathematical modeling to offer insight into the mechanisms of complex 
biochemical pathways has been demonstrated in the study of mitochondrial metabolism[39], 
microbial metabolic pathways [40, 41], cell cycle control [42], and cell signaling [43-45]. A 
formal modeling approach addresses a key problem in the study of biological systems. Although 
it is clear that quantitative differences matter, the significance of quantitative measurements is 
often unclear because the systems they impact tend to be complex.  
The BER pathway is no exception. BER enzymes can have multiple substrates, multiple 
enzymatic activities, and overlapping substrate specificities [10, 28]. The effects of changes to 
system parameters can be difficult to interpret independent of the other system components. 
Furthermore the congruency of data on individual pathway components from separate studies 
cannot be evaluated unless the data are incorporated into a cohesive model of the system. One of 
the impediments to this process is that acquiring useful quantitative data from biological systems 
is difficult. Important quantitative differences are likely to be subtle. This is particularly true of 
the BER system because major BER deficiency does not support life [1, 8]. In spite of the 
difficulties, uncertainty regarding the underlying pathway mechanisms and their impact on 
disease processes is a strong motivation for this study. Epidemiological studies of BER have 
shown contradictory results and the link between BER functionality and disease remains unclear 
[10, 11, 15, 33]. Modeling is a key step in bridging the gap between epidemiology and systems 
biology [46, 47]. 
 In this study I created a mathematical model of the BER pathway. In order to test the 
model, I established protocols for measurement of DNA damage in cultured human cells using 
single cell gel electrophoresis (SCGE). I developed novel software for the quantitation of SCGE 
data. In order to measure the system response following a perturbation, I created three cell lines 
which are deficient in the critical BER enzyme polymerase β (Polβ) using RNA interference 
techniques (RNAi) on HEK 293t cells. Polβ knockdown was confirmed and quantified with 
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Western blotting. Repair curves were generated for wild type and knockdown cell lines using 
SCGE. Model validity was tested by comparing model predictions and experimental results.             
 To generate the formal BER model, Michaelis-Menten kinetics was assumed for each 
step in the pathway (except for several first order reactions described within). Necessary 
parameters were mined from the literature. The model includes the Neil1 and polynucleotide 
kinase (PNK)-dependent sub-pathway which is the only identified pathway capable of AP 
endonuclease-1 (Ape1) -independent BER [48, 49]. The Neil1/PNK sub-pathway is of particular 
interest because of its potential role as a back-up to the other sub-pathways in the system, all of 
which require Ape1 [48, 50, 51]. Furthermore, knockdowns of both Neil1 and PNK have been 
shown to increase cellular sensitivity to MMS induced alkylation damage [52, 53]. Model 
predictions do not show a major role for the Neil1/PNK sub-pathway. Flux through the 
Neil1/PNK sub-pathway is negligible compared to the other sub-pathways of the model. 
 Polβ was chosen as a knockdown target for this study for three reasons. 1) Polβ 5’ dRp 
lyase activity has been identified as the rate-limiting step in BER, although conflicting reports 
have been published [8, 54-56]. 2) Polβ expression changes have been found in cancerous tissue, 
linking Polβ specifically with the disease [31, 32, 57, 58]. 3) Polβ expression changes have been 
shown to induce genomic instability [30, 31, 59-61]. Three cell lines, named C2, C3, and C4, 
stably expressing distinct Polβ knockdown vectors, were created using RNAi techniques. 
Restriction enzyme digestion was used to confirm vector expression and rule out recombination 
following transfection. Western blotting was used to confirm and quantify Polβ knockdown. A 
two sample t-test was run between all of the knockdown samples and 293t samples to test the null 
hypothesis that the mean Polβ/tubulin signal was the same for each group. The null hypothesis 
was rejected at a 1% significance level (α = 0.01). This result supports the conclusion that Polβ 
expression was reduced in the knockdown samples. Chemiluminescent detection was used to 
quantify differences in Polβ expression between knockdown cell lines and wild type cultures. 
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Reduction of Polβ expression was measured at 64%, 63%, and 59% for C2, C3, and C4 cell lines 
respectively. 
 Methyl methanesulfonate exposure generates two major types of alkylation damage on 
the DNA of treated cells: 7-methylguanine and 3-methyladenine [1, 62-64]. BER response to a 
genotoxic methyl methanesulfonate (MMS) dose was measured using the single cell gel 
electrophoresis (SCGE) technique commonly referred to as the comet assay. Comet assay data is 
collected by quantification of fluorescent microscope images. As part of the current study I 
developed novel comet scoring software in MATLAB, dubbed Ascore. The software generates all 
of the most commonly reported comet score types. The software also addresses some of the 
shortcomings of other free comet scoring programs. In particular, comet score algorithms are 
necessarily based on assumptions about the geometry of a comet. Without open source code or 
feedback from the software regarding the basic measurements used to calculate a comet score 
there is no way to determine if a comet has been properly scored by the software. Ascore features 
a preview window which displays a scored comet with markers denoting all of the basic 
measurements used to calculate the commonly reported comet scores. This feature allows mis-
scored comets to be canceled, thus improving the quality of data sets. Using SCGE and Ascore, 
repair curves were generated for the repair of MMS induced alkylation damage in wild type and 
knockdown cell lines. 
 The experimental results of this study support the modeling predictions. Model-data 
analysis revealed that under certain parameter assumptions the model generates a repair curve 
which fits the experimental data for wild-type and knockdown samples. These results 
demonstrate the feasibility of this type of analysis and stress the need for coordinated data 
collection within the field of study. Full validation of the BER model was beyond the scope of 
this study and will require extensive future data collection. 
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1.2 Background  
 
 Base excision repair (BER) is one of the primary means by which cells cope with 
genotoxic stress and resulting DNA damage [1-8]. Sources of genotoxic stress can be endogenous 
or exogenous [10, 11, 65, 66].  Not only has spontaneous decay been estimated to generate 
between 2,000 and 10,000 apurinic/apyridimic (AP) sites per human cell per day [34, 35, 67, 68], 
but reactive oxygen species (ROS) are generated as a direct result of normal cellular metabolism 
[7, 10, 11, 17, 69]. ROS have the potential to induce a variety of damage types, particularly 8-
oxo-7,8-dihydroguanine (8-oxo-G) which is highly mutagenic if left unrepaired [16, 70-73]. 
Other regular sources of genotoxic stress include both endogenously and exogenously generated 
methylation as well as spontaneous hydrolysis of DNA bases [2, 68, 74-78]. This means that even 
in the absence of exogenous stresses such as the ROS by-products of cigarette smoke or UV 
exposure the BER pathway in a cell must be in working order to ensure cellular health [10]. 
Given the mutagenic consequences of unrepaired or poorly repaired DNA lesions, it is not 
surprising that the BER pathway is critical to cell survival and that cancer among other disease 
states can result from deficiencies in BER [3, 10, 18, 36]. 
 DNA repair is not exclusively carried out by the BER pathway. The various biochemical 
responses which restore damaged DNA to its normal sequence and structure are referred to 
collectively as DNA repair [1]. DNA repair is ubiquitous in nature [65, 79]. All living things 
require DNA repair processes to maintain genomic integrity [17, 79]. Some aspects of DNA are 
highly conserved even between prokaryotes and higher order eukaryotes. Human DNA repair 
systems are none the less unique [1].  
There are two major categories of DNA repair which address damaged bases: damage 
reversal, and excision [1]. Damage reversal consists of chemically un-doing the damage and 
excision involves removal and subsequent replacement of damaged DNA bases. Damage reversal 
is direct compared to the multi-step processes of excision repair and is less prone to errors for this 
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reason. Damage reversal primarily repairs specific types of alkylation and UV-induced damage 
[1]. There are four major types of excision repair: nucleotide excision repair (NER), alternative 
excision repair (AER), mismatch repair (MMR), and base excision repair (BER)[1].  
NER involves incision of the damaged DNA strand on both sides of the affected site and 
subsequent replacement of the damaged nucleotide [65, 80]. NER refers to specifically to repair 
in transcriptionally silent regions of the genome. A separate process termed transcription-coupled 
nucleotide excision repair (TC-NER) is responsible for NER in transcriptionally active regions of 
the genome [1]. Alternative excision repair (AER) is the name given collectively to a set of repair 
pathways which act on lesions similar to those targeted by NER. AER pathways are 
biochemically distinct from NER though and involve only a single incision of the damage DNA 
strand [1, 81, 82]. AER pathways have been most thoroughly characterized in prokaryotic cells 
however there is evidence that mammalian AER exists [1]. Mismatch repair (MMR) is the branch 
of DNA repair which recognizes and corrects mismatched base pairs which are most commonly 
caused by DNA replication errors [1, 83]. MMR can also fix insertion-deletion loops which result 
from the slippage of either the primer or template strands during replication [1]. BER is 
biochemically distinct from the other forms of excision repair and involves the excision and 
replacement of a damaged base [1-4, 8]. BER is discussed in greater detail below. In addition to 
the aforementioned pathways for correcting damaged bases, there are DNA repair pathways 
which correct fractures of the sugar-phosphate backbone itself known as single-strand breaks 
(SSB) and double-strand breaks (DSB). Single-strand break repair (SSBR) and double-strand 
break repair (DSBR) occur through a variety of mechanisms which include processes associated 
with recombination as well as non-homologous end joining [1, 84]. 
 Overall, the genomic integrity of all cells depends on a wide variety of DNA repair 
processes. BER is of particular interest among these pathways because it exclusively repairs 
certain lesions which are implicated in development of disease, especially cancer, and because 
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deficiencies in the BER pathway are associated with elevated risk for some diseases [3, 11]. 
Furthermore, the BER pathway has been identified as a therapeutic target for the treatment of 
certain cancers [85, 86]. For example inhibition and over-expression of Aag have both been 
shown to increase the efficacy of chemotherapeutic drugs on tumor cells [87, 88].  
 The BER pathway consists of several overlapping enzymatic pathways. During repair a 
damaged base is removed from the DNA and an undamaged replacement is installed. The human 
BER pathway consists of five distinct enzymatic steps: 1) excision of the damaged base, 2) 
incision of the DNA strand at the resulting AP site, 3) nucleotide replacement, 4) removal of 
terminal end moieties, and 5) resealing of the nicked strand [1, 2, 9]. Most BER enzymes have 
multiple substrate specificities, some of which overlap. Because of the overlapping substrate 
specificities of BER enzymes, repair can proceed through one of several sub-pathways. The 
specific molecular mechanisms involved in repair depend on the sub-pathway used [1, 36, 48]. 
Figure 1.1 shows the five general BER steps as they occur in what is considered the predominant 
sub-pathway [89]. The known human BER enzymes are listed in Table 1.1 and table 1.2. Table 
1.1 lists the known DNA glycosylases. Table 2.2 lists the other BER enzymes. BER also involves 
proteins which lack known enzymatic function. X-ray cross-complimenting protein 1 (XRCC1) 
and poly(ADP-Ribose) polymerase (PARP-1) both play critical roles in the BER [63, 90-97]. A 
thorough description of the pathway is included in the discussion of model formulation in Chapter 
2. 
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Figure 1.1: The most common molecular mechanisms of the five basic enzymatic steps involved in BER. 
A) the damaged base is excised by a DNA glycosylase leaving an apurinic/apyrimidinic (AP) site, B) the 
DNA strand is incised by AP endonuclease I (Ape1), C) a replacement nucleotide is inserted by polymerase 
β (Polβ), D) Polβ dRp lyase activity removes terminal end moieties, E) the strand is re-sealed by DNA 
ligase I or DNA ligase III/XRCC1 complex. This figure was adapted from Wiederhold et al. 2004 [48]. 
 
 
 
Table 1.1: Human DNA glycosylases. Adapted from [1]. 
 
Protein (synonyms) Common name Substrate examples 
UNG Uracil-DNA glycosylase removes uracil 
SMUG1 SMUG DNA glycosylase U,5-hydroxmethyluracil 
MBD4 Methyl-binding domain 
glycosylase 
U or T opposite G at CpG sequences, T 
opposite O6-methylguanine 
TDG Thymine-DNA 
glycosylase 
U,T,or etheno-C opposite G (preferably 
CpG sites) 
Ogg1 8-OxoG-DNA 
glycosylase 
oxidized and ring opened purines including 
8-oxoG and FaPy-G 
MYH MutY homolog DNA 
glycosylase 
A opposite 8-oxoG, 2-OH-A opposite G 
NTH1 Endonuclease III ring saturated or fragmented pyrimidines 
Aag (MPG, ANPG, 
APNG, MDG, MID1) 
3-methyladenine-DNA 
glycosylase I 
3-methylpurines, hypoxanthine, 
ethenoadenine 
Neil1 Endonuclease VIII-like 
DNA glycosylase 1 
ring saturated or fragmented pyrimidines, 
FaPy-A, 8-oxoG, AP sites 
NEIL2 Endonuclease VIII-like 
DNA glycosylase 2 
oxidized or fragmented pyrimidines 
NEIL3 Endonuclease VIII-like 
DNA glycosylase 3 
unknown 
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Table 1.2: Non-glycosylase BER enzymes 
 
Protein(synonyms) Common name primary enzymatic activities 
Ape1 (Fen1) AP endonuclease 1 AP endonuclease, 3'-phosphodiesterase 
Fen1 flap-endonuclease 1 endonuclease activity on 2-7 nucleotides 
PNK polynucleotide kinase 3'-phosphatase 
Pol-β polymerase β dRp lyase, gap-filling 
Pol-δ polymerase δ dRp lyase, gap-filling 
Lig1 ligase I DNA ligation 
LigIII ligase III DNA ligation 
 
 
 
 It is established in the literature that BER deficiencies are a risk factor for disease [3, 98-
101]. The experimental approaches to establishing this link have taken several forms. 1) High 
incidence of DNA lesions exclusively repaired by the BER pathway, are linked to a multitude of 
disease states. Cooke et al. provide a list of over 30 diseases, many of which are forms of cancer, 
that are linked to elevated levels of DNA lesions [11]. 2) Reduced kinetic rates of BER enzymes 
have also been implicated in disease processes. For example lower functionality of Ogg1 in test 
subjects has been linked to occurrence of non-small cell lung cancer [102]. 3) Expression levels 
of BER proteins are also shown to have an impact on risk of disease [103].  While there is 
certainly experimental evidence to support the link between BER and disease, the role of BER in 
disease processes is not fully characterized. Srivastava et al. for example showed that in some but 
not all types of adenocarcinomas, Polβ expression levels are elevated [104]. 
Oxidative stress which is understood to cause many types of DNA lesions, is also 
strongly implicated in cancer risk and development [18, 69, 105]. Both the high incidence of 
ROS-generated BER-specific lesions and high tissue levels of reactive oxygen species (ROS) are 
associated with elevated disease risk [66]. 8-oxoguanine (8-oxoG) is the most commonly studied 
lesion in this category. 8-oxoG lesions have been linked to diseases such as breast cancer, colon 
cancer, Alzheimer’s disease, chronic hepatitis, and small cell lung carcinomas among others [11]. 
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Additionally, aging rates and age related disease onset have been found to be correlated with 
oxidative stress and the BER pathway [2, 106-109].  
 The mechanism by which unrepaired lesions threaten a cell varies depending on the type 
of lesion [66]. Unrepaired 8-oxoguanine (8-oxoG) is particularly mutagenic because it can pair 
with adenine and lead to replication errors [1, 73]. Figure 1.2 shows how 8-oxoG can mis-pair 
with adenine.  Not only can 8-oxoguanine cause replication errors, it can also cause 
transcriptional mistakes in non-replicating cells. Bregeon et al. have shown that RNA polymerase 
II tends to insert adenine opposite an 8-oxoG lesion. The result of such an error is mutation which 
can have a wide range of deleterious effects for the affected cell [72, 110-112]. MYH is the 
glycosylase which handles excision of mis-paired adenines across from 8-oxoG. MYH 
deficiencies and mutations are correlated with high colorectal cancer risk [1, 36]. Uracil can cause 
G-A transitions and hypoxanthine can cause T-C transitions. AP sites when left unrepaired can 
cause single strand breaks and are potentially mutagenic during transcription [1, 113]. AP sites 
are particularly common lesions because they can form spontaneously and because glycosylase 
action creates an AP site as a repair intermediate during the repair of every other lesion specific to 
the BER pathway [30, 114]. Regardless of the specific biochemical mechanisms involved, the 
danger posed by most DNA lesions is that damaged, missing, or partially repaired bases cause 
transcription and replication errors and hence lead to mutagenesis [1, 66, 68]. 
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Figure 1.2: A) Normal guanine and cytosine base pair. B) Normal thymine and adenine base pair. C) 8-
oxoG paired with cytosine. D) 8-oxoG mispaired with adenine. The structural differences between normal 
guanine and 8-oxoG are the NH located at N7 and the oxo group located at C8. Those 2 alterations to 
guanine allow it to mispair with adenine. This figure was adapted from David et al. 2007 [101]. 
 
 
 
 Studies showing that elevated levels of lesions repaired by BER are correlated with 
increased risk for disease serve to establish the importance of BER to an individual’s health. 
Furthermore characterization of the biochemical mechanisms by which DNA lesions lead to 
mutagenesis establishes the danger posed to cells by unrepaired lesions. However, the vast 
majority of DNA lesions are repaired without incident [66, 115]. It is overall capacity of cells to 
cope with genomic insult which is the determining factor in whether a damage load will lead to 
mutagenesis [29]. It is important to note that repair capacity is a loosely defined term. It refers to 
the ability of cells to repair a given damage load. Repair capacity can refer to the speed and 
efficiency of DNA repair or to the total quantity of damage that cells can cope with successfully. 
Comparisons between the BER repair capacity of experimental samples is carried out both 
qualitatively and quantitatively.  
 DNA damage repair capacity is a promising biomarker for oxidative stress and cancer 
risk [3, 87, 116, 117]. This is because deficiencies in BER capacity have been implicated in the 
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disease process. This relationship remains to be fully characterized [85]. For example, peripheral 
lymphocytes of breast cancer patients have been found to have a lower damage repair capacity 
than normal patients [118]. Orlow et al. compared samples of peripheral blood lymphocytes from 
patients who had survived single occurrences of non-small-cell lung cancer (NSCLC) to samples 
from patients who had multiple occurrences of NSCLC. Patients who have had an occurrence of 
NSCLC are at a greater risk for developing the disease again than the general population. The 
study found that treatment with the genotoxic agent benzo(a)pyrene diol epoxide induced more 
damage in cases than in controls. The damage levels were measured using the comet assay. The 
implication of these results is that reduced DNA repair capacity is linked to the increased disease 
occurrence and therefore to an increased disease risk [119]. 
  Although studies such as that by Orlow et al. help to pinpoint how repair capacity is 
related to disease by showing a physiological difference between cancer patients and controls, the 
BER pathway is still treated as a black box. Base excision repair capacity is itself dependent on 
two main factors. The repair pathway is an enzymatic pathway and its functional capacity is 
affected by the effective kinetic parameters of the repair proteins and the expression levels of 
those proteins. The basic model used to describe the speed of an enzymatic reaction (in 
concentration of substrate converted per unit time) is the Michaelis-Menten equation: 
 
            
              
      
    (1.1) 
 
Where V is the reaction velocity (mol/L/s), [E]o is the total enzyme concentration (mol/L), [S] 
(mol/L) is the free substrate concentration (mol/L), kcat (s
-1
) is the catalytic constant, and Km (nM) 
is the Michaelis-Menten constant. Assuming this model is adequate for the description of each 
individual step in the pathway, the overall BER pathway efficiency and therefore total repair 
capacity of a cell given a specific damage load is a function of the inherent kinetic parameters and 
the intracellular concentrations of the BER enzymes.  
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 The optimization of the BER pathway to prevent repair-intermediate build-up is achieved 
via different mechanisms depending on the type of lesions being repaired [120, 121]. Figure 1.3 
shows the BER pathway with major sub-pathways. Due to overlapping substrate specificities and 
redundancy within the BER pathway, a complicated relationship exists between changes to 
protein levels, changes to the kinetic parameters in the pathway, and the resulting changes to the 
repair capacity of the cell [29, 66, 115]. Following are several examples of how the complexity of 
the system can cause non-intuitive responses to changes within the system.   
1) Hofseth et al. showed that an increase in the BER enzymes Aag and Ape1 is an 
adaptive response to ulcerative colitis which is a chronic inflammation of the colon associated 
with an elevated risk for colon cancer development. The over expression of these two enzymes 
was found to be positively correlated with microsatellite instability (MSI) in colon tissue which 
can cause frameshift mutations. Increases in Ape1 or Aag alone were previously found not to be 
correlated with MSI [103]. What this means is that the imbalanced increase in response to 
genotoxic stress of two repair proteins in the pathway could actually be the cause of the increased 
risk for colon cancer associated with chronic inflammation [122]. But over expression of Aag 
alone has also been found to increase cellular sensitivity to MMS induced damage and 
temozolomide, a chemotherapeutic alkylation agent [55, 61, 88].  
2) Up-regulation of Polβ was shown to enhance BER capacity in mouse cells [7]. 
Increase and decrease of resistance to MMS induced genotoxic stress in mouse cells has been 
shown to be associated with an up or down regulation of Polβ respectively [123]. However Polβ 
over expression has also been shown to induce MSI [124]. 
3) Both DNA ligase I and DNA ligase III are capable of re-sealing a nicked DNA strand 
as the final step in BER. Ho and Satoh found that over-expression of DNA ligase III (LigIII) 
increased cellular resistance to alkylation damage while over-expression of DNA ligase I (Lig I) 
had little effect on pathway efficiency [125].  
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4) Using a formal model of the BER pathway, Sokhansanj and Wilson found that a 30% 
reduction in the kcat of Ape1 significantly increases the sensitivity of the pathway to kinetic 
variations of Polβ. The change in Ape1 kinetics leads to a build- up of repair intermediates that 
are then acted on by slower redundant pathways which substantially increases clearance time for 
a bolus damage dose [115]. 
5) In some cases, DNA lesions are less problematic to a cell than the intermediate lesions 
formed during repair. Which means repair of such lesions, for example 7-methylguanine, can do 
more harm than good if the repair process cannot be efficiently completed [66].  
 
 
 
Figure 1.3: Multiple sub-pathways of the BER pathway. Overlapping substrate specificities of most BER 
enzymes and crossover between sub-pathways leads causes complexity in the effects of BER pathway 
perturbations. This figure was adapted from [48]. 
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  Examples of alterations in the BER pathway being correlated with increased risk for 
disease are numerous in the literature [3]. Single nucleotide polymorphisms (SNPs) in the BER 
pathway, which give rise to functional variants of BER proteins, particularly XRCC1 and Ape1, 
have been shown to affect the overall repair capacity of cells [126]. Iwanaga et al. found that a 
mutant form of pol-β plays a role in the development of gastric cancer [127, 128]. Liu et al. 
identified 6 SNPs in BER protein genes which are significantly associated with an increased risk 
for the development of glioma. Although the authors do not suggest how these SNPs affect the 
risk of glioma development, they do suggest that the functionality of the BER pathway is 
somehow impinged by the SNP variant versions of BER proteins. It follows then that the 
effective kinetic parameters of the SNP BER protein variants are different than the kinetic 
parameters of the wild-type BER proteins [129]. SNPs of BER enzyme genes have also been 
shown to be associated with a higher risk for the development of pancreatic cancer [130] and with 
a lower survival rate for the same disease [131, 132]. Patients with myelodysplastic syndromes 
(MDS) were found to exhibit elevated 8-oxo-G levels associated with elevated Ogg1 mRNA 
expression as well as elevated levels of AP sites associated with low Polβ expression. A variant 
form of Ogg1, hOgg1-Cys326, was found to be more common in MDS patients than controls 
[100]. And reduced Ogg1 activity has been associated with an elevated risk for development of 
lung cancer [102]. Frosina provides a list of cancers which have associated BER protein SNP 
variants as potential risk factors for disease development. The list includes lung, gastric, breast, 
ovarian, bladder, esophageal, pancreatic and kidney cancers [85]. 
 The link between disease states and deficiencies in the BER pathway has been well 
established but poorly characterized [11, 15, 85]. While studies such as that by Liu et al. support 
idea that BER performance deficiencies can lead to disease states [129], the findings of other 
studies suggest that the relationship between BER and disease is not straightforward [3]. 
Srivastava et al. found that pol β levels relative to surrounding tissue were up-regulated in some 
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colon, breast, and prostate adenocarcinomas. But in the same study found pol-β levels lowered in 
kidney adenocarcinomas. Studies such as this further establish the link between changes to the 
BER pathway and disease states, but at the same time fail to offer insight into what role such 
BER pathway alterations play in the development of disease [32]. Although many studies show 
the deleterious effects that changes to the BER pathway can cause, there are still others which 
show that some BER alterations can be beneficial. Li et al. report that up-regulation of BER 
proteins is part of the cellular response which prevents ischemic damage in neuronal cells [133]. 
Lo et al. found that a particular polymorphism in the promoter region of the Ape1 gene, -
656T>G, is associated with a decreased risk for lung cancer development [67]. 
 There is a significant amount of literature which presents the case for DNA damage as a 
risk factor for disease. And many of the lesions cited as risk factors are specifically repaired by 
the BER pathway. Furthermore deficits in overall BER capacity have been found to be linked to 
increased disease risk. According to the standard Michaelis-Menten model of enzyme kinetics, 
overall BER capacity is a function of the kinetic parameters of each enzyme and the relative 
expression levels of those enzymes. In an effort to quantitatively predict the effects that changes 
in the expression levels of BER enzymes have on the BER capacity of cells, I have created a 
formal model of the BER pathway. The details of the model are presented in chapter 2. 
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Chapter 2: Model Formulation 
 
2.1 Previous models of the BER pathway 
 
 With the exception of three papers published by Sokhansanj et al. [38, 115, 134], and one 
by Crooke and Parl [135], studies which investigate the effects that changes to the BER pathway 
have on the repair capacity of cells typically focus only on analyzing discrete portions of the 
pathway. While such studies are of critical importance to the understanding of the BER pathway, 
the disadvantage of this approach is that the BER pathway itself is treated as a black box. The 
quantitative data collected from each individual study can only be interpreted in a 
phenomenological sense. To establish the congruency of such studies, it is necessary to compose 
formal models which incorporate the data collected from multiple sources. The advantage of the 
formal modeling approach is that the model can be used to interpret quantitative data 
mechanistically. The model published by Sokhansanj et al. in 2002 was the first such 
comprehensive pathway model to appear in the literature [38]. The model developed in this thesis 
starts from that work. The current model presented here exhibits substantial expansion and 
change from the original, reflecting updated knowledge.  
 The key challenge for developing the BER model was the data mining necessary to 
choose parameter values. The BER model is based on Michaelis-Menten enzyme kinetics and 
therefore appropriate kcat, KM, and concentration values for each enzyme in the pathway were 
taken from existing published data. Experimental data shows that within the crowded cell nucleus 
diffusion efficiency is reduced 5 to 10 fold [115, 136]. To account for this 10-fold increase in the 
literature reported Km values of all enzymes was used. All of the parameters collected from the 
literature were taken from human cell lines. To date, the literature does not contain a complete set 
of kinetic BER parameters for an individual cell line. The published kinetic parameters and 
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intracellular concentrations of BER enzymes are rarely collected from the same cell lines or under 
the same experimental conditions.  
 The preliminary model on which the current study is based was published by Sokhansanj 
et.al in a series of three papers [38, 115, 134]. The first of these introduces the first quantitative 
model of the BER pathway. The original model specifically includes only the enzymes that are 
involved in repair of 8-oxo-G and cannot simulate repair of any other damage. 
 The Sokhansanj-Wilson model can be described in terms of three pathways in this case 
labeled A, B, and C. See figure 2.1. All three pathways begin with the same step, glycosylase 
action by Ogg1. The result is an abasic site upon which Ogg1 can perform an AP lyase activity, 
cleaving the phosphodiester bonds on the 3’ end of the lesion [66]. This second step dictates that 
the repair will now flow through pathway A. Alternatively however, the second step of repair can 
be carried out by AP endonuclease1 (Ape1 or Ref1). Ape1 can displace Ogg1 at the lesion site 
and hydrolyse the phosphodiester bonds on the 5’ end of the lesion which means that repair will 
flow through pathway B [137-139]. 
 Along pathway A the third step of repair is 3’phosphodiesterase activity by Ape1. Polβ 
then inserts an undamaged base into the nicked site, and Lig1 or LigIII complete the repair 
process. Along pathway B the third and fourth steps, a dRp lyase activity and a gap-filling 
activity, are carried out by Polβ in either order. As developed through modeling study, in the 
comprehensive BER model, it is assumed that Polβ does not dissociate from the site between 
steps [38]. Again the resulting nicked site is sealed by one of the ligases. Pathway C represents 
long patch repair.  It can be initiated by Polδ as the third repair step from either pathway A or B. 
Polδ can replace patches of approximately 2-7 nucleotides. Fen1 then removes the old flap of 
nucleotides and as in the other pathways a ligase will complete repair. 
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Figure 2.1: BER network as it is represented in the Sokhansanj-Wilson model. This figure was adapted 
from [134].   
 
 
 
 Using this model of the BER network, Sokhansanj et al. were able to show that the 
favored pathway in this system is the one labeled pathway B in Figure 2.1. This result is 
explained by two factors. Ape1 has a high intracellular concentration compared to other BER 
proteins. And the rate constant for Ape1 activity on an abasic site is approximately three orders of 
magnitude greater than that of Ogg1. Sensitivity analysis also revealed that overall repair rates 
were most sensitive to changes in the kcat of the dRp lyase activity of Polβ, the slowest step of 
pathway B.   
 For the majority of enzymatic reactions in the model, Michaelis-Menten kinetics are 
assumed. When representing all of the reactions in pathway B as second order reactions, 
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however, the model does not generate a repair curve that fits experimental data. Representing the 
second activity of Polβ (regardless of which is carried out first) as a first order reaction, does 
generate a repair curve that can fit experimental data. Representing the Polβ secondary activity as 
a first order reaction implies that Polβ does not dissociate from the lesion site between enzymatic 
steps. This result still remains to be tested experimentally [38]. 
 The second paper of the series used the model established in first paper to test 
experimental data on background DNA damage levels [38, 134]. Data on background damage 
levels reported in the literature range in order of magnitude from 10
2
 to 10
5
 sites per cell for 8-
oxo-G alone [140, 141]. Damage formation rates of 500 8-oxoG/cell/day and 10,000 AP 
sites/cell/day were taken from the literature. Using those numbers, the model predicts steady state 
levels of damage to be approximately 54 total lesions per cell. Compared to the low end 
experimental measurements this figure is quite reasonable. It has been suggested that damage 
induced during DNA extraction and handling could explain, at least partially, the far higher 
estimates of some studies [140, 142]. Variation of the lesion formation rates were used to further 
characterize the system. At a rate of approximately 125,000 8-oxo-G lesions/cell/day the model 
has no steady state solution. This figure is a prediction of the maximum 8-oxoG formation rate 
that a cell can handle.  
 The third paper of the series uses the BER model of the first paper to investigate how 
protein variants, which can be caused by single-nucleotide polymorphisms, can affect the overall 
BER capacity of a cell [115]. Overall the findings suggest that BER capacity is most sensitive to 
kinetic variations in Ogg1, Ape1, and Polβ. Using the kinetic parameters of individual protein 
variants found in human population studies, the model shows only moderate effects on BER 
capacity. However, BER capacity can be affected in surprising ways when multiple variations are 
introduced. For example when an inefficient Polβ variant is used, the clearance time for a dose of 
damage is maximized at 70% Ape1 efficiency. Under these conditions, overall pathway 
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efficiency can be increased by decreasing or increasing Ape1 kinetics. The reason for this effect 
is that a build-up of repair intermediates which have overloaded Polβ end up being processed via 
the other pathways [143-146]. While the findings of this study demonstrate that the complexity of 
the BER pathway can have surprising effects on the repair capacity of a cell, they also suggest 
that the link between BER deficiency and disease risk may be dependent on more than just 
genetically derived differences in kinetic activity of individual proteins. 
 The previous Sokhansanj-Wilson model and the series of papers that stemmed from it are 
the first efforts of their kind with respect to the base excision repair pathway. The first two papers 
demonstrate the important role of quantitative modeling in the study of this system. By 
integrating the data collected in multiple studies, all of which focus on specific parts of the BER 
pathway, the model provides a basis for evaluating the validity of experimental data which is 
subject to a great deal of variability. The third paper begins to investigate the complex effects that 
pathway variation can have on overall BER capacity. Together this series of papers not only helps 
to answer some fundamental questions about BER, but helps to formulate further questions to be 
addressed as well. 
2.2 New BER model 
 As we have formulated it in the model, the first step in BER is cleavage of the N-
glycosidic bond which removes the base from the DNA molecule resulting in an apurinic or 
apyridimic site (also referred to collectively as AP sites or abasic sites). This is based on 
conventional biological understanding [1, 12]. The cleavage is carried out by a class of enzymes 
called DNA glycosylases [147]. There are 11 known DNA glycosylases in human cells. UNG is 
the only one of the human DNA glycosylases with a single known substrate (although the 
function of Neil3 remains unknown [148]). The other nine have multiple substrates for their 
glycosylase action and five of those nine can also carry out AP lyase activity [1, 12].  
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 The expanded model has additional glycosylases which allow simulation of BER for 
more lesion types. The added glycosylases are Aag, Smug1, Nth1, and Neil1. In addition to 8-
oxoG, the expanded model can simulate the repair of Uracil, 5-hydroxyuracil (5-OHU), 3-
methyladenine (3-meA), 7-methylguanine (7-meG), and hypoxanthine (Hx). A glycosylase of 
particular interest that was included in the expanded BER model is Aag. Aag is responsible for 
the excision of alkylation damage, most importantly 3-methyladenine and 7-methylguanine, 
which are the primary forms of damage induced by methyl methanesulfonate (MMS) [149]. 
MMS is the genotoxic agent that was used in most of the DNA damage measurement experiments 
in this study. 
 Neil1 is a significant addition to the model as well. It is a recently discovered glycosylase 
with substrate specificities overlapping that of the other glycosylases in the model. Neil1 has 
substrate specificities overlapping Ogg1, Nth1, Ape1, and Polδ [150-153]. Also, Neil1 can act in 
conjunction with PNK creating a sub-pathway of the BER pathway which is completely Ape1 
independent. PNK acts on the βδ-elimination product of Neil1 and competes with the 3’-
phosphodiesterase activity of Ape1 [48].  The Neil1-PNK sub-pathway is the only known BER 
sub-pathway which is Ape1 independent. This is significant because the Sokhansanj BER model 
did not have any repair sub-pathways which could proceed without Ape1. The full extent of the 
role of Ape1-independent base excision repair is not understood. It has been included in this 
model in order to investigate the quantitative effects that this alternate enzyme sequence may 
have on the overall BER capacity of human cells. 
 There are at least two proteins, which play important roles in the BER process but do not 
have enzymatic function on DNA lesions: poly(ADP-ribose) polymerase-1 (PARP) and X-ray 
cross-complementing protein-1 (XRCC1) [96, 154]. The mechanisms of PARP1 and XRCC1 
action are not fully characterized but they are understood to play critical roles in BER. One of the 
critical functions of XRCC1 is formation of a complex with LigIII that is crucial for LigIII 
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function [155, 156]. It may also interact directly with other proteins in the BER pathway [156]. 
XRCC1 has been identified as critical to the base excision repair of MMS induced alkylation 
damage [93, 155]. And XRCC1 deficient cell lines exhibit impaired BER capacity [38, 96]. A 
potential role for XRCC1, termed “pass the baton” activity, in the coordination of each step of 
BER has been demonstrated recently [157, 158]. The implications of this role for XRCC1 on the 
BER model and the results of this study are discussed in detail in chapter 6. 
 PARP plays a role in multiple cellular processes. During BER, PARP1 binds single-
strand breaks and repair intermediates and may serve to protect cells from excessive DNA 
damage when BER capacity cannot keep up with the damage load [94, 159]. Another major role 
for PARP1 is in regulated cell death. PARP is involved in both the activation and mediation of 
apoptosis [160, 161]. It is also involved in activation of a regulated form of necrosis which cells 
can undergo as a response to excessive alkylating DNA damage [162]. 
 The XRCC1 and PARP1 proteins are not explicitly represented in the BER model 
because they exhibit no known enzymatic functions in the BER pathway. Although XRCC1 has 
been shown to interact with enzymes in the BER pathway during repair, any changes to 
enzymatic efficiency associated with XRCC1 are assumed to be reflected in the kinetic 
parameters used to model the pathway. 
2.3 Detailed model description 
 
 Because the substrate specificities of the newly added enzymes overlap those of the 
enzymes in the original model, the pathways through which damaged sites flow in the Neil model 
are more complex.  The Neil model is organized such that there are two new pathways added to 
the model: pathway E and pathway F.  Both of these pathways end by flowing into the pathways 
A and C. A schematic diagram of the expanded BER model is shown in Figure 2.2. 
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Figure 2.2: The full expanded BER model. 
 
 Pathway E is initiated when Neil1 carries out Βδ-elimination on a substrate.  Ape1 or 
PNK can then act on the βδ-elimination product.  Both PNK and Ape1 turn the Βδ-elimination 
product into a gapped site and repair continues via pathway A from that point [163]. 
 Pathway F is initiated when either Ogg1 or Nth1 create a 3’-deoxyribose phosphate (3’-
dRp) [134, 164].  The 3’-dRp can then be acted on by Polδ, Ape1, or Neil1.  If Polδ acts on the 
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site repair will proceed down pathway C [134].  Ape1 activity will lead to repair via Pathway A 
[134]. Neil1 activity will channel lesions through pathway E [163]. 
 Nth1 has multiple substrates however 5-OHU is the only one currently incorporated into 
the Neil model.  The glycosylase activity of Nth1 results in excision of the damaged base leaving 
an abasic site which is referred to in this model as the Nth1 intermediate.  Nth1 can then carry out 
an additional first-order step on the abasic intermediate, or Ape1 can displace Nth1 and act on the 
intermediate [153]. The outcome of this enzymatic competition determines which pathway the 
damaged site proceeds down. If Ape1 removes Nth1 and acts on the abasic site, repair will 
proceed down pathway B [134].  If Nth1 carries out a first order reaction on the abasic site, it will 
become a 3’-deoxyribose phosphate (3’-dRp) and repair will proceed via pathway F [153]. 
 An 8-oxoG can be excised by either Ogg1 or Neil1 [134, 163]. Neil1 activity in the first 
step of repair will send the damaged site directly down pathway E [163]. Ogg1 activity in the first 
step of repair will create an abasic intermediate site referred to in this model as the Ogg1 
intermediate. Ape1 or Neil1 can then act on the Ogg1 intermediate and the site will be repaired by 
either pathway B or pathway E respectively [134, 151]. In the absence of a competing enzyme, 
Ogg1 will stay bound to the Ogg1 intermediate site and carry out a first-order reaction creating a 
3’dRp [134]. Repair will then proceed down pathway F. 
 Abasic sites, formed either spontaneously or secondary to glycosylase action, can be 
acted on by Neil1 which will lead to pathway E, Ape1 which will lead to pathway B, or by Nth1 
or Ogg1, both of which will lead to pathway F [134, 151, 153]. 
2.4 Reduced version of the new BER model 
 
 The expanded BER model is able to simulate the repair of uracil, Hx, 5-OHU, 8-oxoG, 3-
meA, 7-meG, and AP sites. However all of the experimental data generated in the current study 
for the purposes of model testing and validation was collected from cells treated with MMS 
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[149]. MMS generates alkylation damage in cells which almost exclusively consists of 3-meA 
and 7-meG [1, 62-64]. In order to simplify the visual presentation of the model, a reduced model 
diagram is presented in Figure 2.3. The reduced model diagram displays only the portion of the 
BER model that is involved in simulation of 7-meG and 3-meA repair. Table 2.1 shows the 
enzymes that are active in the expanded model as well as the literature mined parameter values of 
each. Some parameter values were varied, with justification, during data analysis and model 
validation but the numbers shown in Table 2.1 are the default values.  
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Figure 2.3: The reduced version of the expanded BER model. The network presented in this figure 
represents all of the enzymes which are active during the repair of 3-methyladenine and 7-methylguanine.  
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Table 2.1: Enzymes and parameters used in the expanded model. All of the reactions necessary for the 
repair of 7-methylguanine and 3-methyladenine are included in this table. 
 
Reaction  # Enzyme Reaction Description kcat 
(min
-1
) 
Km 
(nM) 
References 
32 Aag 3-meA excision 9.9 11 [165] 
33 Aag 7-meG excision 0.4 32 [165] 
3,27 Neil1 βδ-elimination 0.0658 12.8 [166, 167] 
10 Ogg1 AP lyase 0.0532 7.2 [137] 
6 Ape1 AP endonuclease  158 35.6 [137-139, 168-173] 
25 Ape1 3'phosphodiesterase  0.03 27 [48] 
28 Ape1 3'dRp lyase 3.0 130 [48, 168] 
26 PNK 3' phosphatase 28 16 [48] 
12 Polβ gap filling  27 300 [174-177] 
15 Polβ gap filling on 5’dRp-flap 27 300 [174-177] 
16 Polβ dRp lyase on 5’dRp-flap 4.5 500 [54, 178] 
17 Polβ dRp lyase on Polβ nicked 4.5 n/a [54, 178] 
18 Polβ gap filling 27 n/a [174-177] 
20,29 Polδ gap filling (long patch 2-7 nt)  0.29 67 [179, 180] 
21 Fen1 5’ flap-endonuclease 23.4 39 [181] 
13 Lig1 ligation 0.156 3.4 [182] 
14 LigIII ligation 0.156 3.4 [182] 
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Table 2.2: Enzymes and parameters that are included in the expanded model but are not used for the repair 
of 7-meG or 3-meA. These enzymatic reactions are not tested by the experimental data collected in this 
study. 
 
Reaction 
# 
Enzyme Reaction Description kcat (min^-1) Km (nM) References 
34 Aag Hypoxanthine excision 0.42 42 [183] 
30 UDG uracil excision 9.8 146 [184] 
31 Smug1 uracil excision 0.163 1850 [185, 186] 
24 Nth1 5-hydroxyuracil excision 6.0 579 [153] 
11 Nth1 AP lyase  0.030 n/a [164] 
23 Ogg1 8-oxoguanine excision 0.3 121.5 [137, 187-
191] 
8 Ogg1 AP lyase 0.0532 7.2 [137] 
5,7 Ape1 AP endonuclease 158 35.6 [137-139, 
168-173] 
1 Neil1 β,δ elimination on 8-
oxoG 
0.0028 13.8 [192] 
2 Neil1 β,δ elimination on Ogg1 
intermediate 
0.0658 12.8 [166] 
4 Neil1 5-hydroxyuracil excision 0.0658 12.8 [166] 
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Table 2.3: The enzyme concentrations used in the model. Enzyme concentrations were assumed to be 
constant throughout the repair process and do not change during a repair simulation. 
 
Enzyme Concentration 
(nM) 
Reference 
   
Aag 38 [165] 
Neil1 830 [189] 
Ogg1 406 [121, 189] 
Ape1 2000 [48, 121] 
PNK 4061 [48] 
Polβ 419 [32, 193] 
Polδ 600 [115] 
Fen1 450 [115] 
Lig1 254 [194] 
LigIII 254 [115] 
Nth1 23 [195] 
UDG 324 * 
SMUG1 324 * 
* In the absence of other data concentration assumed equal tothe average concentration of the 
other glycosylases in the model. 
 
 
 
2.5 Michaelis-Menten kinetics 
 
 Michaelis-Menten kinetics was assumed for most of the chemical reactions in the BER 
model. The exceptions to this are the Ogg1 and polymerase β reactions in which the enzyme 
remains bound to the substrate and performs a second enzymatic step before dissociating from the 
damage site. In those cases the second step is modeled as a first order reaction: 
 
                     (2.1) 
 
where V is the reaction velocity (mol/L/s), kcat is the catalytic constant (s
-1
), and [E]o is the total 
enzyme concentration (mol/L).  
 
The Michaelis-Menten equation is derived from the following model of an enzymatic reaction: 
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                       (2.2) 
 
where S represents an un-bound substrate molecule, E represents and unbound enzyme, ES 
represents a bound enzyme-substrate complex, and P represents an un-bound product. The 
association constant and dissociation constant of the enzyme-substrate complex are represented 
by k1 and k -1 respectively. The catalytic constant is represented by kcat and relates the maximum 
reaction velocity Vmax to the total enzyme concentration. 
 
                         (2.3) 
 
         The form of the Michaelis-Menten equation used in the BER model is: 
 
         
              
      
    (2.4) 
 
where [S] is the substrate concentration (mol/L) and Km is the Michaelis-Menten constant (M). 
Although [S] represents the concentration of free substrate, not bound in the enzyme-substrate 
complex, it is assumed that: 
                                             (2.5) 
 
where [ES] represents the concentration of the bound enzyme-substrate complex (M).  
 The common form of the Michaelis-Menten equation is: 
 
        
    
   
  
   
        (2.6) 
 
where Vmax represents the maximum reaction velocity (M/s). When V = Vmax all of the enzyme is 
bound in the enzyme-substrate complex. This occurs when the substrate concentration is 
sufficiently high such that: 
 
                           
  
   
            and             (2.7)  
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The parameter Km is representative of all of the kinetic constants in enzyme reaction model. It has 
units of concentration and is equal to the [S] at which the reaction velocity is at half of Vmax.  
 
        
            
  
     (2.8) 
 
In this case the model being used to represent the enzymatic reaction assumes that there is only 
one intermediate state of the enzyme-substrate complex between substrate consumption and 
product formation. This may or may not be true for all of the reactions in the BER model. 
Regardless of the number of intermediate conformations that the enzyme-substrate complex 
passes through, the equation can always be reduced the form shown in (2.8). Km therefore can be 
treated as the effective dissociation constant for all enzyme bound species. 
 An important assumption in formulation of the BER model is that all of the reactions 
strongly favor product formation. In other words, the rate at which the enzyme-substrate complex 
dissociates to reform the original free enzyme and substrate is negligible compared to the rate at 
which the product is formed. Making this assumption allows the reaction velocity V to be 
represented as the rate of decrease in the substrate concentration. 
 
     
    
  
        
    
  
    (2.9) 
 
It follows then that with some simple algebraic manipulation and by substituting (            for 
Vmax as in (3) the Michaelis-Menten equation can be written in the form used in the BER model. 
 
      
   
   
 
    
   
  
   
       
        
      
        
             
      
   (2.10) 
 
Another assumption which is important to the BER model is that the enzyme concentrations 
remain fixed throughout the repair process. Regarding the biological aspects of this assumption, 
the time-scale of the repair process is considered too short for protein synthesis to affect the levels 
33 
 
of BER proteins during the repair event. Mathematically this implies that at low substrate 
concentrations where Km >> [S], the reaction velocity V is linear with respect to [S]. 
2.6 Coding the model in MATLAB 
 
 The code to solve the BER model was written in MATLAB. The full code for all the 
necessary functions is included in Appendix B. The model was arranged in MATLAB with one 
function containing all of the necessary parameters, which were mined from the literature, as 
listed in Tables 2.1-2.3. A second function contains all of the differential equations which 
describe the system. Model equations are displayed in Table 2.4. There is one equation for each 
possible lesion-intermediate that can form during the repair process. Each differential equation is 
defined as the sum of all of the rates affecting concentration of that repair intermediate. Each 
reaction rate is defined using Michaelis-Menten kinetics.  
 Model solutions were generated in MATLAB using the ode15s solver. The ode15s solver 
is a stiff solver. I chose to use a stiff solver because the reaction rates at different nodes of the 
model may differ by several orders of magnitude during repair.  
 Initial values for each repair intermediate in the model are generated by running the 
model for 30 minutes with a constant rate of damage formation. The model is then run from t = 0 
with the damage formation rate set to zero. It was necessary to simulate the damage formation 
rate in this manner because MATLAB does not accept conditional statements referring to 
variables while the ODE solver is running. Damage is induced in the model in this way to 
simulate the genotoxic treatment used in the comet assays of this study. Experimentally, damage 
is induced by leaving an MMS solution on cells for 30 minutes and then replacing the solution 
with fresh culture medium. In modeling the damage process this way, I have assumed that no 
further damage is induced in my cultured cells after MMS treatments have been removed. 
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 The BER model is a dynamic model described by continuous functions of time. The 
model is deterministic and spatial homogeneity has been assumed. The spatial homogeneity 
assumption overlooks the role of PARP and XRCC1 which function to coordinate BER proteins 
during repair.  To account for the effects that these proteins have on the overall repair rate the 
kinetic parameters used in the model are assumed to represent the effective kinetic parameters of 
those enzymes where the effects of XRCC1 and PARP1 on reaction rates are implicit in the rates 
calculated by the model. 
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Table 2.4: The model equations used to simulate 3-meA and 7-meG repair. 
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Chapter 3: Developing Experimental Protocols for Robust Quantitative Model 
Validation: Single Cell Gel Electrophoresis 
 
I have described in chapter 1 a rationale for studying BER and measuring DNA repair 
capacity. I have further described in chapter 2 a formal model that I created which simulates the 
flow of DNA damage through the BER pathway. The ultimate goal of this study is to use the 
model to predict the effects of changes in BER enzyme expression level on the BER capacity of 
human cells. In order to test the model and to quantify repair capacity it is necessary to be able to 
quantitatively measure DNA damage and repair in human cells. I developed a standardized 
method for experimentally measuring DNA repair in human cells, using single cell gel 
electrophoresis (SCGE) that can be used for model testing and validation. The methods and 
results of my protocol optimization are presented in this chapter. 
Briefly, SCGE, commonly referred to as the comet assay, was first performed by Ostling 
and Johanson in 1984 [196]. A modified version, performed under alkaline conditions, was 
introduced in 1988 by Singh et al. [197]. The protocol used in the current study is a modification 
of the protocol introduced by Singh et al.   It involves suspension of whole cells in a low melting 
point agarose gel. Embedded cells are lysed with a specialized buffer and exposed to a highly 
basic solution which facilitates relaxation of DNA supercoiling [198-201]. Then electrophoresis 
is applied causing DNA to migrate through the gel matrix. The quantity and distance of DNA 
migration from the cell nucleus is a function of the number of DNA single strand breaks (SSBs) 
present in the cell. Quantitative analysis is performed by assigning a score to each individual cell 
based on the quantity and geometry of DNA migration [197, 198, 202]. After electrophoresis and 
fluorescent staining, cells appear comet shaped under the microscope hence the name of the 
assay. 
I chose the comet assay as the experimental technique best suited for DNA damage 
measurement. The comet assay has several advantages as a DNA damage measurement technique 
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[203, 204]. 1) Data are collected from individual cells. Statistical analysis of a population 
response is therefore more robust than methods requiring DNA extraction. 2) The number of cells 
necessary for a sample is small (< 10,000). 3) The comet assay is more sensitive than other 
damage detection techniques such as the micronucleus assay, sister chromatid exchange (SCE), 
and alkali elution allowing for detection of lower damage levels [198, 205, 206].   
There are other potential DNA damage measurement techniques that could be considered 
for model validation experiments. One alternative method of measuring DNA damage involves 
high pressure liquid chromatography (HPLC). The comet assay is preferable to HPLC in this 
study because HPLC detects high levels of background damage. Pouget et al. report that the 
excessive background damage is result of the DNA extraction process and the comet assay was 
found to be a more reliable method [207]. Similarly any method which requires the extraction of 
DNA is prone to elevated background damage [208-210].  
 Another method for measuring DNA damage, which would also avoid DNA extraction, is 
use of antibodies which target particular damage types. This technique is used in histology to 
show regions of high damage in a tissue sample [211]. The comet assay has advantages over this 
approach as well. The cells can be treated with a damaging agent and given time to repair. Cells 
then go into the gel and are electrophoresed within 40 minutes. Thus a repair curve can be 
generated for cells that have all come from a single population. This allows sample differences to 
be attributed to treatment effects and not tissue related effects [211].  
 For these reasons the comet assay remains the most reliable means currently available to 
measure DNA damage in real time [212-214]. Moreover, the comet assay uses readily available 
reagents and does not require the use of complex laboratory instrumentation besides the 
microscope needed to view the resulting images. Raw comet data is collected in the form of 
microscope images generated by staining cells with a fluorescent dye. Quantification of those 
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images is done with specialized software. For the purposes of this study I created a novel program 
for comet scoring called Ascore. The Ascore program is discussed in detail in section 3.4. 
3.1 Experimental Methods 
3.1.1 Cell culture 
 
Jurkat cells (a human T-leukemia cell line) were maintained in RPMI-1640 medium containing 
10mM Hepes, 1mM Sodium Pyruvate, 2mM L-glutamine, 4.5 g/L glucose, and 10% fetal bovine 
serum (FBS) and 0.5mg/mL gentamicin. THP-1 cells were maintained in RPMI-1640 medium 
containing 10% FBS and 0.05mM 2-mercaptoethanol. Human embryonic kidney (HEK 293t) 
cells were cultured in Dulbecco’s Modified Eagles Medium (DMEM) with 10% FBS and 
1000units/mL penicillin and streptomycin. Cells were grown at 37°C with 5% CO2 and 95% 
humidity. 
3.1.2 Sample treatments 
 Comet samples were prepared by seeding cells in 24 well plates. 5 x 10
5
 cells per well 
were seeded 24 hours before the sample treatment. Each sample was taken from a separate well. 
MMS treatments were prepared in 1.5 mL eppendorf tubes in complete growth medium 
appropriate to the cell type. Jurkat and THP-1 samples were treated by spinning cells in a 
microcentrifuge in 1.5 mL eppendorf tubes at 2000 rpm for 2 minutes. Cells were then re-
suspended in medium containing an MMS dose and replaced in their respective wells. MMS 
treatments were left on cells for 30 minutes. Cells were placed in the incubator at 37 ˚C during 
MMS exposure. Some samples required repair time after MMS treatment. In such cases, medium 
containing MMS was replaced with fresh medium after 30 minutes of treatment time and cells 
were again placed into the incubator at 37 ˚C for the appropriate repair time. All cells were spun 
in a microcentrifuge in 1.5 mL eppendorf tubes at 2000 rpm for 2 minutes and re-suspended in 1x 
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PBS without calcium or magnesium ions prior to being embedded in low melting point agarose 
for the comet assay.  
3.1.3 Comet assay 
The comet assays in this study were performed according to the methods of Singh et al. 
with some modifications [197]. Following MMS treatment and sample specific repair time, cells 
were suspended in 1x PBS without calcium or magnesium ions at a concentration of 2 x 10
6
 cells 
per mL.  PBS with cells was then mixed into 37°C low melting point agarose from Trevigen at a 
volumetric ratio 1:10. After pipetting to homogenize mixture, 85μL of agarose containing cells 
was put onto each sample space of pretreated comet slides from Trevigen. Slides were placed at 4 
°C in the dark for 10 minutes to allow agarose to solidify. Unwinding was performed at room 
temperature for 30 minutes in the dark in freshly prepared alkali solution (1mM EDTA; 25mM 
NaOH; 300mM NaCl; pH >12.1 at room temp). Electrophoresis was carried out in a horizontal 
electrophoresis apparatus at room temperature for 10 minutes in alkali solution from the same 
batch chilled to 4°C  (pH >12.1 at 4°C). Voltage was set at 19V (1 V/cm).  Following 
electrophoresis, slides were incubated in 70% ethanol for 5 minutes in the dark at room 
temperature.  Slides were then placed in a desiccator over night before staining.  Staining was 
done with 1x SYBR green in 1x TE buffer for 15 minutes.  Slides were then washed in 1x PBS 
without calcium or magnesium ions quickly and air dried before imaging. 
3.1.4 Imaging 
All comet images were taken on a Leica DMI 4000B microscope using a Leica DFC 340 
FX camera. The imaging software used with the system was the Leica Application suite, 
Advanced Fluorescence 1.9.0 build 1633. Images were taken at an exposure time of 200ms using 
a 10x objective lens. A FITC filter set was used with a peak excitation at 495nm and peak 
emission at 519nm. 
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Some images used for scoring in this study were taken in pairs. Each image pair was collected 
without changing the focus setting or the location of the slide between images. The only 
difference between the images in each pair was the gain setting on the camera. The high gain 
images had the gain set as high as necessary to reveal all of the geometric features of the comets 
in the image. Low gain images had the gain set as high as possible without causing saturation in 
any portion of a comet which could be properly scored. Image analysis was done using software 
developed for this study. Image analysis methods are discussed in section 3.4. 
3.2 Preliminary experiments 
A series of preliminary comet assay experiments were conducted which helped to shape 
further experimental design. The preliminary comet assays tested the choice of genotoxic 
chemical, the dosage for damage induction, and the repair times necessary to observe a damage 
repair curve. No standardized comet assay protocol exists [215]. The goal of the preliminary 
comet assays was to establish experimental conditions necessary to generate a reliable, robust 
response with physiological relevance that could be used for model validation. The choices and 
experimental results are discussed below.   
3.2.1 Choice of genotoxic agent 
Initially, H2O2 was considered as a potential damaging agent in this study because it is a 
readily available oxidizing agent, which is also produced endogenously in cells. H2O2 can be used 
as a damaging agent because it initiates a reaction cascade that ultimately damages DNA [1]. 
Fenton reactions involving H2O2, first described by Henry Fenton in the 19
th
 century [216], are 
thought to be the main source of ROS induced DNA lesions [1]. After consideration, H2O2 was 
rejected in favor of MMS. There are a variety of lesions induced by H2O2 treatment which would 
complicate the interpretation of experimental data using the BER model [1, 217].  
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 In contrast, MMS produces predictable patterns of damage when used as a damaging 
agent. MMS is a mono-functional and direct acting DNA alkylating agent. It creates DNA lesions 
through direct chemical activity with bases and has only one reactive site per molecule [1, 218].  
The alkylation damage created by MMS is primarily composed of two lesion types: 7-
methylguanine (7-meG) and 3-methyladenine (3-meA) in predictable ratios [1, 62, 68, 219]. 
Repair of both 3-meA and 7-meG is initiated by the glycosylase Aag. Because the damage 
patterns of MMS are predictable and repair of both major MMS induced lesions is initiated by the 
same glycosylase, use of MMS as a genotoxic agent instead of H2O2 facilitates the interpretation 
of experimental data using the BER model. 
3.2.2 Choice of MMS dosage and repair time 
 Preliminary comet assays were carried out to determine an appropriate MMS dosage 
range and sufficient range of repair times for the comet assays in this study. I chose to use 30 
minutes as the standard dosage time for MMS treatments throughout this study because I sought 
to reduce the protocols to the minimum necessary timeframe. In the literature, MMS exposure 
time in comet assay studies ranges from 30 minutes to 4 hours [218, 220-223]. Minimization of 
the dosage duration is important because while damage induction is taking place, BER is also in 
progress. So, the final resulting damage level will be a convolution of the damage induced by 
MMS exposure and the function of the BER pathway repairing the damage, both of which vary 
dependent on time. This is an unavoidable source of error in comet assays with chemically 
induced damage because DNA damage cannot be generated instantaneously (with the exception 
of intense radiation, which would generate double strand breaks that are repaired by other 
pathways [1, 224-226]). 
 The preliminary comet assays were carried out using THP-1 and Jurkat cells according to 
the protocols described above. Four comet assays were carried out, one for each repair time 
which was tested: no repair time, 1hr, 2hr, and 4hr. Repair time was measured starting 
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immediately after the MMS dose was removed from the cells. Each experiment had the following 
samples: untreated control, 0.6 mM MMS, 1.2 mM MMS, and 2.4mM MMS. Each of the 4 doses 
were applied to Jurkat and THP-1 samples for a total 8 slides with duplicate samples on each 
slide. The range of damage inducing MMS doses for comet assay measurement that I found in the 
literature was between 10µM and 500µM MMS dissolved in either DMSO or cell culture medium 
[220-223]. The optimum dosage range should produce repairable damage in quantities 
measureable by the comet assay. Because I used a dosage time of 30 minutes which is shorter 
than typical MMS dosage times for comet assays, I tested a MMS doses in a higher range and 
found them adequate for the purposes of the current study. The results of the preliminary comet 
assays are presented in Figure 3.1 below.  
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Figure 3.1: Preliminary comet data from Jurkat and THP-1 cells plotted against repair time in hours. In 
each sub-plot the three separate curves represent samples treated with different MMS doses. Blue with ‘o’ 
data markers indicate a 2.5 mM MMS dose. Red with ‘ * ‘ data markers indicate a 1.25 mM MMS dose. 
Green with ‘ . ‘ data markers indicate a 62 5µM MMS dose. A) Jurkat % tail DNA scores. B) Jurkat tail 
moment scores. C) THP-1 % tail DNA scores. D) THP-1 tail moment scores.  For each cell type the two 
different types of comet scores were generated from the same data set. Error bars show standard error. 
 
 
 
 Results from the preliminary comet assays are presented for Jurkat and THP-1 samples as 
% tail DNA scores and tail moment scores. Both comet score types are equally informative for 
this data set. Each sample was normalized to the mean untreated control score from its respective 
experiment. Jurkat cells were able to repair nearly all of the damage induced by each MMS dose 
given four hours repair time. THP-1 cells were only able to significantly repair the damage from 
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the low MMS dose (0.6 mM MMS) and the majority of the repair occurred within the first hour. 
For the THP-1 cells 1.2 mM and 2.4 mM MMS doses induce irreparable damage loads.  
 The results of the preliminary comet assays show several things. There is a difference 
between the repair capacity of the THP-1 samples and the Jurkat samples. The MMS doses used 
in these experiments are within a useful range for demonstrating differences between the base 
excision repair capacity of cell populations. The differences between repair curves are most 
readily observable within the first two hours of repair. Although the Jurkat cells were able to 
repair the highest doses of MMS, the THP-1 were not. The low MMS dose is more appropriate 
for capturing the behavior of the repair curve. The higher MMS doses created an overdose 
situation in the THP-1 populations and as a result the repair process cannot be measured in those 
samples. Further comet assays in this study were run using MMS doses in the range tested here 
and repair curves were generated with more time points in a range of 0 to 90 minutes.  
3.3 Comet Scoring/damage quantification 
3.3.1 Motivation for development of comet scoring code 
  One of the difficulties of using the comet assay is quantification of the damage which the 
assay detects. During electrophoresis, the DNA of each cell embedded in the agarose gel is 
subject to electromagnetic force which will cause damaged DNA to migrate out of the cell 
nucleus forming a shape which resembles a comet [198, 227]. See Figure 3.1. The quantity and 
geometry of the DNA which has migrated into the tail region of the comets is a function of the 
number of DNA strand breaks and alkali labile sites present during the alkali unwinding step of 
the experiment [205, 227, 228]. 
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Figure 3.2: An image of a typical comet with labeled parts indicated by pink asterisks. The four features 
identified in this figure are the basic features that must be identified in order to generate all of common 
comet scores. 
 
 
Quantification of comet assay results is done by analysis of fluorescent images taken from comet 
slides. Before imaging, slides are stained with SYBR Green dye (or another DNA adhesive dye) 
which binds to DNA and is visible using a FITC filter [229, 230]. One of the assumptions of the 
comet assay is that SYBR green dye binds uniformly to DNA, therefore fluorescent brightness is 
assumed linearly related to DNA quantity. Each cell in the image is selected using specialized 
software and given a score quantifying its damage level. There are multiple types of scores 
sometimes referred to as comet parameters which are regularly reported in the literature. The 
most commonly reported comet parameters are % tail DNA, tail length, tail moment, and Olive 
moment [231].  
 The lack of general agreement on which comet parameter is most important has been 
cited as one of the drawbacks of the comet assay [205]. This lack of standardization does create 
difficulties in comparison between studies. But no one method appears to be appropriate for all 
comet assays [203, 205, 231-233]. Likewise, methods of scoring comets are not standardized 
[231]. The software used to quantify comet data varies from free downloadable software to 
commercialized systems which are fully automated. Visual scoring methods have also been used 
and are reportedly effective although subject to variability between human scorers [202, 234]. 
Due to the nature of the study, a robust, software-based measurement strategy free of the 
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subjective influence of the scorer was necessary. I developed novel comet scoring software in 
MATLAB 2010a which collects a score for each of the commonly used comet parameters from 
each cell that is scored. The software will be referred to as Ascore hereafter. 
Commercially available software packages may be effective but are not always financially 
practical or necessary. Free software options on the other hand tend to be limited in functionality. 
Also, there are no free comet-scoring programs with open source code. When a score is generated 
for a comet, features such as the head, tail, head-centroid, and tail-edge must be identified based 
upon assumptions of the comet shape and relative DNA distribution. Figure 3.2 shows how comet 
geometry can vary as damage level increases. In some cases, such as with heavily damaged cells, 
those features can be distorted and may give rise to a defective score if the assumptions about the 
geometry of the comet are not modified. For example in a heavily damaged cell the tail DNA may 
migrate far enough that it is disconnected from the comet head. If an assumption is used in the 
algorithm that assumes continuous distribution of DNA across the entire comet, the boundary of 
fluorescent pixels would be recognized as the comet edge. In that case the disconnected comet 
head may be scored incorrectly as an undamaged cell. Without open source code in the free 
comet scoring programs there is no way to determine whether an algorithm accounts for all the 
types of comets that can arise in comet samples. 
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Figure 3.3: A series of comets showing increasing damage levels. Grayscale has been inverted to make 
comets more easily visible. A) An undamaged cell. B) A mildly damaged cell with a faintly visible tail. C) 
A typical comet. D) A typical comet with more damage than image C. Note that the tail length is not 
appreciably different but tail intensity is stronger than image C. E) A typical comet more heavily damaged 
than image D. As damage increases, head radius tends to shrink and comet tail becomes wider and more 
intense. F) A heavily damaged comet. Tail length is scarcely longer than images C, D, or E. Teardrop shape 
of tail is distinct. Very little DNA is left in the comet head. The fraction of total DNA that has migrated to 
the tail region of the comet is much higher in image F than in the others. 
 
 
3.3.2 Description of the Ascore Algorithm 
 
 Ascore is the novel comet scoring code used for quantification of comet images in this 
study. It was written in MATLAB version 2010a. The following is a description of the steps 
involved in the scoring algorithm. 
1. A comet image is loaded by the user. The images must be grayscale bitmaps. The user is 
presented with the image and must then select a sub-image to score. The sub-image is selected 
with the mouse. The sub-image is rectangular and must incorporate one and only one comet for 
scoring.  
 
2. Background thresholds are set for each sub-image. Keyboard input is used to increase or 
decrease background cut-off threshold. If the full image has homogeneous background 
A B C 
D E F 
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fluorescence, automatic background removal can be implemented in which case the user defines 
the background threshold for the whole image at the start of the scoring algorithm. In general the 
necessary background threshold differs across a comet slide image and must be adjusted 
manually for each comet scored. Figure 3.4 presents an example of an image with non-
homogeneous background fluorescence.  
 
 
Figure 3.4: A comet image with non-homogeneous background fluorescence. For an image of this type it is 
necessary to manually specify the background threshold on a cell by cell basis. 
 
 
3. The center of the comet head is identified and the head radius is measured. First the center of 
the comet head is identified by setting all pixels at less than 85% of maximum intensity to zero. 
This default threshold can be set to any value necessary by the user. The resulting sub-image is 
then passed to a function which identifies the centroid of the image. The preview window 
(described below) will display any error in head-centroid detection allowing manual override. In 
this case, the sub-image is presented to the user and a single mouse-click on the center of the head 
will define that point as such. With the center of the comet head defined, the program will 
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iteratively check each pixel to the right of the head center. When it reaches a pixel with a value 0, 
the distance between it and the center is defined as the radius of the comet head. 
 
4. Head and tail regions are defined and tail centroid is located. Every pixel which is less than one 
head radius length to the left of the center of the comet head is set to zero. The result is a new 
sub-image in which only the tail of the comet remains. This sub-image is then passed to the 
function which finds the centroid of an image. This function returns the coordinates of the tail 
centroid.  
 
5. Centroid migration distance is calculated. Once the head centroid, tail centroid, and head radius 
have been defined, the algorithm calculates the distance of tail-centroid migration in pixels as the 
distance between the tail centroid and the left edge of the comet head. 
 
6. The percentage of DNA in the tail is calculated as the percentage of total fluorescent intensity 
in the tail region of the comet. The percentage of tail DNA is calculated as the total tail intensity 
divided by the total comet intensity. Any comet with no tail is given a score of zero at this point. 
 
7. Comet scores are calculated from the basic comet measurements. The program returns and 
stores the % tail DNA, tail length, tail moment, tail-centroid migration distance, Olive moment, 
and head radius for each comet scored.  
 
8. User selects another comet for scoring. After scores are generated for a comet the full comet 
slide image is presented again. A number is displayed over each scored comet to prevent 
recounting a scored comet.  
 
50 
 
9. The data for the entire image is written to a comma separated values (CSV) file after the 
program is terminated by the user. 
3.3.3 Additional Features 
There are additional features in the Ascore program which increase its utility. 
1. The preview window:  After a comet is scored, a set of sub-images is displayed in the preview 
window. The comet is displayed in its original form, with background fluorescence removed, and 
with only the tail region showing. The centroid and edge of both the head and tail region are 
marked on the sub-images. All of the comet parameters reported by Ascore are derived from the 
measurements displayed in the preview window. The preview window therefore allows the user 
to determine whether comets have been properly scored by the algorithm. Figure 3.5 shows the 
sub-images presented in the preview window. 
 
2. Manual score cancellation:  After the scored comet is displayed in the preview window but 
before a new comet is selected, manual score cancellation can be used to keep that score out of 
the final data set.  
Two cases arise where Ascore will automatically cancel a comet score. At least one column of 
pixels set to an intensity level of zero (during background elimination) must be between the 
comet head and the edge of the sub-image, or else the algorithm cannot mark edges and will 
reject the score. The situation occurs when either the comet has been cropped during selection, or 
when the background threshold has been improperly selected and some of the background was 
not set to zero.  In both cases the user will be informed of the cancellation in the MATLAB 
command window.  
 
3. Manual comet-head centroid identification:  Automatic head centroid location is a default 
operation for the Ascore code. However, if automatic head-centroid identification is unsuccessful 
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it will be evident in the preview window.  Automatic head identification can be overridden if 
necessary for an individual cell or the entire slide. 
When manual head definition is activated, the head-centroid identification window will display 
an enlarged view of the comet sub-image and the user can place crosshairs over the center of the 
comet head with the mouse and select that point with a single mouse-click. If an error is made it 
will be visible in the preview window, the score can be canceled, and the comet can be re-scored. 
The head-centroid identification window is shown in Figure 3.6. 
Automatic head-centroid detection in this software is dependent on the assumption that the head 
is the brightest region of the comet. The intensity threshold is user defined. Comets which have 
their brightest region located in the tail can only be correctly scored if the manual head-centroid 
identification is used in the scoring process. Other comet types, ghost comets (explained below), 
comets with disconnected heads, and overlapping comets cannot be scored properly with Ascore 
and therefore should not be represented in data sets. Comets with disconnected heads are formed 
when a small fraction of DNA remains in the head region and there is no longer a continuous 
distribution of detectable DNA between head and tail regions. Comets of this type are considered 
damaged beyond the range of quantification by this method.  
 Ghost comets form from heavily damaged cells. They are many times larger than normal 
comets and appear comet-like in shape but are only faintly visible; hence the name [235]. Ghost 
comets tend to overlap each other significantly and lack heads because all detectable DNA has 
migrated away from the site of the cell nucleus. Figure 3.7 shows three ghost comets. Ghost 
comets cannot be scored properly and are not included in data sets.  
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Figure 3.5: The preview window is shown above. It displays the changes that the algorithm makes to the 
sub-image of the selected comet. A) The unaltered sub-image. B) The sub-image after background 
fluorescence has been removed. C) The tail segment isolated from the rest of the comet. Pink asterisks are 
shown (from left to right on each sub-image) at the tail edge, tail centroid, head centroid, and head edge. 
All of the scores reported by Ascore can be calculated from the information presented in the preview 
window. 
 
 
 
Figure 3.6: The manual head-centroid selection window is shown above. The window displays the selected 
comet in an enlarged view. The user must use the mouse to place the crosshairs over the center of the comet 
head. A single click selects the point as the head-centroid. The default algorithm assumes that the brightest 
part of a comet is in the center of the head. This is generally true. Only heavily damaged cells form comets 
in which the tail is the brightest part. Once all of the DNA detectable by fluorescent imaging has migrated 
to the tail, the cell cannot be scored as a comet. 
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Figure 3.7: This image shows comets which have nearly become ghost comets. A) A normal comet with a 
damage level that is within the quantifiable range of the assay. B, C, and D) Comets so heavily damaged 
that no detectable DNA is left in the head. More damage or more electrophoresis time would have caused 
the exaggerated tails to expand even further creating large diffuse ovals called ghost comets which cannot 
be quantified. 
 
 
3.3.4 Parameters reported by Ascore 
 Ascore reports the most common comet parameters: tail length, percent tail DNA, tail 
moment, and Olive moment. It also calculates a novel comet parameter called the synthetic 
moment. The synthetic moment is a variation of the Olive moment in which two duplicate images 
with different gain settings are used to calculate the Olive moment product. The synthetic 
moment scores were used to test the robustness of the Olive moment scores with respect to gain 
settings during image acquisition. The synthetic moment will be discussed in greater detail below.  
 The comet measurements collected and reported by Ascore are: percent tail DNA, 
distance of tail centroid migration, tail length, and head radius. Percent tail DNA can only be 
A 
B 
C 
D 
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calculated for the low gain image (which is not saturated), but the other three measurements are 
reported for both the high and low gain versions of each comet. The other scores reported, 
calculated from those 4 basic measurements, are the Olive moment, synthetic moment, and tail 
moment. Each of these parameters can be used to measure differences between the levels of DNA 
damage in different cell populations. However, each of these scoring parameters focuses on 
certain aspects of the comet image and excludes others. 
 The percentage of DNA located in the comet tail (%tail DNA) increases as DNA strand 
breaks and alkali labile sites increase.  DNA percentage measurements are based on the 
assumption that SYBR Green dye binds uniformly to DNA and therefore that the distribution of 
intensity across the comet image reflects the distribution of DNA in the gel. Once the comet is 
segmented into head and tail regions, the percentage of the total comet intensity that is located in 
the tail is calculated as the % tail DNA. 
 Tail length is one of the easiest comet scores to measure and has been effectively used as 
a measure of DNA damage in some studies. In some cases comet length (tail length + head 
length) is used instead of tail length [236]. The distinction has no effect on the data interpretation; 
it simply introduces a shift in the data set. However, the tail length has been shown to have a 
limited range of sensitivity. Tail length tends to saturate after a damage threshold is reached [203, 
237]. 
 Tail moment is the product of tail length and % tail DNA [205, 238]. It is used because it 
takes into account the amount of DNA that has migrated into the comet tail as well as how far 
that DNA has migrated. Using the product of the two basic measurements is intended to make the 
score more robust. Lee et al. report that the tail moment has greater uniformity in quantile 
dispersion plots than % tail DNA and consider tail moment the more reliable measure of damage 
[205]. 
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 The Olive moment is a modification of the tail moment. The Olive moment is the product 
of %tail DNA and the migration distance of the tail centroid. Tail centroid migration distance is 
used because it is considered more robust to saturation than tail length alone. The reason is that 
the fragments of DNA that migrate during electrophoresis in the comet assay vary in size. The 
smallest fragments move with the highest velocity through the gel. Therefore, tail length is a 
function of only the migration distance of the smallest fragments. Centroid migration distance 
however, is a function of the migration distance of all DNA fragments [228, 236]. 
3.3.5 Novel comet score: the synthetic moment 
 The synthetic moment is a novel comet score developed for this study. It is a variation of 
the Olive moment. The synthetic moment, like the Olive moment is the product of the migration 
distance of the tail centroid and %tail DNA. The difference is that the two measurements are 
taken separately from a pair of images. The images are identical except for the gain setting. 
Tail-centroid migration distance depends on the geometry of the comet tail which can be 
affected by how high the gain is set during image capture. If scores are collected from a single 
image, increases in gain setting are limited by the saturation of comet heads. Because of the large 
dynamic range of a typical comet image, the gain setting which makes the full shape of the comet 
tails visible often causes saturation in the comet heads. If there is saturation in the comet heads 
then the %tail DNA cannot be measured.  
The synthetic moment scores were collected in order to test the robustness of the Olive 
moment scores to gain setting during imaging. Synthetic moment scores are collected from a pair 
of images: a low-gain image with the gain set as high as possible without causing saturation on 
any score-able comets and a high-gain image in which the gain was set as high as necessary to 
visually reveal the full geometry of the comet tails. An example of a pair of comet images taken 
with low and high gain settings is shown in Figure 3.8. 
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I wanted to test whether capturing the full tail geometry would affect the centroid 
migration measurements and increase the sensitivity of the synthetic moment compared to the 
Olive moment. When calculating the synthetic moment the tail centroid migration distance is 
measured from the high-gain image and %tail DNA is measured from the low-gain image. By 
measuring tail centroid migration and %tail DNA in separate images, the limit on gain setting 
imposed by the dynamic range of the comets is eliminated.  
The six comet parameters described above: %tail DNA, tail length, tail moment, centroid 
migration distance, Olive moment, and synthetic moment were collected for every comet scored 
with the Ascore program. Due to the lack of consensus in the literature concerning the best comet 
parameter to use in data analysis, it was necessary to evaluate all of the choices. The results 
obtained with each major comet parameter are presented below in section ###. 
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           A            B 
 
Figure 3.8 A) An image of a typical comet slide. Gain setting on this image is as high as possible without 
saturating any portion of a score-able comet. B) A duplicate of image A except the gain setting is as high as 
necessary to reveal all of the geometric features of the comets. 
  
 
3.3.6 Comparison between the Olive moment and the synthetic moment 
Dose response data from Jurkat comet assays was collected using the Ascore program. 
Figure 3.9 shows mean values for Olive moment scores and synthetic moment scores. Dose 
response is shown after 90 minutes, 60 minutes and 0 minutes of repair time. Both data sets come 
from scoring the same cells. Every Olive moment score has a corresponding synthetic moment 
score generated from the same comet.  
In general, for the damage ranges investigated in this study, the synthetic moment presents no 
advantages over the Olive moment. The Olive moment was found to be robust to changes in the 
gain setting during imaging. Figure 3.9 shows little difference between the synthetic moment 
scores and the Olive moment scores though the mean synthetic moment scores tend to be slightly 
higher. This is likely caused by extra centroid-migration distance measured in the high-gain 
images used to generate synthetic moment scores. No statistical significance between the score 
types could be shown. Student’s t-test was used to compare the Olive and synthetic moment 
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scores at each dose and repair time. The t-test was run using the MATLAB 2009a ttest2 function. 
Using α = 0.05, the null hypothesis that the Olive and synthetic means were equal could not be 
rejected for any samples. Error bars showing standard error were excluded from this plot because 
the error bar ranges are all smaller than the data markers.  
  
 
Figure 3.9 Jurkat dose response data. A) 0min repair data, B) 60min repair data, C) 90 min repair data. Data 
sets are displayed as both Olive moment and synthetic moment scores. Synthetic moment scores are 
indicated by solid red lines and Olive moment scores are indicated by dotted blue lines. Olive moment and 
synthetic moment data show negligible differences over the whole dosage range and at all repair times. At 
each MMS dose and each repair time Student’s t-test was used to test the null hypothesis that the Olive 
moment and Synthetic moment means are equal, α = 0.05. Null hypothesis could not be rejected for any 
sample. Standard error bars were excluded from this graph because at all points the size of the data marker 
symbols exceeds the range of the error bars. Student’s t-test was run using the MATLAB 2009a ttest2 
function. 
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3.3.7 Comparison of dose-response measured with each comet score 
 
The choice of %tail DNA as the optimum comet score for data analysis in this study was 
based on the dose response data from the Jurkat comet assay with 0 minutes repair time. Results 
are presented in Figure 3.10. Data for each score type were generated from the same cells. (i.e. 
every %tail DNA score has a corresponding score of each other type taken from the same cell.) In 
order to evaluate the usefulness of each score type, only data from samples given no repair time 
were used. Once cells have been given the chance to begin repair, the complexities of the repair 
process are likely to mask differences between the score types because the rate of BER is non-
linearly related to damage concentration. Standard error bars were left out of all of the graphs 
because all samples had error bar ranges smaller than the size of the data markers. 
Damage levels measured as tail length and centroid migration tend to saturate as dose 
increases. Synthetic moment, Olive moment, tail moment, and %tail DNA all increase linearly 
with respect to increasing MMS dose. Linear regression was used to find the best fit lines for each 
parameter which showed a linear dose response. Regression analysis was performed with the 
curve fitting tool in MATLAB 2010a. Table 3.1 shows the R
2
 value, slope, range, and sensitivity 
of the fit line for each of those parameters. 
Based upon the results shown in Figure 3.10 and Table 3.1 %tail DNA was chosen as the 
best comet parameter to use for data analysis in this study. Tail length and centroid migration 
distance were not used because they begin to saturate as MMS dose increases within the linear 
range of the other parameters. Among the other four parameters, % tail DNA is the simplest 
measurement. Tail, Olive, and synthetic moments are all products of % tail DNA and either tail 
length or centroid migration distance. The sensitivity of each parameter was calculated by 
normalizing the slope of the best fit line to the range of the data. All four parameters which gave a 
linear dose response have the same sensitivity level. Since tail moment, synthetic moment, and 
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Olive moment are all products of % tail DNA and there is no difference in the sensitivity of those 
parameters to damage detection, there is no reason to use those parameters. It is only because the 
%tail DNA data is robust, that the best fit curves for the moment scores are linear. The moment 
scores are all generated by multiplying the % tail DNA scores by either tail length, or centroid 
migration distance, both of which tend to saturate. Based on these results, % tail DNA was the 
parameter of choice for all subsequent comet data analysis in this study. 
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Figure 3.10: Dose response curves for Jurkat 0min repair comet data. All six score types represent the same 
data set. Scores are plotted against MMS dose (mM) A) %tail DNA, B) tail moment, C) tail length, D) tail-
centroid migration distance, E) synthetic moment, F) Olive moment. Fit lines for A, B, E and F are shown 
in red and were generated in MATLAB 2009a using the curve fitting toolbox. 
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Table 3.1 Regression results for all of the comet parameters showing a linear dose response with 0 min 
repair time. Regression analysis was run using the curve fitting tool in MATLAB 2009a. Sensitivity is 
calculated as the slope/range for each score type which showed a linear dose response. 
 
Comet parameter R
2
 slope range sensitivity 
% Tail DNA 0.97 0.29 0.64 0.45 
Tail moment 0.98 15 32.69 0.46 
Synthetic moment 0.98 6.5 14.48 0.45 
Olive moment 0.98 6.4 14.36 0.45 
 
 
3.4 Discussion of experimental protocol development 
 
 Experimental model validation requires methodology for robust and reproducible data 
measurements. The goals of this portion of the study were to 1) develop experimental protocols 
that would allow the measurement of the BER response to genotoxic insult, and 2) develop a 
method for quantification of that raw data. The comet assay has become a widely used 
experimental technique for the measurement of DNA damage and repair. However, no 
standardized protocols have been established for the assay in general and comet data has not 
previously been collected for the purpose of validating a quantitative BER model.  
To accomplish the first goal I established an experimental protocol which allowed me to 
measure a biologically relevant response which could be compared to model predictions. To this 
end MMS was chosen as the genotoxic agent and a damage-dose and exposure-time were chosen 
which would generate a damage load both measureable and repairable. A 30 minute exposure to 
0.6 mM MMS was found to generate a damage load small enough to be repairable but large 
enough to show a graded measureable change over a 90 minute interval. The ability to measure 
the change as the damage load is repaired is critical to the model-data comparison which is the 
ultimate goal of this study. 
 The timescale on which base excision repair takes place is such that repairable genomic 
damage levels are expected to clear within minutes or hours rather than days. Therefore, the 
comet assay protocols used in this study were chosen to minimize the time between damage 
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induction and sample electrophoresis. Given that criterion for protocol optimization, each step in 
the protocols was conducted in the shortest effective timeframe. With the exception of the lysis 
step all comet assay steps were conducted for the minimum recommended time in the Trevigen 
protocols. Following sample treatment the duration of comet assay steps was 10 minutes of 
cooling time at 4°C for LM agaraose, 30 minutes of alkali unwinding, 10 minutes of 
electrophoresis, and 5 minutes of DNA fixation in 70% ethanol. The only step which was 
significantly altered from the Trevigen protocols was the lysis step. 
Duration of the comet assay lysis step varies between studies from 40 minutes to overnight [219, 
237]. I found no studies in which the lysis step was eliminated from the comet assay protocols. 
However, the lysis step was found to have no effect on the outcome of the comet assays 
performed in this study (data not shown). The lysis step was therefore eliminated in order to 
minimize the time between sample treatment and electrophoresis. 
 To accomplish the second goal, development of a method for quantification of raw comet 
data, the novel comet scoring code Ascore was created. Ascore has advantages that make it the 
ideal software for data collection in this study. It is designed to accurately score comets that may 
vary significantly in their geometry. It allows the user to monitor the scoring process via the 
preview window and to cancel inaccurate scores from the data set. The code is open source and 
easily modified. It generates a novel score: the synthetic moment. And it allows selective use of 
manual or automatic features on a cell by cell basis.  The trade-off is that scoring large data sets is 
inefficient. Lack of automation is the main limitation of Ascore. 
 The work presented in this chapter represents a critical step in the validation of the BER 
model. I established reliable methods for measuring a BER response to a genotoxic insult. I 
established a software based method for quantification of experimental results which will allow 
comparison of experimental data and model predictions. Modified experimental protocols were 
established to cope with the inevitable convolution of the damage and repair processes during 
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damage induction. Namely protocols were established to minimize the time between initial 
exposure to the genotoxic agent and the completion of the assay. The methods established in this 
chapter were used for the remainder of the study to generate the data used in model validation. 
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Chapter 4: Developing Experimental Protocols for Robust Quantitative Model 
Validation: Protein Knockdown 
 
4.1 Polymerase β Knockdown introduction 
 
 I have described in detail the creation of a formal BER model as well as a method for 
quantitatively measuring DNA damage using the comet assay. In order to test the predictive 
capabilities of the model, I introduced a perturbation to the BER pathway of the human cell line 
HEK 293t. I wanted to test the BER response of cell lines, which differ as little as possible from 
each other aside from a single change to the BER pathway. To run such experiments I created 
293t cell lines with reduced expression of a BER enzyme. I used RNA interference (RNAi) to 
create three different Polβ knockdown cell lines. I then used western blotting to confirm and 
quantify Polβ knockdown. Comet data were collected from both the normal 293t cells and the 
293t knockdowns. Repair curves were generated from that comet data. The detailed analysis of 
that comet data using the BER model is described in chapter 5. 
 In order to attempt model validation, it is necessary to measure the system response 
following controlled, measureable change to a system parameter. Under the assumptions of 
Michaelis-Menten kinetics this requires that either the kinetic constants or the expression level of 
a BER enzyme must be altered. Introducing change to the kinetic constants of an enzyme could 
be done in two ways: 1) Genetic modification of a cell line or 2) use of an enzyme inhibitor 
specific to the BER pathway. Neither approach is satisfactory for the goals of this study. Genetic 
modification of a cell line is non-trivial and even the kinetic constants of the known naturally 
occurring functional variants have yet to be characterized. Regarding enzyme inhibition there are 
no validated pathway inhibitors that may not have other complicating effects on system behavior. 
Furthermore the effective kinetic parameters resulting from the influence of an enzyme inhibitor 
could not be measured in a satisfactory manner. Therefore I opted to change the expression level 
of a key BER enzyme using RNAi which has several advantages. RNAi has specific inhibitory 
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function due to the nature of its action. An interfering RNAi strand matches its target and can 
inhibit no other protein expression. Furthermore there are established experimental techniques (in 
this case Western blotting was used) available to measure the change in protein expression 
introduced by RNAi. This is important for model validation. I wanted to change only one 
parameter and I wanted to be able to quantify that change. 
 Polβ is known to be a critical enzyme for overall DNA repair functionality (including 
BER, NER, and SSB repair) [96, 123, 239-241]. Polβ was chosen as the RNAi target for several 
reasons. 1) Polβ 5’ dRp lyase activity has been identified as the rate-limiting step in BER, 
although conflicting reports have been published [8, 54-56, 104]. 2) Polβ expression changes 
have been found in cancerous tissue, linking Polβ specifically with the disease [31, 32, 57, 58]. 3) 
Polβ expression changes have been shown to induce genomic instability [30, 31, 59-61]. 
Therefore quantification of the effects of knockdown on overall BER pathway performance has 
potential clinical relevance. And finally, for practical reasons: five different Polβ knock-down 
constructs were available to me from the RNAi resource library of Dr. Saunders in the Drexel 
Bioscience department. RNAi resources are not available for all BER enzymes. 
 The choice of cell type for RNAi was HEK 293t (Human Embryonic Kidney 293T/17) 
cells. HEK 293t cells are an adherent, epithelial cell type. The 293t cells used in this study were 
obtained from the American Type Culture collection (ATCC). HEK 293t cells are a highly 
transfectable derivative of HEK 293 cells which have a SV40 T-antigen gene inserted [242]. 
A549 cells were also considered as a possible choice. A549 cells are derived from human lung 
carcinoma tissue. HEK 293t cells were ultimately chosen because all of the viable RNAi 
constructs were successfully transfected into 293t cultures. I was unsuccessful in transfecting any 
of the RNAi constructs into A549 cultures. The details of the transfections are presented in the 
next section. 
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 Western blotting was used to confirm and quantify the change in Polβ expression effected 
by RNAi on the 293t cultures. Quantitative western blotting has been used in a variety of studies 
[32, 48, 189, 239, 243-248]. There are two major categories of techniques available for 
quantitation of specific proteins in a cell culture: antibody labeling and mass spectrometry [249, 
250]. Mass spectrometry is more sensitive and would likely yield higher quality data [249, 251, 
252]. But mass spectrometry requires expensive instrumentation and establishment of protocols is 
more difficult [251, 252]. For those reasons mass spectrometry was not a feasible option for this 
study. Although there are other antibody based detection alternatives to western blotting, such as 
the ELISA assay [253, 254], the western blot presents a distinct advantage. Antibody labeling is 
subject to the generation of background signal due to non-specific antibody-protein binding 
[252]. Hence western blot protocols involve a blocking step intended to saturate non-specific 
binding sites. Because the western blot involves 2D polyacrylamide gel electrophoresis (PAGE), 
proteins are separated by weight before blotting and protein detection. Thus the detection signal 
(chemiluminescence in the current study) is associated with a molecular weight. This gives a 
much needed metric by which to determine whether the origin of the signal is the protein of 
interest.  
All of the western blots in which Polβ was successfully detected in this study were 
conducted with Abcam primary antibody. The western blot protocols used in this study were 
based on the protocols supplied by Abcam [255]. However, extensive modification and 
optimization were necessary in order to detect and quantify Polβ. The series of western blots used 
for protocol optimization are presented and discussed in detail in section 4.3 following the 
discussion on RNA interference. 
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4.2 RNAi Background 
 RNA interference (RNAi) is regulatory pathway which allows the post-transcriptional 
silencing or knockdown of protein expression by triggering the degradation of mRNA in 
eukaryotic cells [256, 257]. RNAi also refers to the newly developed techniques used to exploit 
that pathway and trigger the knockdown of specific proteins in vivo [258]. Since its discovery it 
has been used extensively in the study of cellular function and many promising therapeutic uses 
are under investigation although specific delivery to target cells remains a challenge [258-261]. 
 RNA interference (RNAi) was first discovered in the nematode worm Caenorhabditis 
elegans. C. elegans exhibit a response leading to sequence specific gene silencing when treated 
with double stranded RNA (dsRNA) [262, 263]. From this discovery techniques for gene 
silencing in a variety of organisms were developed which make use of short-interfering RNA 
(siRNA). siRNA are short RNA sequences which trigger the gene-silencing response because 
after cellular processing they closely resemble the form of the dsRNA interference triggers. 
However, RNAi techniques which make use of siRNA were of little use in studies mammalian 
cells. The mechanisms by which many organisms amplify the siRNA signal and thereby silence 
sequence specific genetic expression are lacking in mammalian cells [264]. In addition, 
mammalian cells have a non-specific response to dsRNA exposure which essentially blocks the 
transcription of dsRNA and precludes the use of typical dsRNA for gene silencing [265, 266].   
 In order to achieve stable RNAi in mammalian cells short-hairpin RNA (shRNA) 
techniques must be used [267, 268]. shRNA is a precursor to siRNA in mammalian cells [265]. 
shRNA strands do not elicit the anti-viral response initiated by protein kinase PKR which 
degrades most dsRNA. Even so, effective, stable gene-silencing in mammalian cells requires a 
different method of delivery to the cells than the techniques used in other organisms. Although 
mammalian cells accept shRNA strands and exhibit gene-silencing behavior in response to such 
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treatments, the cells still lack the siRNA signal amplification process which makes siRNA so 
effective in many invertebrates [263, 266, 268].  
 In order to achieve stable gene-silencing in mammalian cells additional steps are 
required. Briefly, an oligonucleotide which codes for the appropriate shRNA is incorporated into 
a plasmid vector [269]. The plasmids themselves are amplified in bacterial culture and then 
extracted. The plasmid DNA is then transfected into a mammalian cell culture. The plasmid must 
code for both the shRNA strand necessary for sequence-specific gene-silencing and for a 
resistance marker [269]. For the plasmids in this study the marker coded for resistance to 
puromycin. Puromycin is lethal to mammalian cell cultures that lack the specially transfected 
resistance marker [270]. Thus, after transfection has taken place, puromycin selection ensures that 
any cells which continue to grow and divide in the culture contain the plasmid and therefore are 
expected to produce the shRNA of interest. 
4.3 RNAi transfection 
 Five shRNA constructs for RNAi knockdown of polymerase β (Polβ) were obtained from 
the RNAi resource library of the Drexel Department of Bioscience and Biotechnology. The RNAi 
resource center provides constructs from the Expression Arrest™ human shRNA library by Open 
Biosystems. The constructs available for RNAi knockdown of Polβ are listed in Table 4.1 and 
will be referred to hereafter by the arbitrary construct numbers assigned to them here.  
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Table 4.1: The RNAi constructs listed by Expression Arrest™ catalog number. Concentration of the stock 
plasmid solutions extracted from the E. coli cultures is shown. 
   
Construct  
number 
Expression Arrest™  
catalog number 
Extracted plasmid  
Concentration (µg/mL) 
1 2209 309 
2 2325 47 
3 2476 167 
4 2479 24 
5 2455 29 
  
 
 
 The constructs are dispensed from the Expression Arrest™ library as frozen stock 
cultures of E. coli (DH10bpir116). Five cultures were grown from each of the five constructs. 
Cultures were grown in 5mL of 2x lysogeny broth ( 2x LB broth) at 37 ˚C in a shaker at 225 
RPMs. Cultures were given 16 hours of growth time. LB broth contained 20g/L peptone, 10g/L 
yeast extract, 5g/L NaCl, and 50µg/mL of chloramphenicol. The RNAi constructs are contained 
in a pSHAG-MAGIC2 (pSM2) vector. The pSM2 vector contains a bacterial selection marker for 
chloramphenicol. The bacterial selection marker ensures that all the cells in the culture carry the 
plasmid of interest. Cultures were the spun in a microcentrifuge at 15,000 RPMs in order to pellet 
cells. Cell pellets were frozen at -20 ˚C until plasmid extraction was carried out. Plasmid 
extraction was done using a mini-prep kit from Qiagen [271]. Qiagen protocols were followed 
directly. The kit elutes plasmid DNA in a Tris buffer. 
 Quantification of the Polβ RNAi plasmids was done on the spectrophotometer in the lab 
of Dr. Howett in the Drexel Department of Bioscience and Biotechnology. Sample absorbance 
was measured at 260nm and 280nm. The absorbance ratio of A260/A280 was greater than 1.5 for all 
samples indicating that the purity of each sample was adequate for experimental purposes. 
 Restriction digestion was done to check the extracted plasmids for recombination. 
Restriction enzymes were from Open Biosystems. Restriction digestion of the plasmids was 
carried out according to the protocols provided by Open Biosystems [272]. Digestion was run in a 
solution containing 14.8µL sterile H2O (prepared by HPLC), 2µL restriction buffer, 0.2 µL 10x 
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BSA, 1µL plasmid sample, 1 µL HindIII, and 1µL Xba1.The restriction enzyme pair HindII/Xba1 
produce three bands in non-recombinant samples: 3690 base pairs (bp), 2260 bp, and 1253 bp. 
Digestion was run at 37˚C overnight. Samples were then heated to 70˚C for 20 minutes to 
denature the enzymes. Following digestion the samples were run on in a 1% agarose gel and 
stained with ethidium bromide. 
 Results of the restriction analysis are shown in Figure 4.1. The ladder used in the analysis 
was New England Biolabs 1kb DNA ladder. The expected pattern of DNA bands was found in 
constructs 2, 3 and 4. Constructs 1 and 5 showed different patterns, indicating recombination in 
those samples. 
 
 
 
 
 
Figure 4.1: Restriction digestion of plasmids for RNAi. HindIII/Xba1 digestion of the pSM2 vector will 
yield 3 bands: 3690 bp, 2260 bp, and 1253 bp. 5 samples of each construct were run. Construct 1 in lanes 1-
5, construct 2 in lanes 6-10, construct 3 in lanes 11 and 13-16, construct 4 in lanes 17-21, and construct 5 in 
lanes 22-26. Ladder was run in lanes 12 and 27. Complete visualization of samples required contrast 
settings which made the ladders difficult to read. Both ladders are duplicated to the right of their respective 
image with contrast adjusted for easier visualization. Constructs 2,3, and 4 show expected digestion 
patterns. Constructs 1 and 5 do not, indicating recombination within the samples. 
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 Optimization of transfection reagents was carried out in 24 well plates using A549 cells. 
Two transfection reagents were tested: Arrest-In from Open Biosystems and Trojan porter from 
Genlantis. Both reagents were tested across the range of recommended doses and across the range 
of recommended reagent to DNA ratios. Purified green fluorescent protein (GFP) plasmid was 
used to test reagents. Maximum transfection efficiency was determined by observation of cultures 
using a fluorescent microscope with a FITC filter set.  The FITC filter set has and excitement 
peak at 495nm and an emission peak at 519nm. By comparison of a bright-field image with a 
corresponding fluorescent image of the same region, the percentage of cells expressing GFP can 
be roughly determined. The results of the optimization experiment indicated that the most 
efficient transfection was achieved with 0.5µg plasmid and 2.5µg of Arrest-In per well in a 24 
well plate. Although Open Biosystems gives a range of doses to try, 0.5µg plasmid and 2.5µg of 
Arrest-In are recommended as optimum. Arrest-In was found to be more effective than the Trojan 
porter reagent. All further transfection was performed with Arrest-In using the optimum reagent 
dose and reagent to DNA ratio found in this experiment. 
  Cells were seeded in 24 well plates 24 hours before transfection to allow for monolayer 
attachment of cells. 5 x 10
4
 cells were seeded in each well. Transfection was done using the 
transfection reagent Arrest-In.  Each sample was treated with 0.5µg plasmid and 2.5 µg of Arrest-
In as per the recommendations of Open Biosystems as well as the results of the previous 
transfection optimization experiment. 0.05 µg GFP plasmid was also included in each sample. 
GFP allows plasmid expression to be visualized under a fluorescent microscope. The initial 
concentration of GFP was only 10% of the initial concentration of the plasmid of interest. 
Transfection efficiency of the plasmid of interest is assumed greater than or equal to that of GFP. 
Transfection with RNAi plasmids was done in 24 well plates. A549 and 293t cultures were used.  
Both cell lines were transfected with each of the non-recombinant plasmids (constructs 2, 3, and 
4) in individual wells. The plasmid for construct 5 was used as well because DNA bands 
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observed after digestion were close to the expected pattern. I thought that the 3960kb band in the 
construct 5 samples may have been obscured by the dye front of the DNA loading dye (see Figure 
4.1). Samples transfected with construct 5 were did not survive puromycin selection following 
transfection and the assessment that recombination had occurred and the extracted plasmid could 
not be utilized was then accepted. 
The protocols used for transfection were as follows. Cell cultures were 60-80% confluent 
in the 24-well plate on the day of transfection. DNA and Arrest-In were mixed together in 100µL 
serum free medium (SFM) then incubated at room temperature for 20 minutes to allow the 
transfection reagent to form complexes with the plasmids. After 20min, the volume of the 
DNA/Arrest-In mixture was increased to 250 µL with SFM. Cells were then washed with PBS 
and the mixture was added to the cells. Treated cells were placed back into the incubator at 37˚C 
for 6 hours. Transfection was carried out in the absence of antibiotics and fetal bovine serum 
(FBS). Following the 6 hour incubation period, 250 µL of media with 20% FBS was added to 
each sample. Normal cell culture medium contains 10% FBS. The transfection reagent was left on 
the cells. The additional medium added at 6 hours brought the FBS concentration to the 10%, the 
appropriate level for culture maintenance.  
48 hours post-transfection, samples were moved from the original 24-well plate to 6-well 
plates to allow for culture expansion. Fresh media containing 10% FBS and 4 µg/mL puromycin 
was put on all samples.  Puromycin is an antibiotic which is lethal to mammalian cells. The pSM2 
vector contains a PKG-puro selection marker which makes transfected cells resistant to 
puromycin. Old medium containing the DNA/Arrest-In treatment was discarded. Samples of non-
transfected A549 and 293t cells were also given medium containing 4µg/mL. All of the cells 
from each of those samples were dead after 48hrs.  
96 hours post-transfection (48hrs after beginning puromycin selection) 293t samples 
transfected with construct 5, non-transfected 293t samples, and all A549 samples were killed by 
74 
 
puromycin selection. In the remaining 293t samples culture medium with 4µg/mL puromycin was 
replaced with normal culture medium containing 2 µg/mL puromycin. Thereafter stably 
transfected 293t cell lines were maintained in normal culture medium containing 2µg/mL 
puromycin. The plasmids which were successfully transfected and stably maintained were Polβ 
knockdown constructs 2, 3, and 4. Stably transfected 293t cell lines are hereafter referred to as 
C2, C3, and C4 respectively. The results of the puromycin selection indicated that the transfection 
efficiency of the A549 cells was too low for the establishment of stably transfected A549 
cultures. 
Additional 293t samples were transiently transfected with construct 3. No puromycin 
resistance selection was carried out. 293t cells from those samples were used in a comet assay 4 
days post-transfection. The 8-18-08 comet assay ran non-transfected 293t samples and C3 
transfected samples to test whether differences in repair capacity could be observed without 
stably transfected cell lines. Both groups had 4 samples: 60 minute, 30 minute, and 0 minute 
repair time and untreated control. The cells were treated with a 590 µM dose of methyl 
methanesulfonate (MMS) which was left on the cells for 30 minutes. Comet assay protocols are 
described in detail in chapter 3. No difference was found between the comet assay results of the 
non-transfected and the transiently transfected cells. All further experiments in this study were 
performed on stably transfected cells. 
4.4 Optimization of western blotting protocols 
Polymerase-β (Polβ) knockdown was verified using western blots. The western blot 
protocols used in this study were based on protocols supplied by Abcam [59]. Polβ detection 
proved to be difficult and extensive optimization of western blotting protocols was necessary. The 
following is a discussion on the establishment of the specific western blotting methods used in 
this study. The results of the optimization western blots and the protocol changes made to each 
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subsequent blot are described in detail. Individual western blots will be referred to by the date on 
which they were performed.  
Preliminary western blots carried out on 7-12-07, 8-7-07, 8-22-07, and 8-27-07 using 
THP-1 and Jurkat cells showed no signal for Polβ, LigaseI, LigaseIII, or PARP. Coomassie blue 
staining indicated that poor transfer efficiency was likely a contributing factor to the failure mode 
of those experiments. On     9-6-07 a western blot was performed using a wet transfer technique. 
Coomassie blue staining of the gel from this experiment indicated that a larger portion of the total 
protein loaded into the gels was transferred out of the gel during the wet transfer than during 
semi-dry transfer. Based on the indication of higher protein transfer efficiency with a wet-transfer 
technique compared to semi-dry transfer, a series of experiments were conducted between 4-14-
08 and 6-25-08 in order to optimize all of the aspects of the wet-transfer protocol.   
Though fairly efficient transfer was achieved using the wet-transfer technique, a tendency 
toward non-homogeneous transfer of protein to the membrane was observed which necessitated a 
switch to an alternative transfer method. Initial wet-transfer results were achieved on 9-6-07 using 
a transfer apparatus borrowed from the lab of Dr. M.K. Howett.  Within one month of that date, 
the Sokhansanj laboratory relocated to work in a new laboratory facility in Drexel’s School of 
Biomedical Engineering, Science and Health Systems. Among the new equipment in the lab was 
a new wet-transfer apparatus: a C.B.S. Scientific DCX-700.  The western blots carried out 
between 4-14-08 and 6-25-08 were aimed at optimizing the performance of the device to 
maximize protein transfer efficiency.  
The western blots performed in the optimization series of experiments revealed a pattern 
on both the gel and the membrane. The pattern reflected the structure of the plastic cassette which 
holds the gel during transfer. The cassette is designed in a square mesh pattern which holds the 
transfer- sandwich of gel, membrane and blotting paper together during transfer and allows the 
transfer buffer to directly contact the transfer-sandwich (see Figure 4.2). Visualizing that mesh 
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pattern on the gel via Coomassie blue staining and on the membrane with Ponceau red staining 
indicated that protein transfer was more efficient in the area between the grid lines than directly 
below the mesh. Homogeneous transfer is necessary for the purposes of the western blots in this 
study. Attempts to overcome the non-homogeneous nature of the wet-transfer technique focused 
on increasing overall protein transfer in order to move the remaining protein out of the gel. 
Increases in transfer time, increases in voltage during transfer, and changes to the pH of the 
transfer buffer were all found to affect the transfer efficiency without eliminating the grid pattern 
from either the gel or membrane; transfer efficiency remained non-homogenous. 
 
 
 
 
Figure 4.2: The cassette used to hold the transfer sandwich during wet-transfer is shown. There is a hinge 
between the red and black sides and a clip at the top of each. When the cassette is closed it holds the gel, 
membrane, and blotting paper together. The cassette sides are an open mesh which allows the transfer 
solution to soak through. After transfer, ponceu red staining on the membrane and coomassie blue staining 
on the gel revealed a pattern matching the cassette mesh. Evidence of that pattern on both gel and 
membrane using stains which detect protein, indicates that transfer to the membrane was non-
homogeneous. Figure adapted from ClearPAGE™ Precast Gel Running Instructions for SDS PAGE and 
DNA/Native Gels [273]. 
 
 
Wet-transfer was eliminated as a preferred technique because of the observed non-
homogeneity in transfer efficiency across the membrane. Following the 6-25-08 western blot 
semi-dry protein transfer was the only available option. On 7-9-08 and 7-15-08 western blots 
were carried out using a semi-dry transfer apparatus and the protein Ape1 was detected in Jurkat 
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and THP-1 samples (see Figure 4.3). Polβ however, was the protein of interest. Probing for Ape1 
served to demonstrate the general utility of my western blotting protocols. Western blots 
conducted between 8-7-08 and 9-17-08 using semi-dry transfer yielded no results when probed 
with Polβ primary antibody From Thermo Scientific. 
 
 
 
 
 
 
   
 
 
Figure 4.3: 7-15-8 western blot image. Ape1 is a 37 kDa protein. Lanes 1, 4, and 6 show weak but distinct 
bands at 37 kDa. This western blot served to demonstrate the general utility of my western blot protocols.  
 
 
 
After the null results for Polβ detection of the semi-dry transfer experiments between 7-9-
08 and 9-17-08 dry transfer was sought as an option. After some inquiry I found that the 
laboratory of Dr. Clyne from Drexel’s Mechanical Engineering department had an iblot system, a 
dry transfer apparatus from Invitrogen. Dr. Clyne generously allowed me to use the apparatus. 
The first western blot in the current study using dry-transfer was performed on 9-23-08 with 
A549 and 293t samples following the protocols set forth by Invitrogen for using the iblot system 
[274]. Polβ was detected in the 9-23-08 experiment in A549 samples. The 293t samples showed 
non-specific binding but no distinct Polβ band was detected. The 9-23-08 blot was repeated on 
10-9-08 with 4 changes to the protocol, intended to reduce background signal and non-specific 
binding. 1) Denaturing of samples was carried out at 95˚C instead of 70˚C. 2) Blocking time was 
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shortened from overnight to 60 minutes. 3) Following primary antibody incubation, the 
membrane was stored at 4˚C in 1xTBST buffer overnight. 4) Membrane washing in TBST 
following antibody incubation was done for 60 minutes each time with buffer changes every 15 
minutes. The results of the 10-9-08 western blot showed that Polβ was still only detected in A549 
samples and not 293t. Background luminescence and non-specific binding were however reduced 
in the 10-9-08 blot compared to the 9-23-08 blot.  
 
 
 
 
A      B 
Figure 4.4:  A) 9-23-08 western blot results. The membrane was probed for Polβ but many non-specific 
bands were detected. Lanes 1-4 contained replicate samples of A549 extract, lanes 5-8 contained replicate 
samples of 293t extract, lane 9 contained pure collagen, and lane 10 contained the ladder. B) 10-09-08 
western blot results. The membrane was again probed for Polβ and this time non-specific binding was 
greatly reduced but signal strength was weak. Lanes 1-5 contained A549 extract, lanes 6-9 contained 293t 
extract, and lane 10 contained the protein ladder. Bands detected in lanes 1-5 are at 37 kDa and are 
considered to be Polβ. The images have the grayscale reversed to make visualization easier. Gamma 
adjustment was also necessary to enhance visualization. Gamma correction was not used during any 
quantification of protein bands. 
 
 
 
Changes to the 10-9-08 protocols were made in an attempt to increase the signal strength 
of Polβ, specifically in 293t samples. On 10-17-08 A549, Jurkat, and THP-1 samples were 
included as well as extracts from the three 293t Polβ knockdown lines: C2, C3, and C4. The blot 
was transferred at 21V. In order to increase signal strength, transfer time was increased to 11 
minutes from 8 minutes. 11 minutes is the maximum setting on the iblot system. Very little 
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protein signal was detected on the 10-17-08 blot (membrane image is not shown because there 
was no signal to see).  
The 11-3-08 western blot is shown in Figure 4.5. It was run to show the general utility of 
the protocols used between 9-23-08 and 10-17-08. Jurkat, A549, and 293t cells were run in a 
western blot with a transfer time of 11 minutes and voltage increased to 23V.  The membrane was 
probed with a Cell Signaling Technologies α/β tubulin primary antibody. Tubulin signal was 
detected in all lanes with clear, distinct bands, low background, and low non-specific binding. 
Results of the tubulin probing confirmed the general functionality of the protocols. The 
membrane was then stripped by boiling in dH2O for 10 minutes and re-probed with Polβ primary 
antibody from Thermo Scientific. Results were poor and Polβ signal was not detected (see Figure 
4.5B).     
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A   
 
B  
Figure 4.5: The 11-03-08 western blot results. Samples were loaded by lane as follows: 1-4 293t, 5- A549, 
6-Jurkat, 7-9 293t, 10-ladder. A) The blot was probed first for α/β tubulin. Bands were detected in all lanes 
and non-specific background signal is not visible. The results show that the general protocols are functional 
and indicate that experimental difficulties are specifically related to Polβ detection and not related to 
protein detection in general. B) After stripping, the membrane was re-probed for Polβ. The signal detected 
is all non-specific binding. Lanes 5 and 6 show lower signal because less protein was loaded into those 
wells.  
 
 
 
Although Polβ was detected in A549 cells during the first dry-transfer blot performed, 
adequate detection in the 293t cell line was the goal. The western blot performed on 11-18-08 
maintained the protocol changes introduced on 10-7-08 but the primary antibody was switched to 
a Polβ primary from Genetex. No signal at all was detected in the 11-18-08 blot. 
Important results were obtained in the 1-09-09 western blot shown in Figure 4.6. A549, 
THP-1, 293t and 293t Polβ knockdown samples were used. A new batch of Polβ primary 
antibody from Abcam was used (ab1831). All other experimental protocols were the same as the 
10-7-08 protocols. With the exception of the THP-1 and C4 knockdown samples, Polβ signal was 
detected in all samples.  Abcam Polβ primary antibody was then used in all subsequent 
experiments. Although the bands were detected and the Abcam antibody was deemed effective by 
   1          2          3          4           5            6         7           8          9          10 
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the results of the 1-9-09 blot, signal strength was still too low to be effective in demonstrating 
Polβ knockdown. Gamma correction of the image was needed in order to observe the results. 
 
 
 
 
Figure 4.6: The 1-09-09 western blot shows Polβ signal detected in all but 2 lanes. The THP-1 extract may 
not have shown Polβ signal because the protein concentration of the samples was low. C4 samples are 
supposed to have reduced Polβ signal so the results were expected. Polβ primary antibody was purchased 
from Abcam and used for all subsequent western blots.  
 
 
 
The results of the western blot protocol optimization experiments up to this point resulted 
in the choice of dry-transfer technique. General functionality of the western blot protocols in use 
was demonstrated by tubulin detection on the 11-3-08 blot. Ponceau red and Coomassie blue 
staining of each blot showed dry transfer to be homogenous and efficient. Likewise Polβ antibody 
from Abcam was shown to be functional by the results of the 1-9-09 blot. Further optimization 
experiments were focused on increasing the Polβ signal to a strength that would allow 
comparison between the Polβ expression levels of 293t cells and the 293t Polβ knockdown cell 
cultures. 
The first attempt at increasing signal strength by altering the protocols established as of 
1-9-09 (see Figure 4.6) was in the 1-15-09 western blot. The transfer time was doubled from 11 to 
82 
 
22 minutes and the transfer voltage was increased from 23V to 25V (the maximum voltage 
allowed by the iblot system). The purpose of these protocol changes was to increase Polβ signal. 
No signal was detected. The increase in transfer time and voltage heated and dried the membrane 
significantly and the absence of signal was credited to that effect. 
 The 1-21-09 western blot is shown in Figure 4.7. The results of the 1-21-09 western blot 
were particularly important to the establishment of a working western blot protocol for this study. 
Two changes to the 1-09-09 protocol were made. One change was an increase in transfer time of 
3 minutes for a total of 14 minutes of transfer at 23V. The other change was in the pre-
experimental collection methods of the samples. After investigating the effects of transfer 
method, transfer conditions, buffer composition, antibody source, cell type, and duration and 
temperature of antibody incubation, the possible alternative means of increasing signal strength 
seemed limited. In general 50µg total protein is the maximum protein mass that is loaded per 
western blot sample under any protocol. On 12-19-08 high concentration Jurkat extracts were 
collected with a concentration of approximately 10,000 µg/mL of total protein in Ripa buffer. 
Using the high concentration extract, Jurkat samples in the 1-21-09 western blot were 
loaded with 130µg/sample. Using the protocols established as of 1-09-09: dry transfer using the 
iblot system and primary Polβ antibody from Abcam, as well as a 3 minute increase in transfer 
time, to 14 minutes total, a visually observable, clean, 37kDa protein band was detected in the 
Jurkat samples and only the Jurkat samples on the 1-21-09 western blot. 293t and 293t Polβ 
knockdown samples did not show signal. 
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Figure 4.7: The 1-21-09 western blot. Samples were loaded into lanes as follows:  1-3 293t, 4-6 Jurkat, 7- 
C2 extract, 8-C3, 9-C4, 10 ladder. Dry transfer was carried out at 23V for 14 minutes. Polβ probing was 
done with an Abcam primary antibody. Polβ was detected in lanes 4, 5, and 6 in Jurkat extracts. The Jurkat 
samples were loaded with 130µL of protein per sample (more than double the typical limit). Polβ detection 
in Jurkat samples was primarily attributed to high protein concentration. 
 
 
 
 
Following the successful detection of Polβ in the high concentration samples of the 1-21-
09 western blot (Figure 4.7), high concentration protein extracts were collected from 293t and 
293t Polβ knockdown cell lines. Protein extraction methods are described in the next section. On 
3-04-09 a western blot was run using the high concentration extracts from Jurkat, 293t, and 293t 
Polβ knockdown construct C4 (Figure 4.8). Transfer time was again reduced to 11min at 23V 
because protein concentration of samples was considered the dominant factor affecting the 
strength of the Polβ signal. 11 minutes is the max setting on the iblot apparatus. Longer transfer 
times can be achieved by restarting the machine. Results showed no signal in the 293t or 
knockdown samples. Jurkat samples showed Polβ signal but it was visibly weaker than the Jurkat 
signal from the 1-21-09 blot. Thereafter transfer conditions were set at 23V and transfer time was 
increased to 14 minutes. 
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Figure 4.8: The 3-04-09 western blot. Lanes were loaded with the following samples: 1-3, 8, and 9 Jurkat, 4 
and 6 293t, 5 and 7 C4. All samples in this blot came from high concentration extracts. Signal strength was 
visibly reduced compared to the 1-21-09 western blot. Decreased signal strength was attributed to the 
shorter transfer time used in the 3-04-09 blot, 11min vs. 14min. 
 
 
 
In the 1-21-09 western blot, shown in Figure 4.7, Polβ detection in Jurkat samples was 
highly dependent on protein quantity per sample. Based on these results the 3-04-09 western blot 
was run with high concentration Jurkat, 293t, and C4 samples. Polβ was again only detected in 
the Jurkat samples. 293t and C4 samples did not show a Polβ signal. To further test the effects of 
protein mass per sample a 3-05-09 western blot, shown in Figure 4.9, was run with a high 
concentration Jurkat sample for reference and 293t and C4 samples were loaded with varied 
protein quantity. It was considered that 293t and C4 samples in the 3-04-09 western blot could 
have been hindered by loading too much protein per sample which may have inhibited protein 
migration in the gel. In contrast the high concentration extracts may still have had too little 
protein for Polβ detection. 293t and C4 samples in the 3-5-09 blot were therefore run at stock 
concentration, ½ stock concentration, and 1/10 stock concentration with 20µL sample volumes. 
40 µL is the maximum volume of a sample using Invitrogen 10 well gels. 293t and C4 samples 
were also run at full stock concentration and 40µL volume to achieve 2x protein mass per sample. 
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The resulting blot was very sloppy. Polβ signal was detected in the ½ stock concentration 293t 
sample (Figure 4.9, lane 3). That sample was loaded with 137µg total protein. The other 293t and 
C4 samples did not have clean, detectable Polβ signal. The ½ stock concentration of the 293t 
extract was then chosen as the optimum extract concentration for sample preparation. The stock 
extract concentration for the 293t extracts was 21.14 mg/mL.  
 
 
 
Figure 4.9: The 3-05-09 western blot. The mass of protein loaded in each sample was varied. 1x sample 
concentration indicates stock concentration of extracts. Dilutions were made by adding Ripa buffer to the 
whole cell extracts. 2x concentration indicates that sample volume was doubled. Lanes contained the 
following samples: 1 - 293t, 2 - C4, 3 - 293t 1/2x, 4 - 293t 1/10x, 5 - 293t 2x, 6 – C4 1/2 x, 7-C4 1/10x, 8- 
C4 2x, 9 – Jurkat 1x, 10 – ladder. The results show that most samples ran poorly but lane 3 contains a clear 
and distinct Polβ band at 37kDa indicating that 1/2 the stock concentration was the most effective protein 
concentration for 293t samples. Polβ detection in the Jurkat sample was clean and distinct. 
 
 
 
 
 The 3-09-09 western blot, shown in Figure 4.10, was run using Polβ antibody from 
Abcam and 20µL high-concentration 293t and C4 samples run at ½ stock concentration. Transfer 
was done on the iblot system at 23V for 14 minutes. Jurkat, 293t, and C4 samples were run. 
Sonication of protein extracts was carried out as part of the extraction protocol for all extracts 
used in this study. Sonication is done to homogenize protein extracts by breaking-up DNA and 
cell membrane debris. Extraction methods are discussed in full in the next section. In the 3-09-09 
western blot, half of the 293t and C4 samples were re-sonicated immediately before the 
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experiment. This was done in an attempt to improve the flow of samples thorough the gel matrix. 
Multiple samples in the 3-05-05 western blot showed uneven progression of the dye front during 
electrophoresis which is typical in non-homogenized samples.  Clean Polβ bands were detected in 
all samples. However, re-sonication seemed to degrade rather than improve the quality of results 
and was not repeated in future experiments. C4 samples showed visibly reduced intensity 
compared to 293t samples. The protocols and conditions used in the 3-09-09 western blot were 
then established as the optimized western blot protocols which were followed for all subsequent 
western blot experiments in the study. 
 
 
 
 
Figure 4.10: The 3-09-09 western blot. Lanes contained samples as follows: 1 – Jurkat, 2, 3, 6, 7 – 293t ½ 
x, 4, 5, 8, 9 – C4 ½ x, 10 – ladder. All samples were sonicated during initial extract collection. Samples 6-9 
were re-sonicated for 90 seconds on a VWR waterbath sonicator at 4 ˚C before the western blot. In all other 
aspects, samples 6-9 were duplicates of samples 2-5. The best results were achieved without the extra 
sonication treatment. 
 
 
 
4.5 Extraction Protocols 
 
 Protein extraction was done according to the following protocols. Cells were grown at 37 
˚C in 5% CO2 and 95% humidity. Jurkat cells were grown in Corning T75 flasks. 293t cells were 
grown on 15cm plates. Jurkat cells were harvested at a cell density of 1E6 cells/mL and 293t cells 
were harvested when plates were between 80 and 90% confluent. Cells growing in monolayer 
were trypsinized with 0.05% trypsin for 3 minutes to detach from plate then complete media with 
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FBS was added to neutralize trypsin. After cells were harvested they were placed into 15mL tubes 
and spun in a centrifuge at 1000rpm for 5 min to pellet. Cell pellets were then re-suspended in 1 x 
PBS  to rinse and were spun again at 1000rpm for 5 min. PBS rinsing steps were repeated three 
times.  
 Polβ expression has been shown to be cell cycle independent [32, 275]. Cell cycle was 
not synchronized or accounted for in experimental samples. 
 After rinsing cells were counted using a hemacytometer. All cell populations had greater 
than 95% viability during counting as determined by Trypan blue exclusion. Cells were lysed 
using the protein extraction buffer Ripa from ThermoScientific.  Ripa was prepared at 4 ˚C with 
1 L aprotinin, 1µL pepstatin, 1µL leupeptin, 1µL 1M DTT, and 9µL/mL of PMSF per mL of 
Ripa. Cells were suspended in Ripa buffer at a concentration of 250e6 cells/mL Ripa in a 1.5 mL 
eppendorf tube. Tubes were then placed on ice for 10 min. Following 10 min on ice the tubes 
were placed into the freezer and stored at       -20˚C. Before use in assays, extracts were sonicated 
in a Branson waterbath sonicator at 4˚C for 90 seconds on a 50% duty cycle. Following 
sonication, extracts were spun in 1.5 mL eppendorf tubes in a refrigerated microcentrifuge at 4 ˚C 
for 20min at 15,000 rpm. Supernatant was then aliquotted to 1.5 mL tubes and stored at -20 ˚C.   
4.6 Protein Quantification 
Whole cell extracts were collected for Jurkat and 293t cell lines. 293t extracts were 
collected for normal 293t cultures as well as three different 293t Polβ knockdown cell lines. The 
293t Polβ knockdown lines will be referred to as C2, C3, and C4 which stand for the shRNA 
construct that each culture was transfected with: construct 2, construct 3, and construct 4 
respectively. Construct numbers were assigned arbitrarily and are matched to constructs from the 
RNAi library of Dr. Saunders’ lab from the Drexel Bioscience Department. Construct numbers 
are shown in Table 4.2.  
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 Protein quantification was done using a Pierce bicinchoninic acid (BCA) protein assay 
from Thermo Scientific. 10 µL of protein extract were used per sample with 90 µL of Pierce 
reagent. Protein quantification samples were prepared in a 96 well clear Corning plate at room 
temperature. The plate was then covered in aluminum foil and incubated at 37 ˚C for 30 minutes. 
After incubation absorbance of each sample was measured using a Tecan infinite M200 
microplate reader. A standard curve was created to calibrate protein concentration versus 
absorbance using bovine serum albumin (BSA) standards with known protein concentration.   
 Protein samples were prepared at full stock concentration, half stock concentration, and 
1/10 stock concentration for protein quantification. Samples prepared at 1/10 concentration were 
the only samples that had absorbance measurements within the working range of the assay and 
stock concentrations were calculated from those samples.  Half stock concentration and full stock 
concentration samples all had absorbance readings higher than the working range of the assay. 
Results are shown in Table 4.2. 
 
Table 4.2: Protein extract concentrations (µg/mL). Because of the high protein content of the samples, it 
was expected that concentrations of some or all samples would be out of the working range of the assay. 
Dilutions of the stock concentration were also quantified. Only the samples diluted to 10% stock 
concentration were in the working range of the assay used to measure protein concentration. 
 
% stock 
concentration: 
 
100%          50% 
 
10% 
calculated 
stock 
concentration 
(µg/mL) 
Jurkat 4112 2867 1014 10140 
293t 5619 3806 2114 21140 
C2 6292 5552 2290 22900 
C3 6200 5156 2164 21630 
C4 4907 3534 1021 10200 
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4.7 Western Blot Protocols 
 
 Western blot protocols vary between laboratories and between investigators. The 
establishment of the western blot protocols used in this study is discussed at length in section 4.4. 
The protocols are as follows. 
 Protein samples were prepared as described in section 4.5. Aliquots of protein were 
thawed on ice. Western blot samples were prepared by mixing 13µL protein extract (in Ripa) 
with 2µL reducing agent and 5µL protein loading buffer, both from Invitrogen. Samples were 
mixed by brief pipetting in a 1.5 mL eppendorf tube and then heated at 90˚C on a heat block for 
10 minutes. After incubation, samples were spun briefly to consolidate tube contents. 
 Samples were then loaded into a 4-12% Bis-Tris gel from Invitrogen. Running buffer was 
1xMES buffer from Invitrogen. PAGE (polyacrylamide gel electrophoresis) was run at 200V for 
50 minutes. Protein transfer was run using an Invitrogen iblot system. Proteins were transferred 
from the gel to a PVDF membrane from Millipore with 22µm pore size at 23V for 14 minutes.  
 Following transfer the membranes were blocked for at least 60 minutes at 4 ˚C in 
1xTBST containing 5% BSA (w/v). After blocking, membranes were probed with a Polβ 
monoclonal antibody from Abcam at a 1:500 (v/v) ratio in 1 x TBST with 2% BSA (w/v). 
Primary antibody incubation was done overnight on a rocker table at 4 ˚C. Secondary antibody 
probing was done with a sheep anti-mouse antibody from GE Healthcare at a 1:10,000 (v/v) ratio 
in 1 x TBST with 2% BSA (w/v). Secondary antibody incubation was carried out at room 
temperature on a shaker table for 60 minutes. Following each antibody-incubation was a wash 
step. Washing was done on a shaker table at room temperature in 1xTBST for 30 minutes. TBST 
was changed at 15 minutes.  
 After imaging, membranes were stripped by submersion in boiling water for 10 min. 
After stripping, membranes were probed again with α/β-Tubulin primary antibody from Cell 
Signaling Technologies. The antibody solution was prepared at a 1:1000 (v/v) ratio in 1 x TBST 
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with 2% BSA (w/v). Membranes were incubated in the antibody solution at room temperature for 
1 hour on a shaker table. Secondary antibody probing was done with a goat anti-rabbit antibody 
from Sigma at a 1:10,000 (v/v) ratio in 1 x TBST with 2% BSA (w/v). Secondary antibody 
incubation was carried out at room temperature on a shaker table for 60 minutes. Following each 
antibody-incubation was a wash step. Washing was done on a shaker table at room temperature in 
1xTBST for 30 minutes. TBST was changed at 15 minutes.  
 Western blots were developed using a Pierce chemiluminescence kit from Thermo 
Scientific. Chemilumniescent reagents were mixed and applied to the membranes 5 minutes 
before imaging. Membranes were sandwiched between two pieces of clear plastic cut from an 
overhead projector transparency and the whole sandwich was covered in aluminum foil until 
imaging. Membrane imaging was done using an Alpha Innotech FluorChem SP. For each 
membrane imaged a 40 image series was collected. Images were stacked using the Alpha Ease FC 
software and the image used for quantification was the highest number image in the stack that did 
not show saturation on the protein bands of interest.  
4.8 Western Blotting Results 
Following optimization of the western blotting protocols a series of western blots was 
conducted in order to confirm and quantify the knockdown of Polβ in the C2, C3, and C4 cell 
lines. The results of those experiments are presented below. 
The series of western blots which yielded quantifiable Polβ bands were conducted 
between 3-09-09 and 5-26-09. The protocols used in these experiments were established through 
a series of troubleshooting experiments which culminated in a successful blot with clear, distinct 
Polβ signal on 3-09-09. Based on the success of the 3-09-09 blot the other western blots in the 
series were conducted according to the same protocols.  Each western blot in the series was 
probed and developed twice, first for Polβ and then after stripping, re-probed for α/β tubulin. 
Images of both developments are shown for all of the blots in the series in Figures 4.11-4.15.  
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Protein bands were quantified using the AlphaEaseFC software version 4.0.0 ©Alpha 
Innotech Corporation. Integrated density value (IDV) was calculated for each protein band. 
Background levels from each individual lane were subtracted from respective samples. The Polβ 
levels were normalized to tubulin levels for sample comparison. Quantification results are shown 
in Tables 4.3-4.6. Results are presented as Polβ IDV/ tubulin IDV for each sample. 
The 3-09-09 western blot was run with one Jurkat sample, 4 293t samples, and 4 C4 
samples. Images of the 3-09-09 blot are shown in Figure 4.11.  Two of the 293t samples and two 
of the C4 samples were re-sonicated immediately prior to the start of the experiment. The extra 
sonication step was part of the attempts to optimize the western blot protocols. The samples that 
did not receive the extra sonication gave cleaner bands and better results. Tubulin bands were 
detected in all samples. Lanes 2-9 were all quantified and the results are shown in Table 4.3. 
 
 
 
 
Figure 4.11: The 3-09-09 western blot. A) Membrane after Polβ probing. B) Membrane after α/β tubulin 
probing.  Lanes contained the following samples: 1) Jurkat 2) 293t 3) 293t 4) C4 5) C4 6) 293t 7) 293t 8) 
C4 9) C4 10) ladder. Samples 6-9 were re-sonicated immediately before electrophoresis. All samples had 
quantifiable bands for both Polβ and α/β tubulin. 
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Table 4.3: Protein signal quantification results from the 3-9-09 western blot. Integrated density values 
(IDV) are shown for Polβ and α/β-tubulin bands from each sample. Normalization to background 
fluorescence was done individually for each lane. Polβ signal for each sample was then normalized to the 
respective α/β-tubulin signal. Protein per sample is the total protein mass loaded per well in the gel. 
Samples were loaded equally according to cell count/extract volume for this blot. 
Lane# Sample Protein per 
sample (µg) 
Polβ IDV α/β-Tubulin IDV Polβ/Tub 
1 Jurkat 65 38,381,112 128444225 0.30 
2 293t 137 23,720,362 71840725 0.33 
3 293t 137 46,674,222 86939116 0.54 
4 C4 66 10,097,208 61659117 0.16 
5 C4 66 5,093,660 46870326 0.11 
6 293t 137 22,570,898 38993625 0.58 
7 293t 137 28,726,005 44718723 0.64 
8 C4 66 8,787,317 75776361 0.12 
9 C4 66 6,545,361 114538545 0.06 
 
 
 
 
 The 3-11-09 was run as a duplicate to the 3-09-09 western blot with one exception. All 
four of the 293t samples are replicates and all four of the C4 samples are replicates. None of the 
samples were re-sonicated before the experiment. Images of the 3-11-09 western are shown in 
Figure 4.12. The 3-11-09 blot was unsuccessful. The blot showed some tapering of protein lanes 
during electrophoresis which interferes with protein band quantification. In addition, Polβ 
probing showed multiple non-specific bands in each lane. Much of the non-specific binding 
resulted in signal much stronger than the signal from the protein of interest. The non-specific 
binding in combination with the tapering of protein lanes prevented any successful quantification 
of Polβ in the samples.  
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A              B 
 
Figure 4.12: The 3-11-09 western blot. Lanes contained the following samples1) Jurkat 2) 293t 3) 293t 4) 
C4 5) C4 6) 293t 7) 293t 8) C4 9) C4 10) ladder. A) After Polβ probing, very little distinct signal was 
found. All lanes showed non-specific binding. B) Tubulin signal was detected in all lanes. Due to the 
tapering of the lanes and weak signal none of the samples in from this western blot were used for 
quantification. 
 
 
 
 The 5-07-09 western blot was run with Jurkat, 293t, C2, C3, and C4 samples. Protein 
concentration of samples was increased from 3-09-09 and 3-11-09 western blots because Polβ 
signal was weak in the 3-11-09 blot. The membrane is shown in Figure 4.13. The 293t, C2, C3, 
and C4 samples were in lanes 2-5 respectively and had duplicates in lanes 6-9. The 293t and C4 
lanes all show clean quantifiable bands for both Polβ and tubulin. The C2 and C3 samples show 
no bands at 37 kDa. While Polβ knockdown was the expected and desired result, complete 
knockdown was not expected and the C2 and C3 samples from this blot were not used for 
quantification. Quantification results for the other samples are shown in Table 4.4. The image of 
the membrane after tubulin probing, shown in Figure 4.13b, shows that protein from both pairs of 
C2 and C3 samples clogged and did not run the full length of the gel during electrophoresis. To 
correct the problem, aliquots of both extracts were re-sonicated for 90 seconds on a VWR 
waterbath sonicator at 4 ˚C and spun in a refrigerated microcentrifuge at 4 ˚C and 15,000 rpm for 
20 minutes. Supernatant was then transferred to new eppendorf tubes and stored at -20 ˚C. The 
additional sonication corrected the issue and the C2 and C3 samples ran cleanly in the 5-19-09 
and 5-26-09 blots. 
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Figure 4.13: The 5-07-09 western blot. Lanes contained the following samples: 1) Jurkat 2) 293t 3) C2 4) 
C3 5) C4 6) 293t 7) C2 8) C3 9) C4 10) ladder. Quantifiable bands were detected for Polβ and tubulin in 
Jurkat, 293t, and C4 samples. A) Membrane after Polβ probing. B) Membrane after tubulin probing. In the 
C2 and C3 samples the lanes were clogged by non-homogeneous protein extracts and could not be properly 
quantified. 
 
 
 
Table 4.4: Protein signal quantification results from the 5-7-09 western blot. Integrated density values 
(IDV) are shown for Polβ and α/β-tubulin bands from each sample. Normalization to background 
fluorescence was done individually for each lane. Polβ signal for each sample was then normalized to the 
respective α/β-tubulin signal. All samples were loaded with 264µg total protein. 
 
lane# sample Polβ\ IDV tubulin IDV Polβ/tub 
1 Jurkat 44,840,781 77,371,470 0.58 
2 293t 27,144,756 21,603,659 1.26 
5 C4 14,499,041 6,053,125 2.40 
6 293t 25,812,325 21,611,835 1.19 
9 C4 8,787,918 14,737,524 0.60 
 
 
 
 The 5-19-9 western blot was a duplicate of the 5-07-09 western blot. Polβ and tubulin 
bands were detected in all samples. Both C4 samples showed weak tubulin signal. The C4 protein 
extracts were collected at the same time as the 293t extracts and were stored and prepared under 
the same conditions. Also, the Polβ signal detected in the C4 samples was comparable to that of 
the other Polβ knockdown samples. However the Polβ signal from the same batch of C4 extract 
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was stronger in the 3-09-09 and 3-09-11 western blots, which indicates that some protein decay 
may have occurred in the C4 stock. C4 samples from this blot were not used for quantification. 
Results of quantification on the other samples are presented in Table 4.5. 
 
 
 
 
Figure 4.14: The 5-19-09 western blot. Lanes contained the following samples: 1) Jurkat 2) 293t 3) C2 4) 
C3 5) C4 6) 293t 7) C2 8) C3 9) C4 10) ladder. A) Membrane probed for Polβ. B) Membrane probed for 
tubulin. The C4 samples (lanes 5 and 9) show a low tubulin signal possibly caused by degradation of 
protein extract stocks. C4 samples were excluded from quantification. 
 
 
 
Table 4.5: Protein signal quantification results from the 5-19-09 western blot. Integrated density values 
(IDV) are shown for Polβ and α/β-tubulin bands from each sample. Normalization to background 
fluorescence was done individually for each lane. Polβ signal for each sample was then normalized to the 
respective α/β-tubulin signal. All samples were loaded with 264µg total protein. 
 
lane# sample Polβ IDV tubulin IDV Polβ/tub 
1 Jurkat 36,791,076 95,741,738 0.38 
2 293t 44,996,625 73,398,855 0.61 
3 C2 48,399,498 139,852,965 0.35 
4 C3 23,902,390 185,993,940 0.13 
6 293t 33,870,978 85,609,291 0.40 
7 C2 33,184,032 192,844,488 0.17 
8 C3 15,931,272 250,524,228 0.06 
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The 5-26-09 western blot was the final western blot of the series, shown in Figure 4.15. 
The experiment was a replication of the 5-07-09 and 5-19-09 western blots with one exception. 
There are 3 C4 samples and only one C2 sample. C2 extract was limited and only one sample 
could be prepared. During electrophoresis some of the lanes were distorted but quantifiable Polβ 
bands were found in one each of the 293t, C2, and C3 samples: lanes 2,3 and 4 respectively. The 
other samples ran poorly and were excluded from the final analysis. Quantification results for the 
5-26-09 western blot are presented in Table 4.6. 
 
 
 
Figure 4.15: The 5-26-09 western blot. Lanes contained the following samples: 1) Jurkat 2) 293t 3) C2 4) 
C3 5) C4 6) 293t 7) C3 8) C4 9) C4 10) ladder. A) Membrane probed for Polβ. B) Membrane probed for 
tubulin. Lanes were distorted during PAGE. Only lanes 1-4 were quantifiable. Lane 2 showed low tubulin 
signal which makes quantification results less reliable. It was included in the results because it is the best 
choice for a quantifiable 293t sample to compare against the C2 and C3 knockdown samples. 
 
 
 
Table 4.6: Protein signal quantification results from the 5-7-09 western blot. Integrated density values 
(IDV) are shown for Polβ and α/β-tubulin bands from each sample. Normalization to background 
fluorescence was done individually for each lane. Polβ signal for each sample was then normalized to the 
respective α/β-tubulin signal. All samples were loaded with 234µg total protein. 
 
lane# sample Polβ IDV tubulin IDV Polβ/tub 
1 Jurkat 22228899 58264965 0.38 
2 293t 37633869 22430980 1.68 
3 C2 30527000 78088197 0.39 
4 C3 79149885 84058542 0.94 
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4.9 Western blot analysis 
 
 The results from all of the quantifiable western blot samples are presented in Tables 4.7-
4.10. Polβ signal normalized to tubulin signal was used as a measure of Polβ expression. The 
mean Polβ/tubulin signal values for all score-able samples from each cell line are presented. The 
5-26-9 blot had no duplicate samples.  
 
 
Table 4.7: 3-9-09 western blot results. Polβ: α/β-tubulin ratios are presented for all quantifiable samples. 
 
Lane# Sample Polβ/tub Lane# Sample Polβ/tub 
2 293t 0.33 8 C4 0.12 
3 293t 0.54 9 C4 0.06 
6 293t 0.58 4 C4 0.16 
7 293t 0.64 5 C4 0.11 
mean  0.52 mean  0.11 
 
 
 
Table 4.8: 5-7-09 western blot results. Polβ: α/β-tubulin ratios are presented for all quantifiable samples. 
 
Lane# Sample Polβ/tub Lane# Sample Polβ/tub 
2 293t 0.93 9 C4 0.44 
6 293t 1.21 5 C4 0.84 
mean  1.07 mean  0.64 
 
 
 
Table 4.9: 5-19-09 western blot results. Polβ: α/β-tubulin ratios are presented for all quantifiable samples. 
 
Lane# Sample Polβ/tub Lane# Sample Polβ/tub Lane# Sample Polβ 
/tub 
2 293t 0.63 7 C2 0.16 4 C3 0.13 
6 293t 0.40 3 C2 0.35 8 C3 0.06 
Mean  0.51 mean  0.25 mean  0.09 
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Table 4.10: 5-26-09 western blot results. Polβ: α/β-tubulin ratios are presented for all quantifiable samples. 
 
lane# sample Polβ /tub 
2 293t 1.68 
3 C2 0.39 
4 C3 0.94 
 
 
 Percent Polβ reduction for each knockdown cell line was calculated on two separate 
blots. Percent reduction was calculated as the difference between the  mean knockdown 
Polβ/tubulin signal and the mean 293t Polβ/tubulin signal from the same blot divided by the 
divided by the mean 293t Polβ/tubulin signal shown in equation 1. Those scores and the mean of 
each pair are reported in Table 4.11. The mean value for each knockdown cell line is roughly 
60% knockdown. 
 
   % reduction  =  ( knockdown – 293t) / (293t)   (4.1) 
 
Table 4.11: The percentage of total knockdown is shown for each of the three transformed cell lines. Each 
% reduction score shows the proportion of signal reduction between the average 293t scores and the 
average scores from the transformed cell line on a specific western blot. Each transformed cell line was 
successfully measured on two separate blots. The mean of those two scores is presented for each 
knockdown. The Polβ reduction is roughly 60% for each construct. 
 
C2 fold reduction C3 fold reduction C4 fold reduction 
5/19/2009 0.51 5/19/2009 0.82 3/9/2009 0.79 
5/26/2009 0.77 5/26/2009 0.44 5/7/2009 0.40 
mean 0.64 mean 0.63 mean 0.59 
 
 
4.10 Discussion of western blot results 
 
The purposes of the western blots in this study were to confirm and quantify a decrease in 
Polβ expression in 293t cell lines transfected with shRNA constructs. The results of the western 
blots confirm Polβ knockdown. Between the four successful western blots, there were nine 
quantifiable 293t samples and 12 quantifiable knockdown samples. A two sample t-test was run 
between all of the knockdown samples and 293t samples to test the null hypothesis that the mean 
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Polβ/tubulin signal was the same for each group. The null hypothesis was rejected at a 1% 
significance level (α = 0.01). This result supports the conclusion that Polβ expression was 
reduced in the knockdown samples. Unfortunately there were not enough samples to test the C2 
and C3 cell lines independently. The same t-test repeated with only the C4 samples in the 
knockdown set rejected the null hypothesis at α = 0.05 but not at α = 0.01. 
Quantification of the change in Polβ expression was achieved for each of three 
transfected cell lines: C2, C3, and C4. However there were too few samples quantified from each 
cell line to allow for statistical evaluation of the results. The small samples sizes for each group 
cast doubt upon the validity of the 60% knockdown calculations. Regardless the data collected in 
this series of experiments is all indicative of a successful decrease in Polβ expression in cell lines 
that are not expected to differ in any other capacity. The western blot results are sufficient to 
support the view that differences in the behavior of the knockdown cell lines and the normal HEK 
293t line in the comet assay experiments can be attributed to Polβ expression differences.  
Although the percentage reduction numbers are not statistically significant based on the 
data collected, they are still the best possible choices to use during model-data analysis because 
they are in good agreement with each other and because no other numbers are available. The 
possibility that knockdown was achieved in different percentages will be considered and 
discussed in chapter 5.  
The results of this portion of the study have been collected for the purpose of model 
validation. With that goal in mind RNAi techniques are distinctly advantageous. In the context of 
the BER model RNAi presents the opportunity to alter a single pathway parameter. Furthermore 
the technique requires only basic laboratory equipment and is relatively inexpensive. As I found 
in this study however, RNAi is not without limitations. Successful transfection is necessary for 
the implementation of RNAi. This imposes a strong predisposition for the use of cell lines 
precluding the use of any which cannot be successfully transfected. The advantage of using 
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primary cells, which are taken directly from living tissue and therefore better represent the in vivo 
conditions of the tissue of origin, is lost. Multiple population doublings must occur before an 
RNAi knockdown cell line is stable. Furthermore the transfection process in inherently 
inconsistent. The need for puromycin selection highlights this. It forces the selection of a subset 
of the original population. The influence of such selection on the phenotype of the cell culture is 
difficult if not impossible to characterize. Despite limitations RNAi is a useful technique allowing 
the selective knockdown of protein expression through relatively simple laboratory techniques. 
 The western blots carried out in this study highlight difficulties facing systems biology in 
general. Western blotting is a well-established technique. Even so, extensive protocol 
optimization was required to detect adequate Polβ signal for knockdown confirmation and 
quantitation. The need for this protocol optimization was imposed by the goals of the study. Polβ 
signal has been detected by western blot previously [32, 239, 276]. But in this case it was 
necessary to detect Polβ in a cell line that could be made to stably express the RNAi plasmid. 
Thus a convolution of experimental limitations is imposed on the collection of data for model 
validation.  
 Ultimately the successful, thorough validation of the BER model will require the use of 
mass spectrometry for protein expression measurements. Severe BER deficiency is not 
compatible with life [8]. Therefore the differences in the BER pathway that impact health will 
necessarily be subtle. Thus there is a need to acquire data from the most sensitive, quantitative, 
and reproducible methods, in this case mass spectrometry. This highlights a fundamental need in 
systems biology. There is a flexibility in general conceptual models which allows investigators 
from separate laboratories to compile qualitative data and make useful and accurate deductions 
about biological systems. Turning conceptual models into formal mathematical models however 
imposes stricter limitations on data collection. Not only that but the amount of work necessary to 
generate model-worthy quantitative results is significant. Model validation therefore is dependent 
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on the successful incorporation of data from multiple laboratories. Overall this points towards a 
need for thorough standardization of experimental techniques. It is necessary that data from 
different labs be comparable and also that the data is compatible with model structure. 
The protein knockdown portion of this study was successful in generating useful results 
for model validation. The difficulties encountered in this portion of the study mirror the general 
difficulties in systems biology. Formal model validation is necessary to thorough pathway 
understanding. If pathway knowledge cannot be used to accurately predict system response then 
there is clearly a gap in the knowledge base concerning the system. The work presented in this 
chapter represents an important step towards model validation in the BER system. 
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Chapter 5: Model Validation: Integration of Experiments and Simulation 
 
5.1 Introduction to model-data integration 
 The development of useful pathway models entails the integration of experimental data 
and modeling predictions [47]. Due to the nature of biological experimental techniques the 
amount of qualitative data collected and published exceeds the amount of quantitative data by a 
large margin. The result is that conceptual models of pathway mechanisms and dynamics 
traditionally advance more quickly than formal mathematical models which depend on 
quantitative data for construction and validation. This has been especially true for the BER 
pathway. In the current study I have created a mathematical pathway model using published 
quantitative data on the BER pathway. Model construction was informed and guided by the 
conceptual models put forth in the literature. As described in chapters two and three, I collected 
quantitative experimental data on pathway performance under differing parameter conditions. 
The work presented in this chapter deals with the integration of the formal mathematical BER 
model described in chapter two and the quantitative data presented in chapters three and four. 
 As described in the preceding chapters, the method used in this study to measure DNA 
repair experimentally, the comet assay, does not directly measure the repair process itself. Repair 
cannot be visualized or measured independently. Instead what is measured is relative lesion 
concentration [198, 202-204, 277]. Likewise the simulated BER model output is generated as 
lesion concentration. According to the Michaelis-Menten assumptions of the BER model, repair 
rates are dynamic and the repair rates of individual enzymes in the BER pathway all vary 
continuously as a function of substrate concentration. In order to interpret the simulation results, 
model generated data is presented as lesion concentrations plotted against simulation time, which 
in principle provides temporal data that may be compared against experimental measurements of 
lesion levels.  
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Deficient BER capacity is often cited as a risk factor for disease [8]. Investigations of 
BER frequently focus on identification of factors which affect BER capacity [8, 278-283]. The 
goal of this study is to use quantitative modeling to predict a change in experimentally measured 
BER capacity based on a quantified change in a BER system parameter. Currently there is no 
standardized or absolute measure of BER capacity, or more generally, DNA repair capacity. In 
the absence of an absolute scale, reduced BER capacity is assessed by comparing quantitative 
measures of BER performance between experimental samples [8, 278-283]. The most common 
assay used for this purpose is the comet assay [8]. Using the comet assay, quantification of DNA 
repair capacity can be done using several features of the repair curve, such as: 1) peak damage 
induced by a genotoxic dose, 2) residual damage repaired after a given repair time, 3) repair time 
necessary to reach a particular residual damage level, or 4) repair rate over a specific interval of 
the repair curve (i.e. the slope of the repair curve). All are viable parameters for comparison of 
DNA repair capacity [8, 237]. Which of these measures is appropriate in a given application 
depends on the nature of the data.  
Peak damage is not simply dependent on the concentration of induced lesions. One may 
assume that if a given dose of genotoxic agent is administered to a cell population and that dose 
has the capacity to induce a certain number of lesions then peak damage in the DNA repair curve 
would simply be a function of the genotoxic dose. However, damage levels, as measured by the 
comet assay, do not represent the total number of lesions but rather the total number of lesions 
present in comet-detectable form. The comet assay is only able to detect strand breaks [202, 225, 
238, 284]. For some types of DNA repair, such as alkylation damage reversal, the damage is 
repaired without interrupting the integrity of the DNA backbone [1]. However, BER requires 
incision of the DNA backbone, and therefore comet-detectable strand breaks are formed 
whenever BER is initiated. 
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The residual damage after a given repair time and the repair time necessary to reach a 
given residual damage level are different approaches to measuring the same data feature. The 
nature of the data determines which is appropriate. In the case of the comet data in this study, 
there are a limited number of discrete repair times so between the two, measuring the residual 
damage at a given time point is the necessary choice. However, the residual damage at a given 
time point is a function of the repair rate and the peak damage. So ultimately there are only two 
unique features of a DNA repair curve which allow for comparison of repair capacity between 
cell populations: peak damage and the slope of the repair curve. Furthermore under the 
assumptions of Michaelis-Menten kinetics, the rate of each step in the repair process increases 
proportionally to the substrate concentration. Therefore differences in the peak damage level will 
affect the slope of the repair curve. Thus the peak value of the repair curve is the primary means 
by which the DNA repair capacity of differing cell populations is compared in this study. In the 
event that two cell populations have the same peak damage value, the slope of the repair curve 
may be useful for quantitatively distinguishing differences in repair capacity. 
Formation of strand breaks during the BER process is an important factor in the risk 
associated with a given damage load. Partially repaired lesions can often be more detrimental to 
cells than completely unrepaired lesions [1, 285]. If the early steps of the BER pathway 
(glycosylase and endonuclease activity) are carried out too efficiently as compared with the 
following steps, then a build-up of damage intermediates can occur [285-287]. Thus the repair 
capacity of a cell population, as measured by the peak damage during repair, depends on not only 
the speed of the individual enzymes in the sequence but on the balance between them. This point 
furthers the arguments in favor of studying this repair pathway with a model representing all of 
the enzymatic steps as opposed to drawing conclusions about repair capacity based the activity of 
a single BER protein or its concentration level in isolation from the whole system. 
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5.2 Calibration of BER model and scaling of experimental data 
 
One of the difficulties of integrating experimental data and modeling predictions is 
calibration of the model. The first step to model calibration was to establish the relationship 
between model output and experimental data. The model deals with damage in concentration 
units because it is necessary under the Michaelis-Menten assumptions. The comet assay was used 
to collect BER data because it has the unique ability to capture quantitative repair data from 
individual cells on the time scale of interest in this study. Comet data was collected as % tail 
DNA. Data analysis was carried out under the assumption that % tail DNA scores are linearly 
correlated to SSB concentrations. This assumption is substantiated by evidence from the literature 
[202, 238]. Under the assumption that the % tail DNA measurements are proportional to the 
damage quantities that they represent, I can treat model concentration predictions as proportional 
to experimental % tail DNA measurements. 
The second step towards model calibration was calculation of the lesion concentration 
induced by the MMS dose used in my experiments. MMS is a mono-functional and direct acting 
DNA alkylating agent [1, 218]. It creates DNA lesions through direct chemical activity with bases 
and has only one reactive site per molecule. Molecular dosimetry studies have shown a linear 
relationship between MMS exposure dose and lesion formation in human cells [288, 289]. A 
linear relationship between MMS exposure time and adduct formation has also been 
demonstrated by Pachkowski et al [63]. Pachkowski et al. report that DT40 cells exposed to a 1 
mM MMS dose for 30 minutes accrued 50 7-meG lesions per 10
6
 nucleotides. Under the 
assumption that induced lesion concentration is linearly correlated to both the MMS dose 
concentration and the exposure time, I calculated the expected 7-meG concentration induced by 
the 0.6 mM MMS dose used to induce damage in the 293t cells for this study. To do so I also 
assumed that the cell nucleus was spherical with a radius of 2.5 µm [115] and that each nucleus 
contained 2.91e9 base pairs and therefore 5.82e9 bases [290]. The calculation is presented below. 
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Assuming a spherical cell nucleus with a radius of 2.5 µm, the volume of a cell nucleus is: 
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The expected concentration of 7-meG induced by a 30 minute exposure to a 0.6 mM MMS dose 
is therefore: 
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The assumption that induced lesion concentration is linearly correlated to both the MMS 
dose concentration and MMS dose exposure time are supported by Jurkat comet data shown in 
Figure 5.1. The data were collected using the protocols described in chapter 3. The MMS doses 
used in this study were chosen based on preliminary results which were presented in chapter 3. A 
1x standard dose was chosen as 600µM MMS. This 1x dose was found to induce a damage 
quantity that is not fatal to cells. A dose too low may be repaired too quickly and its effects would 
not be measureable via comet assay. Too high a dose would induce damage beyond the capacity 
of cells to repair and would ultimately be fatal. The 1x dose used in this study was found to fall 
sufficiently with that range such that a half-strength dose and up to 4 fold dose would also induce 
measureable but repairable damage. Therefore using doses in that range, data were collected from 
Jurkat cells to create a dose response curve.  The data are plotted in Figure 5.1. Using % tail DNA 
as the measure of damage, Jurkat cells treated with MMS for 30 minutes and given no repair time 
show a linear dose response. This supports the assumption that MMS dose is linearly correlated to 
the lesion concentration induced and the assumption that lesion concentration is linearly 
correlated to % tail DNA. Under both assumptions it is expected that MMS dose is linearly 
correlated to % tail DNA. 
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Figure 5.1 Mean comet scores, represented as % tail DNA, are plotted against treatment dose of MMS as 
applied to Jurkat cells. The error bars show standard error. Regression line is shown. Where error bars are 
not shown, the standard error range is smaller than the data marker. After 30 minutes of MMS exposure, 
these cells were immediately run in a comet assay and given no time for repair. All methods and protocols 
used were described in chapter 3. 
 
 
 
 There are confounding factors that were considered in the above calculations. Although it 
is reasonable to assume that MMS induced damage is linearly proportional to the treatment 
dosage, it is important to note that MMS produces alkylation damage that is not directly 
detectable by the comet assay. Alkylation damage does however lead to strand breaks because 
incision of the DNA strand is a necessary step in the BER pathway [1, 291]. All lesions 
downstream to the AP sites (formed by glycosylase action) are effectively strand breaks and are 
detected by the comet assay [202]. AP sites are detected as well. AP sites are alkali labile and 
during the alkali unwinding step of the assay (described in chapter 3), AP sites are converted to 
comet detectable strand breaks [202]. This highlights an important point about comet data and 
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BER with respect to data analysis in this study. The BER pathway is active during the damage 
induction phase. The lesions detected in samples given no repair time are the intermediate lesions 
generated during the damage induction phase. The linear relationship between MMS dose and % 
tail DNA observed in the Jurkat samples is dependent on two factors. 1) The rate at which 
alkylation induced lesions are introduced into the comet detectable pool is dependent on the 
glycosylase action which is proportional to substrate concentration (i.e. available 7-meG and 3-
meA lesions). 2) The rate at which nicked sites are ligated and passed out of the detectable lesion 
pool is slow enough during the damage induction phase that the effects are not detected. 
 The damage induction process was simulated in the BER model. MMS induces two 
major lesion types, 7-meG and 3-meA. I assumed that 3-meA was produced at 25% of the 
concentration of 7-meG and that all the concentrations of other induced lesions were negligible. 
This has been experimentally demonstrated [1]. Damage doses were input to the model as the 
total lesion concentration expected from 30 minutes MMS exposure. Assuming linearity in lesion 
formation over time, the rate of damage was calculated as (1/30 of the total expected lesions) / 
(minute) for both lesion types. The damage rate was then applied for the first thirty minutes of the 
model simulation. 
 The result is that the model simulates a continuous damage process in which repair is 
occurring during the damage induction. In order to implement this strategy the model is simply 
run for 30 minutes with a continuous damage formation rate and then stopped. The values at t = 
30 for each substrate in the model are then used as the initial values for each respective substrate 
during a second, longer simulation in which the damage induction rate is set to zero. 
 The final step towards model calibration was to scale % tail DNA data for model 
comparison. The samples used to determine the scaling factor were samples given no repair time. 
Although repair occurs continuously during damage induction, the effect is accounted for in the 
simulation and it is minimized by using the samples which went directly into the assay following 
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the removal of the MMS dose. After scaling the % tail DNA data to match lesion concentration 
units, data were able to be compared to model output. Under the arguments presented above, the 
% tail DNA scores are assumed linearly related to lesion concentrations and a relative change in 
% tail DNA is interpreted as an equivalent change in relative lesion concentration. 
5.3 Fitting model predictions to 293t comet data 
In order to carry out further analysis it is necessary to establish a fit between model 
predictions and experimental data. An initial comparison shows that under default parameter 
conditions the model is a poor fit to the data (Figure 5.2). The model predicts that repair will take 
place at a faster rate than experimental measurements indicate. To account for this discrepancy I 
introduced a 7-fold reduction in all model kcat values. There is no specific data in the literature 
that supports this choice quantitatively. However there is reasoning to support the parameter 
adjustment.  
The comet assay has been used extensively and is well represented in the literature. There 
is no basis on which to question the nature of the comet data. In other words there is no cause to 
suggest that the signal measured in the comet assay is due to something other than the presence of 
BER lesion intermediates in the form of SSBs. Furthermore although the repair rate of the 
experimentally generated repair curve is slower than the model predicts, the data trends in the 
manner expected. This suggests that the discrepancy is due to an over-estimation of the in vivo 
repair rate. 
In addition, there is no basis on which to question the general model structure. Although 
quantitative modeling of the BER pathway is in the early stages of development, the conceptual 
model of the pathway is sound. Extensive literature supports the structure of the BER model. 
There are no major, justifiable, structural adjustments that could conceivably improve the fit of 
the simulation curve to the experimental data. 
110 
 
Contrary to the model structure and the nature of the comet assay data, there is cause to 
consider that the kinetic parameters of the model could have been overestimated. The 
experimental repair curve represents measurement of the kinetic performance of the entire BER 
pathway in vivo. However the kinetic parameters mined from the literature were all collected for 
individual pathway steps in vitro. BER processes were reconstituted from purified protein 
extracts in order to measure enzymatic activity. This was done from necessity. There are no 
techniques available for the measurement of enzyme kinetics on individual BER steps within a 
working cell. It is reasonable to speculate that the kinetic parameters of BER enzymes measured 
in vitro overestimate the kinetic parameters governing the reactions in vivo. Furthermore, scaling 
all kcat parameters down by a factor of 1/7 was the only adjustment that I found which could 
generate a model repair curve capable of fitting the experimental data. Figure 5.3 shows the 
simulated repair curve with all kcat values reduced by a factor of 1/7 fit to the 293t experimental 
data. 
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Figure 5.2: The model repair curve plotted in solid blue shows the simulation results obtained with default 
model parameters. 293t comet data is plotted is plotted in red with ‘’ data markers. Comet assay methods 
were described in detail in chapter 3.  
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Figure 5.3 The model repair curve plotted in solid blue shows the simulation results obtained with all kcat 
values decreased by a factor of 1/7. 293t comet data is plotted is plotted in red with ‘’ data markers. 
Comet assay methods were described in detail in chapter 3. 
 
 
 
5.4 Use of medians versus means for data analysis 
 
 The choice to use median values from experimental data rather than mean values was 
based on the distribution of data in the 293t data sets. Figure 5.4 shows histograms for data at four 
different repair times. The data from samples given short repair times tends to have a normal 
distribution. However, given sufficient repair time a disproportionate number of cells with no 
damage or low damage give a skewed shape to the damage distribution. This precludes the use of 
parametric statistical approaches and makes median values more appropriate for data analysis 
than mean values. Because all data is plotted as median values, error bars in Figure 5.5 show the 
interquartile range. The need for the use of interquartile range in this case is unfortunate. Figure 
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5.5 shows a sample of 293t data plotted with median values using interquartile range for error 
bars and mean values using standard error for error bars. The use of the standard error shows the 
data to be more reliable than is seemingly indicated by the interquartile ranges. For this reason 
error bars have been excluded from most data plots. 
 
 
 
 
Figure 5.4 Histograms of 293t comet data are presented above. Data is shown as % tail DNA. A) 0 minutes 
repair time. B) 15 minutes repair time. C) 45 minutes repair time. D) 60 minutes repair time. 
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Figure 5.5 293t data plotted against repair time. Mean data is plotted in blue with ‘.’ data markers. Error 
bars show standard error. Medians of the same data set are plotted in red with ‘◊’ data markers. Error bars 
show interquartile range.  
 
 
5.5 Exclusion of C3 data set 
Comet assay data were collected on each of the three 293t Polβ knockdown cell lines: C2, 
C3, and C4. There was no basis for exclusion of the C3 data set from analysis based on visual 
inspection of the comet images. Also, there is a trend towards repair over time in the C3 data set.  
But I found no reasonable parameter combination that would fit a model curve to the C3 data set. 
Consequently there is little to say regarding the C3 data set and it has been excluded from further 
analysis. Figure 5.6 shows the C3 data plotted as %tail DNA. 
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Figure 5.6: The C3 comet data set. Data is presented as %tail DNA. I found no reasonable parameter 
combination in the BER model which would generate a simulation curve to fit this data set. 
 
 
 
5.6 Model predictions compared to experimental data 
  
 Comet assay data was collected from 293t, C2, and C4 cell lines. Samples were exposed 
to 0.6mM MMS treatments for 30 minutes. All protocols and methods are presented in chapter 3. 
Figure 5.7 shows plots of repair time-course data for each cell line. C2 data show a distinct 
decrease in peak damage as well as repair rate following peak damage compared to 293t data. C4 
data show an increase in both peak damage levels and repair rate following peak damage as 
compared to 293t data. Analysis of the response of the C2 and C4 cell lines respectively to 
alkylation damage is presented separately for each cell line. The differences in the measured 
response of the two knockdown cell lines warrant different approaches to analysis. 
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Figure 5.7 Comet data plotted against time. A) C4 data is plotted in blue with ‘□’ data markers. B) 293t 
data is plotted in red with ‘‘ data markers. C) C2 data is plotted in black with ‘◊’ data markers. The 0-
minute repair 293t score was assumed equivalent to the model prediction of lesion concentration for cells 
given a 30 minute, 600µM MMS dose. All other data for 293t, C2, and C4 scores was converted to lesion 
concentration on the same scale. 
 
 
 
5.7 Analysis of C2 data using BER model 
 
 The decrease in peak damage of the C2 cell line cannot be accounted for by changes in 
Polβ concentration. Model predictions show a negligible change in peak damage concentration 
from increases in Polβ. And the effect of Polβ decrease is an increase in peak damage 
concentration. In order to simulate a decrease in peak damage concentration and generate a repair 
curve that can fit the C2 experimental data it is necessary to alter the flux of lesions into and out 
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of the SCGE detectable pool. All lesions downstream to the glycosylase activity and upstream to 
ligase activity are considered SCGE detectable. Therefore to effect a change in the simulated 
repair curve such that a fit could be generated for the C2 data I tried decreasing the concentration 
of the glycosylase (Aag) and increasing the concentration of the ligases (Lig I and LigIII). Figure 
5.8 A shows the effects of fold changes to the concentration of Aag on the model generated repair 
curve. Figure 5.8 B shows the effects of fold changes to the concentration of the ligases on the 
model generated repair curve. 
 Individually, changes to the concentration of Aag and the concentration of the ligases 
could not generate a repair curve suitable for a fit to the C2 data. Figure 5.9 shows the effect of 
changing the concentration of Aag and the ligases simultaneously. Simultaneous decrease in the 
Aag concentration, which controls the influx of lesions to the SCGE detectable pool, and increase 
in the ligase concentrations, which control the outflow of lesions from the SCGE detectable pool, 
generates a repair curve which can fit the C2 data reasonably well. The implications of these 
results will be addressed in the discussion section. 
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Figure 5.8: 293t and C2 comet data are plotted against repair time. 293t data are plotted with blue ‘◊’ data 
markers. C2 data are plotted with red ‘‘ data markers. The 293t 0-minute repair median was calibrated to 
model predictions with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 
5.###). All other data were scaled by the same factor. A) Simulated repair curves with fold changes to Aag 
concentration are plotted. Legend indicates Aag fold changes for each curve. B) Simulated repair curves 
with fold changes to Lig 1 and LigIII concentration are plotted. Legend indicates ligase fold changes for 
each curve.  
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Figure 5.9: A) 293t and C2 comet data are plotted against repair time. 293t data are plotted with blue ‘◊’ 
data markers. C2 data are plotted with red ‘‘ data markers. The 293t 0-minute repair median was 
calibrated to model predictions. All other data were scaled by the same factor. Model curve to fit 293t data 
was run with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 5.3) and is 
plotted in solid blue. Model curve to fit C2 data, plotted as a dashed red line, was run with Polβ 
concentration reduced by a factor of 0.64, Aag concentration reduced by a factor of 0.5, and the 
concentration of both Lig 1 and LigIII increased by a factor of 1.3.  
 
 
 
5.8 Analysis of C4 data using the model 
 The behavior of the repair curve for the C4 comet data differs considerably from the C2 
data. Qualitatively the response of the C4 cell line compared to the 293t cell line shows the 
expected behavior. The damage peak of the C4 data was increased, indicating a decrease in the 
repair capacity of the C4 cell line. Unlike the C2 cell line the general qualitative response of the 
C4 data is predicted by the model. When Polβ concentration is decreased, the damage peak 
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increases. However the model predicts only a very slight increase in the damage peak from the 
59% Polβ expression decrease measured with the quantitative western blots, see Figure 5.10. If 
Polβ concentration is set to zero the model prediction for peak damage increase is still not enough 
to match experimental data and the repair curve is a poor fit (Figure 5.10).  
 Figure 5.11 shows the effects of parameter changes on the model fit to the C4 data. 
Changes to the Aag and ligase concentrations were again employed to attempt a model data fit. 
Figure 5.11 A shows the effects of increasing fold changes to the Aag concentration in the model. 
Although the peak damage level increases and shifts earlier as Aag concentration increases. A 5 
fold Aag increase generates a repair curve with a peak damage value nearly matching the C4 
experimental data. But the slope of the repair curve following the peak is increased significantly 
and model predictions do not match the data. The effects of decreasing fold changes to the 
concentration of Lig 1 and LigIII are similar to the effects of Aag increase and likewise do not 
generate a curve with an adequate fit to the experimental data, see Figure 5.11 B.  
 Figure 5.8 B shows that an increase of Lig 1 and LigIII concentration will decrease the 
slope of the damage curve and lower the damage peak. Therefore, as with the fit presented for the 
C2 data in Figure 5.9, I tried simultaneous changes to Aag and ligase concentrations. Unlike the 
C2 data however, the model cannot generate a repair curve to fit the C4 data even if expression 
changes to the Aag and ligases are implemented simultaneously. The best fit curve using this 
method is shown in Figure 5.12 
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Figure 5.10: 293t and C4 comet data are plotted against repair time. 293t data are plotted with blue ‘◊’ data 
markers. C2 data are plotted with black ‘‘ data markers. The 293t 0-minute repair median was calibrated 
to model predictions. All other data were scaled by the same factor. Model curve to fit 293t data was run 
with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 5..3) and is plotted 
in solid blue. The red dotted line plots the model prediction for a repair curve with Polβ concentration 
reduced to 41% of the default value. The black dashed line plots the model predictions for a repair curve 
with Polβ concentration set to zero.  
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Figure 5.11: 293t and C4 comet data are plotted against repair time. 293t data are plotted with blue ‘◊’ data 
markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-minute repair median was calibrated to 
model predictions with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 
5.3). All other data were scaled by the same factor. A) Model simulated repair curves are plotted with 
increasing fold changes applied to Aag concentration. Legend indicates fold change for each plot. B) Model 
simulated repair curves are plotted with decreasing fold changes applied to the concentration of Lig 1 and 
LigIII. Legend indicates fold change for each plot. 
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Figure 5.12: 293t and C4 comet data are plotted against repair time. 293t data are plotted with blue ‘◊’ data 
markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-minute repair median was calibrated to 
model predictions with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 
5.3). All other data were scaled by the same factor. Blue solid line plots model predictions for repair curve 
with default parameters. Red dashed line plots model predictions with a simultaneous 5 fold increase in 
Aag concentration, 1.5 fold increase in the concentration of Lig 1 and LigIII, and a 59% decrease in Polβ 
concentration. 
 
 
5.9 Alternative model structures 
 
Analysis of the C2 data was done by introducing alterations in the expression of BER 
enzymes to the model parameters. Reduction of Polβ alone cannot reduce the damage peak of the 
repair curve to produce a fit for C2 data. Alteration of the model structure does not change this. 
The C4 data however is different. The damage peak of the C4 data is increased compared to the 
293t data and changes to Polβ expression have a qualitatively corresponding effect on model 
predictions. Even so, complete elimination of Polβ from the model does not change the repair 
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curve enough to generate a fit to the C4 data. Furthermore the approach of varying the expression 
of Aag and the ligases, as used on the C2 data as well, does not improve the fit of model 
predictions to the C4 data. Therefore an alternate approach to fitting the model to the C4 data was 
used; simulations were run using alternative model structures and the results were compared to 
the 293t and C4 data. 
The original BER model was constructed using all of the enzymatic reactions involved in 
the repair of 3-meA and 7-meG for which I found literature support. Reduced versions of the 
original model are presented below as alternative model structures. An ideal alternative model 
would reduce the complexity of the BER model and improve its predictive capabilities. There are 
18 different sub-pathways through the network of the original BER model. Each is capable of 
completing the BER process on the types of lesions examined in this study. I have grouped the 
sub-pathways into three main BER sub-pathways labeled A, B, and C in the figures below. 
Deactivation of these BER sub-pathways in different combinations gives rise to six alternative 
models of interest. They are presented below. Figures 5.13 through 5.18 show versions of the 
BER network diagram representing each of the proposed alternative models and model 
predictions using the alternative structure fit to the 293t and C4 data. In each figure the portions 
of the pathway which are inactive in each alternative model are shown in gray. Each alternative 
network diagram is presented with a series of model simulations showing the effects of Polβ 
reduction on the repair curve using the respective alternative model structure. Simulation results 
are compared to experimental 293t and C4 data. Full sized versions of each alternative model 
structure diagram are presented in Appendix A. 
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Figure 5.13: Alternative model structure 1. A) 293t and C4 comet data are plotted against repair time. 293t 
data are plotted with blue ‘◊’ data markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-
minute repair median was calibrated to model predictions with default parameters (all kcat values reduced 
by a factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model 
predictions are plotted using alternative model structure 1. Polβ concentration was varied for each model 
run: full Polβ concentration is plotted in solid blue, 59% reduction is plotted with a red dashed line, 90% 
reduction is plotted in green with a dash-dot line, and 100% Polβ reduction is plotted with a black dotted 
line. B) Network diagram for alternative model structure 1. Sub-pathway A has been deactivated. To create 
this alternative model the reaction rates v3, v27, and v28 were all set and held equal to zero. Under these 
conditions Neil1 is inactive and Ape1 does not perform 3’-dRp lyase activity. Inactive portions of the BER 
pathway are shown in gray. 
  
 
 
 
126 
 
 
Figure 5.14: Alternative model structure 2. A) 293t and C4 comet data are plotted against repair time. 293t 
data are plotted with blue ‘◊’ data markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-
minute repair median was calibrated to model predictions with default parameters (all kcat values reduced 
by a factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model 
predictions are plotted using alternative model structure 2. Polβ concentration was varied for each model 
run: full Polβ concentration is plotted in solid blue, 59% reduction is plotted with a red dashed line, 90% 
reduction is plotted in green with a dash-dot line, and 100% Polβ reduction is plotted with a black dotted 
line. B) Network diagram for alternative model structure 2. Sub-pathway B has been deactivated. In this 
alternative model, reaction rates v10 and v20 were set and held at zero. Under these conditions Ogg1 does 
not perform its AP lyase activity and Polδ does not perform its gap-filling activity. Inactive portions of the 
BER pathway are shown in gray. 
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Figure 5.15: Alternative model structure 3. A) 293t and C4 comet data are plotted against repair time. 293t 
data are plotted with blue ‘◊’ data markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-
minute repair median was calibrated to model predictions with default parameters (all kcat values reduced 
by a factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model 
predictions are plotted using alternative model structure 3. Polβ concentration was varied for each model 
run: full Polβ concentration is plotted in solid blue, 59% reduction is plotted with a red dashed line, 90% 
reduction is plotted in green with a dash-dot line, and 100% Polβ reduction is plotted with a black dotted 
line. B) Network diagram for alternative model structure 3 is a combination of alternative models 1and 2. 
Sub-pathways A and B have been deactivated. To create this alternative model reaction rates v3, v10, and v20 
were all set and held at zero. Under these conditions Neil1 does not function, Ogg1 does not perform its AP 
lyase activity, and Polδ does not perform its gap-filling activity. Inactive portions of the BER pathway are 
shown in gray. 
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Figure 5.16: Alternative model structure 4. A) 293t and C4 comet data are plotted against repair time. 293t 
data are plotted with blue ‘◊’ data markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-
minute repair median was calibrated to model predictions with default parameters (all kcat values reduced 
by a factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model 
predictions are plotted using alternative model structure 4. Polβ concentration was varied for each model 
run: full Polβ concentration is plotted in solid blue, 59% reduction is plotted with a red dashed line, 90% 
reduction is plotted in green with a dash-dot line, and 100% Polβ reduction is plotted with a black dotted 
line. B) Network diagram for alternative model structure 4. Sub-pathway C has been deactivated. To create 
this alternative model reaction rate v6 was set and held constant at zero. Under these conditions Ape1 does 
not perform AP endonuclease activity. The inactive portions of the pathway are shown in gray. 
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Figure 5.17: Alternative model structure 5. A) 293t and C4 comet data are plotted against repair time. 293t 
data are plotted with blue ‘◊’ data markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-
minute repair median was calibrated to model predictions with default parameters (all kcat values reduced 
by a factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model 
predictions are plotted using alternative model structure 5. Polβ concentration was varied for each model 
run: full Polβ concentration is plotted in solid blue, 59% reduction is plotted with a red dashed line, 90% 
reduction is plotted in green with a dash-dot line, and 100% Polβ reduction is plotted with a black dotted 
line. B) Network diagram for alternative model structure 5. Sub-pathways A and C have been deactivated. 
To create this alternative model reaction rates v3, v6, v27, v28 were set and held constant at zero. Under these 
conditions Ape1 and Neil1 are inactive. The inactive portions of the pathway are shown in gray. 
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Figure 5.18: Alternative model structure 6. A) 293t and C4 comet data are plotted against repair time. 293t 
data are plotted with blue ‘◊’ data markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-
minute repair median was calibrated to model predictions with default parameters (all kcat values reduced 
by a factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model 
predictions are plotted using alternative model structure 6. Polβ concentration was varied for each model 
run: full Polβ concentration is plotted in solid blue, 59% reduction is plotted with a red dashed line, 90% 
reduction is plotted in green with a dash-dot line, and 100% Polβ reduction is plotted with a black dotted 
line. B) Network diagram for alternative model structure 6. Sub-pathways B and C have been deactivated. 
To create this alternative model reaction rates v6 and v10 were set and held constant at zero. Under these 
only Neil1 can act on an abasic site. The inactive portions of the pathway are shown in gray. 
 
 
 
The results of the model simulations with varied Polβ concentration for each alternative 
model structure are presented above in Figure 5.13 – 5.18. I found no alternative model structure 
which could generate a repair curve capable of fitting the full C4 data set. The implications of this 
will be addressed in the discussion section. However, changes to the model structure can affect 
the model output such that the damage levels of C4 data at 15, 30, and 45 minutes repair time can 
be approximated by a model generated repair curve following a decrease in Polβ concentration. If 
the curve fit to this sub-set of data points is used as a metric, some useful insight can be gained 
from the alternative model structure simulations.   
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Alternative model structure 1 (Figure 5.13) generates a fit similar to the full model 
structure. But to achieve this Polβ concentration must be set to zero. This condition does not 
match with experimental results. Polβ expression was detected in the C4 cell line. Therefore 
alternative model structure 1 was rejected.  
Alternative model structures 4, 5, and 6 are presented in Figures 5.16, 5.17, and 5.18 
respectively. None of these three alternative model structures generated a repair curve which 
could fit the 293t data. These alternative model structures therefore decrease the predictive power 
of the BER model. The similarity between these three alternative structures is that sub-pathway C 
is inactive in all of them. This suggests that sub-pathway C was active and played a significant 
role in the repair response of the 293t samples. Therefore analysis of the experimental data with 
the BER model should include sub-pathway C. On this basis, alternative model structures 4, 5, 
and 6 were rejected. 
 Alternative model structures 2 and 3 are more viable options than the other alternative 
model structures. The simulations from each produce curves that can fit the 293t data. And both 
can fit the C4 data in the 15-45 minute range by introducing a decrease in Polβ concentration. 
The reduction of Polβ necessary to fit the C4 data in the 15-45 minute range is between 95% and 
97%. These results are shown in Figure 5.19. This agrees qualitatively with the western blot 
results but suggests that the western blot data under-estimates the extent of Polβ knockdown. 
Figure 5.18 shows that model simulations predict that sub-pathway A is capable of repair and but 
cannot fit the 293t comet data independent of sub-pathway C. However, as shown in Figure 5.19, 
the difference in the simulated repair curves between alternative models 2 and 3 is negligible. 
This indicates that when both sub-pathways A and C are active, sub-pathway C is dominant and 
sub-pathway A does not contribute significantly unless the sub-pathway C is lacking. This agrees 
with the suggested role for sub-pathway A in the literature and will be addressed in the discussion 
section. Selecting from the alternative model structures presented above, alternative model 
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structure 3 is the simplest model with the greatest predictive power. Further analysis will make 
use of alternative model structure 3 (hereafter referred to as alt3). 
  
  
 
 
Figure 5.19: 293t and C4 comet data are plotted against repair time. 293t data are plotted with blue ‘◊’ data 
markers. C4 data are plotted with red ‘‘ data markers. The 293t 0-minute repair median was calibrated to 
model predictions with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 
5.3). All other data were scaled by the same factor. Polβ concentration was varied for each model run: full 
Polβ concentration is plotted in solid blue, 95% reduction is plotted with a red dashed line, 96% reduction 
is plotted in green with a dash-dot line, and 97% Polβ reduction is plotted with a black dotted line. A) 
Simulations run with alternative model structure 2. B) Simulations run with alternative model structure 3. 
 
 
5.10 Sensitivity analysis 
  A single parameter sensitivity analysis was performed on the full model and Alt3. The 
sensitivity was measured as the fold-change in model output for a given fold-change in parameter 
value. The parameters used for sensitivity analysis were the concentrations of each enzyme in the 
model. Under the Michaelis-Menten assumptions of the model, a fold-change to an enzyme 
concentration is equivalent to a fold-change in the kcat of each reaction involving that enzyme. 
The results are displayed in Tables 5.1 and 5.2. 
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Table 5.1: Results of sensitivity analysis for the full model structure. Sensitivity is presented as the fold 
change in the peak value of the repair curve. Sensitivity was calculated for fold-changes in the 
concentration of each enzyme in the model individually . 
 
Enzyme fold-
change: 
0.1 0.5 2 10 
Aag 0.949 0.273 0.127 1.665 
Ape1 0.001 0.000 0.000 0.000 
Polβ 0.062 0.013 0.008 0.015 
Lig 1, LigIII 0.495 0.207 0.345 0.844 
Neil1 0.000 0.000 0.000 0.000 
PNK 0.000 0.000 0.000 0.000 
Polδ 0.001 0.001 0.001 0.010 
Fen1 0.002 0.000 0.000 0.000 
Ogg1 0.000 0.000 0.000 0.000 
 
 
 
   
Table 5.2: Results of sensitivity analysis for Alt3. Sensitivity is presented as the fold change in the peak 
value of the repair curve. Sensitivity was calculated for fold-changes in the concentration of each enzyme 
in the model individually . 
 
Enzyme fold-
change: 
0.01 0.1 10 100 
Aag 0.949 0.273 0.127 1.662 
Ape1 0.001 0.000 0.000 0.000 
Polβ 0.093 0.015 0.009 0.017 
Ligases 0.493 0.206 0.343 0.838 
 
  
5.11 Analysis of additional data features 
 
 Figure 5.20 shows the 293t, C2, and C4 data sets with 5 minute and 90 minute repair data 
included. The plots show the complete data sets collected from each comet assay. The additional 
data was left out of the initial model-data fitting. The reason is that the 5 minute and 90 minute 
repair data show fluctuations in the repair curve that cannot be accounted for by the model in its 
original state. Nor can any of the alternative models presented so far account for the behavior of 
the repair curves in the comet data sets. Model alterations introduced previously for fitting the 0, 
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15, 30, 45 and 60 minute repair data required parameter adjustment and reduction of the model 
network.  In order to fit the 5 and 90 minute repair data trends the model needed modifications 
that were more easily performed after the model was fit to the other data. Fitting the 90 minute 
repair data was the simpler task and is discussed first. Alt3 was used for this portion of the 
analysis. 
 
 
 
 
Figure 5.20: Full comet data sets including 5 minute and 90 minute repair time data. Median values are 
plotted. 293t data is plotted in blue with ‘o’ data markers. C4 data is plotted in red with ‘’ data markers. 
C2 data is plotted in green with ‘◊’ data markers. The 293t 0-minute repair median was calibrated to model 
predictions with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 5.3). 
All other data were scaled by the same factor. 
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5.11 The 90 minute increase 
 
 The increase in damage levels after 90 minutes of repair time was an unexpected result.  
It is not predicted by the Michaelis-Menten based BER model in which the parameters of each 
enzymatic reaction remain fixed throughout the simulation. The trend was common to all of the 
comet data sets suggesting that it is not merely an experimental artifact. I used the 293t data set to 
explore the possible causes for the 90 minute increase because the 293t data can be fit by model 
predictions better that the C2 or C4 data sets. 
 As discussed in section 5.1, the comet detects damage in the form of strand breaks. This 
implies that the methylation damage induced by MMS exposure is not detectable in its initial 
form but rather becomes comet assay-detectable after excision by Aag. It is unlikely that an 
exogenous factor caused the increase in damage levels after 90 minutes repair time. The untreated 
control samples did not show damage on the scale of the 90 minute damage increase. That 
suggests that the increase was due to endogenous changes resulting in a build-up of lesions in 
comet-detectable form. 
 Under the Michaelis-Menten assumptions of the BER model, in order to increase the 
proportion of comet-detectable damage after 60 minutes of repair time, there would need to be a 
change in the parameters of one or more reaction in the pathway. The kcat and Km values are 
fundamental to each enzyme and would not be altered unless an inhibitor was introduced to alter 
the effective kcat of one or more enzymes during the repair process.  
I tested the possibility of enzyme inhibition by simulating the maximum possible effect, total 
inhibition, for Ape1, Polβ and both ligases. In each case the enzyme in question was set to a 
concentration of zero at 60 minutes repair time. None of these conditions generated a fit to the 
data. Ligase increase at t = 60 does cause the repair curve to trend upward slightly but it is 
insufficient to reproduce the 90 minute increase observed in the comet data. Ligase removal 
creates a situation where no further damage can flow out of the comet-detectable pool. Since this 
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was not sufficient to account for the build-up, an increase in the flow of damage into the comet-
detectable pool is necessary to match the increase measured in the data. 
 Figure 5.21 shows the effects of increasing the concentration of Aag at t = 60 minutes. A 
10-fold increase in Aag concentration was necessary to fit the 90 minute data point. I found no 
literature to support this change in glycosylase concentration nor to suggest a precedent for this 
finding in the data. But the up-regulation of a BER enzyme in response to a damage load is a 
realistic possibility and the model shows quantitatively that such a change could account for the 
data. I modeled the glycosylase increase in the simplest way possible. The model simply 
increases the concentration of Aag by 10-fold at t = 60 minutes. If the increase were achieved by 
protein synthesis alone this would be an inadequate function to represent the change. However 
the limited temporal resolution of the comet data does not allow for further refinement of the 
function describing the glycosylase increase so I opted for the simplest possible implementation 
of the change in the model. 
 
 
 
 
 
 
137 
 
 
 
Figure 5.21: 293t comet data are plotted against repair time with red ‘‘ data markers. The 293t 0-minute 
repair median was calibrated to model predictions with default parameters (all kcat values reduced by a 
factor of 1/7 as presented in section 5.3). All other data were scaled by the same factor. Model output, using 
Alt3, is plotted as a blue solid line. Aag concentration was increased 10-fold at t = 60. 
 
 
5.12 The 5 minute dip 
 
 I tried two approaches to recreating the dip in lesion concentration which occurs in all the 
comet data sets at the 5 minutes repair time point. Briefly, the two approaches were 1) to 
represent the recruitment of Ape1 during the initial stages of repair by gradually increasing Ape1 
concentration to its maximum value during the first thirty minutes of repair, 2) to introduce a 
spike in Parp-1 at the appropriate time which binds strand breaks for a brief time and therefore 
temporarily removes them from the pool of comet detectable lesions. Parsons et al. suggest that 
Parp-1 binds strand breaks in general if they exceed a threshold concentration and then releases 
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them for repair [94]. The second approach proved to be able to recreate the trend of the comet 
data but to be thorough I have presented the results of both modeling approaches beginning with 
the Ape1 recruitment strategy.  
5.12.1 Ape1 recruitment 
 
 Ape1 has multiple functions within the cell. Aside from its role in DNA repair it is most 
notably involved in redox regulation of transcription factors [292]. Not all Ape1 activity occurs 
within the nucleus. Therefore a recruitment time is necessary following a large influx of DNA 
lesions before Ape1 concentration reaches its peak in the nucleus. To model this effect, I 
switched the constant Ape1 concentration value of 2000 nM with a time dependent logistic 
function. The initial value of Ape1 concentration was set to 100 nM and increased to a full 
concentration of 2000 nM according to equation 5.1: 
                   
    
  
            
   
 
    (5.1) 
 
 where y18 represents Ape1 concentration (nM), r  = 0.2, and K = 2000 nM. Ape1 concentration 
over time is shown in Figure 5.22. Figure 5.23 shows Ape1 recruitment has a negligible effect on 
the shape of the repair curve. 
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Figure 5.22: Ape1 concentration over time increasing logistically with a maximum value of 2000nM.  
 
Figure 5.23: Repair curves are shown above for two model runs. The green line shows the repair curve for 
an Alt3 simulation with default parameters. The red dashed line shows the repair curve for Alt3 under the 
same conditions with one exception: Ape1 concentration began at 100nM and increased according to the 
logistic function to a maximum value of 2000nM. The effect of this was had negligible effects on the shape 
of the repair curve. 
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5.12.2 PARP-1 binding 
 
 The second approach to modeling the dip in the repair curve data at 5 minutes was to  
introduce a transient concentration of PARP-bound SSBs with its peak at 5 minutes. A PARP-1 
influx was introduced to the model and assumed to bind strand breaks making them undetctable 
by the comet assay. This was represented in the model by excluding a lesion concentration equal 
to PARP-1 concentration from the repair curve. 
 Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear protien with multiple functions 
[293]. PARP-1 functions include but are not limited to the following:  1) PARP-1 plays a role in 
regulated cell death as a response to excessive genetic insult [294]. Such a response can be 
apoptotic [160] or necrotic [295] and PARP-1 plays an active role in each. 2) PARP-1 is 
important in BER because it is involved with XRCC1 in the recruitment of BER enzymes to 
damage sites [96]. 3) PARP is involved in the protection of the cell against cytotoxicity following 
an influx of DNA lesions [63, 94, 296]. It is the third PARP function which I have included in the 
model to account for the dip in lesion concentration observed in my comet assay data.The role of 
PARP-1 in maintaining genomic integrity derives from its ability to bind SSBs [63, 94, 96, 293, 
294, 296-299]. Initially this function was considered to possibly inhibit BER because repair 
enzymes cannot access a lesion site to which PARP-1 is bound [298, 299]. PARP-1 poly(ADP-
ribosyl)ation is necessary for the dissasocitation of PARP-1 from a SSB site. If poly(ADP-
ribosyl)ation is inhibited, PARP-1 binds irreversibly to SSBs and BER enzymes are blocked from 
completing repair [297]. And it has been shown in vivo that in the absence of PARP-1 BER can 
still proceed to completion [94, 297].  
 However, recent studies have shown that PARP-1 binding to SSBs including BER 
intermediates is important to genomic stability. Horton et al. have shown that even in Polβ -/- and 
XRCC1-/- cells PARP-1 inhibition increases sensitivity of mouse fibroblasts to MMS induced 
cytotoxicity. This is indicative of a PARP-1 role in BER beyond just enzyme recruitment [96]. 
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Pachkowski et al. have shown an increase in MMS sensitivity to PARP-1 deficient DT40 cells (a 
chicken B lymphocyte lacking PARP-2). Parsons et al. were able to show that PARP-1 binding of 
SSBs in HeLa cells protects SSBs from degradation by nucleases before the compeltion of BER 
[94]. Taken together these studies suggest that PARP-1 contributes to genomic stability by 
binding SSB lesions and protecting them from further degradation as they await repair by the 
BER machinery. 
Transient binding of BER intermediates by PARP-1 suggests a possible explanation for 
the dip in repair intermediate concentration observed in the comet assay data. The comet assay 
detects strand breaks [202].  Although I found no supportive evidence in the literature, it is 
reasonable to suppose that PARP-1 bound BER intermediates would not be detected by the comet 
assay. Parsons et al. report that in HeLa whole cell extract incubated with double stranded 
oligonucleotides containing uracil, PARP-1 is the first protein present at lesion sites. They further 
report that gradual dissociation of PARP-1 from lesions took place within 4 minutes. The dip in 
the repair curve of my comet data occurs 5 minutes after  the removal of the MMS dose. 
Although my comet data lack further temporal resolution, the timing of the dip reasonalby 
coincides with the behavior of PARP-1 descrived by Parsons et al. [94]. I therefore accounted for 
this PARP-1 behavior in my BER model and generated a model repair curve which fits the comet 
data with the 5 minute dip included. 
 To implement this strategy in the model I created a function describing PARP-1 
concentration with a spike at 5 minutes repair time. After peaking at 5 minutes the PARP-1 
concentration decays to zero and remains there. To simulate the binding of repair intermediates 
by the influx of PARP-1, the PARP-1 concentration curve was subtracted from the repair curve 
which represents all comet detectable lesions. It was assumed that all PARP-1 introduced into the 
simulation was bound to a lesion intermediate. In this respect the PARP-1 concentration curve 
shown in Figure 5.24 actually represents the concentration of the PARP-1 bound lesions. 
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Additional free PARP-1 or PARP-1 involved in other processes is expected to be present as well 
but is not represented in this case. Equation 5.2 is the function used to describe Parp influx in the 
model over the interval        . 
                          ,          (5.3)  
             ,             
where A = 400,     ,      and b = 2. 
 
 
 
 
Figure 5.24: Simulation run using Alt3 and plotted with the 293t data. The data set includes the 5 minute 
repair time point. The model simulation is plotted as a blue dashed line. 293t median comet data scores are 
plotted in red with ‘◊’ data markers. The 293t 0-minute repair median was calibrated to model predictions 
with default parameters (all kcat values reduced by a factor of 1/7 as presented in section 5.3). All other data 
were scaled by the same factor.  All other model parameters were set to default values. The simulation 
included a spike in PARP-1 which was assumed to bind intermediate BER substrates. PARP-1-bound 
intermediates were not counted among comet detectable lesions until after release. The red dotted line 
shows the concentration of PARP-1-bound intermediates during simulation. 
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 Figure 5.25 shows the fit of Alt3 with PARP-1 binding to the 293t comet assay data. It 
suggests that PARP-1 binding of BER intermediates could explain the 5 minute dip in the comet 
assay data. But a true test of the PARP-1 binding model could not be carried out with the data 
collected in this study. And furthermore the function used to model the PARP-1 influx was 
arbitrarily chosen because it made the model fit the data. I was unable to find quantitative data 
reflecting the behavior of PARP-1 binding to SSBs in response to a damage influx. The model 
results do however suggest that the qualitative description of PARP-1 behavior is a viable 
explanation for the trend observed in the data and warrants further investigation in future studies.  
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Chapter 6: Discussion 
6.1 Preamble to the discussion 
 
 It is well established in the literature that BER deficiencies are a risk factor for disease [3, 
98-101]. There are numerous studies focusing on individual enzymes or sub-pathways of BER. 
But there has been little quantitative assessment of the dynamic interactions between the major 
components of the BER system following an influx of damage. This is important because 
quantitative differences in cellular function are necessarily related to quantitative differences in 
protein function, which in turn are related to differences in protein expression or kinetic 
parameters. And quantitative differences in BER proteins have been linked to many disease 
processes [11, 32, 102, 103] .  
Biological systems can be too complex for the significance of a quantitative difference to 
be understood without a mathematical description. A formal model is the manifestation of that 
mathematical description [46]. But a formal model requires validation or it is of little value. This 
presents a distinct difficulty. It is not easy to collect accurate quantitative data from biological 
experiments. This difficulty is compounded by the requirement that the data must be collected in 
a form which is compatible with the model. The congruency of various experimental data can 
only be verified qualitatively if it cannot be integrated into a formal model.  
There has been a wealth of data published on the proteins involved in BER and the roles 
of those proteins in various disease processes. The result has been the establishment of a strong 
conceptual model of the BER mechanism and a clear understanding that deficient performance of 
this mechanism can have dire consequences for an organism. To date there are a comparatively 
small number of publications which have endeavored to coalesce portions of that data into a 
mathematical model [38, 115, 134, 135]. Furthermore there have been no previous attempts to 
validate a formal BER model by altering in vivo a pathway parameter and measuring the 
response. This is an important step to be made if we are to develop a robust mathematical model 
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with valuable predictive capability. The work presented in this study is important because it is the 
first effort of this kind. 
 The initial curve fit of the full BER model to the 293t comet data, shown in Figures 5.2 
and 5.3,  is great example of the usefulness of the model. In order to fit the experimental data I 
had to scale down the kcat values of all reactions by a factor of 1/7. This was not an arbitrary 
adjustment made simply to fit a curve to experimental data. It has physiological relevance. The 
extent of qualitative data collected on the BER system has served to validate the conceptual 
pathway model sufficiently so that the basic network structure is not in question. Therefore it is 
far more likely that failure of the model to fit the 293t data initially was due to a mistake in 
parameter estimation. The ability of the model to fit the experimental data with a systematic 
decrease of kcat values suggests that those values may be over-estimated. This is a likely due to 
the necessity of measuring enzyme kinetics in vitro. The effective kinetic parameters of BER 
enzymes within the crowded nucleus are quite likely slower than those measured in a 
reconstituted BER assay. The usefulness of the model is that it provides a means to compare 
those measurements against the performance of the pathway in vivo. The comet assay provides a 
means to measure the performance of the pathway as a whole but the individual steps cannot be 
measured; the model allows for quantitative data collected only on individual steps to be 
incorporated. 
6.2 Integration of model and data 
 
 The C2 and C4 comet data required different approaches for analysis. The C2 data show 
a distinct decrease in damage levels compared to the 293t data. This was not the expected 
response of the C2 cell line. The only expected difference between the 293t and C2 cell lines was 
a decreased Polβ expression in C2. Although there were too few western blot samples collected to 
give a robust quantification of the extent of Polβ knockdown, a t-test (α = 0.01) performed 
between knockdown samples supports the conclusion that Polβ expression was reduced. However 
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there is no change in Polβ concentration that can match a model simulation to the C2 data. The 
value of the model in this case is that it provides a means to evaluate likely causes of the 
unexpected data behavior and rule out less likely causes. Model analysis suggests that 
simultaneous up regulation of the Ligases and down regulation of Aag is the only way to produce 
the BER response measured in the C2 cells. This is a confusing result which raises further 
questions. If co-regulation of multiple BER enzymes was truly observed in the C2 cell line, why 
not also in the other cell lines? If changes in enzyme expression level were not responsible for the 
C2 behavior, what unknown factor contributed? More data will need to be collected before such 
questions can be addressed.  
 Consideration of another interpretation of the C2, C3, and C4 data is warranted as well. 
Although all three constructs were considered viable for Polβ knockdown and were used to create 
stably transfected cell lines, it may be that only the C4 construct truly coded for the shRNA 
necessary for targeted Polβ knockdown. The DNA gel shown in Figure 4.1 was run to check for 
recombination in the RNAi plasmids stored in frozen E. coli cultures. Although the C2 and C3 
constructs showed the expected band pattern following restriction enzyme digestion, additional 
faint bands were detected in both samples indicating some recombination of the plasmid DNA. 
The C4 construct was the only construct to yield the expected band pattern following restriction 
enzyme digestion with no other visible bands detected. The C4 cell line, created with the C4 
construct was the only cell line to behave qualitatively in agreement with model predictions. This 
suggests that the C4 construct was the only viable construct for performing RNAi in this study 
and may explain the qualitatively unexpected experimental behavior of the C2 and C3 cell lines. 
 Analysis of the 90 minute repair data, showing a distinct increase in damage 
concentration after 90 minutes of repair for all three cell lines, also required up-regulation of an 
enzyme in the model to generate a curve fit to the data. The consistent appearance of the 90 
minute increase in multiple data sets strongly suggests that the observed damage increase is a real 
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data feature and not noise. I found no literature to specifically support a 10-fold increase in Aag 
expression following 60 minutes of BER on alkylation damage. Experimental data will be 
necessary to test this prediction. But the model results provide a starting point for investigation. 
 The need to adjust enzyme expression in the model in order to fit experimental data 
highlights a shortcoming of the model. It does not include any feedback or pathway regulatory 
mechanisms. The nucleus of a living cell is a highly controlled environment and it is important to 
consider that regulatory mechanisms must play an important role in BER. For example p53 has 
been shown to play an active role in BER, not through transactivation-dependent mechanisms but 
through direct interaction with the BER machinery [300]. The exclusion of p53 and other 
potential, similar BER regulatory factors from the BER model is necessary at this stage of model 
development. There are no quantitative data available to account for such effects and so they 
cannot be incorporated in the model structure. 
Fitting the model predictions to the C4 data required a different approach than with the 
C2 data. C4 response in the comet assay qualitatively matched expectations. Polβ expression was 
reduced and peak damage level was increased compared to 293t cells. However the model did not 
predict the extent of the increase in peak damage observed in the C4 data set, nor the steeper 
slope of the C4 repair curve compared to the 293t samples. Improving the fit to the C4 data 
without sacrificing the fit to the 293t data was used as a benchmark to assess alternative model 
structures. Ultimately, the model could not predict the full behavior of the C4 data. The damage 
peak of the C4 data was greater than model predictions and occurred earlier. As a result, the fit to 
the 15-45 minute C4 data was used for comparison between curve fits. 
Even complete elimination of Polβ from the model did not increase the damage peak of 
the simulated repair curve sufficiently to match the C4 data. And no adjustment of the expression 
levels of other enzymes in the model was able to improve the fit. Furthermore the western blot 
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data does not indicate total knockdown of Polβ. This suggests that the contribution of sub-
pathway B to the model is over-estimated by the full model structure. 
The inclusion of Polδ in the BER model was based on literature support for the ability of 
Polδ to perform its gap-filling function on single nucleotide gaps [38, 115, 134, 301]. Blank et al. 
also reported that Polδ was important in the repair of MMS damage in Saceharomyces cerevisiae 
[302]. And it has been shown that Aag initiated BER can be completed by short patch or long 
patch repair [1, 303]. For these reasons it was interesting to include Polδ in the BER model and 
investigate the extent of its role in the BER pathway. However there is also literature supporting 
the exemption of Polδ from the BER model. The main role of Polδ in the cell is in chromosome 
replication [1, 179, 180] and it can only bind to single stranded DNA [301]. And Matsumoto et al. 
report that Polδ cannot act on single nucleotide gaps and that Fen1, which removes the flap 
created by Polδ activity, requires a flap of at least 2 nucleotides in order to function [304]. In light 
of the simulation results produced by the model it seems that an alternative BER model in which 
Polδ is excluded is favorable to the original model. 
 Analysis of the C4 data using alternative model structures led to a choice of an alternate 
model structure incorporating sub-pathway C only. My results show that in the absence of the 
other sub-pathways, sub-pathway A is capable of clearing a damage load with reduced efficiency. 
But in the presence of sub-pathway C the contribution of sub-pathway A is negligible. Sub-
pathway A contains Neil1 and PNK, representing the only known Ape1 independent BER 
pathway [48, 49]. Although Neil1 chiefly functions as a glycosylase, its βδ-elimination on 3’dRp 
and AP site repair intermediates are the only functions included in the model [48, 305, 306]. 
Neil1 has no known glycosylase activity against 7-meG and 3-meA, the two lesions produced in 
significant quantity by MMS treatment. All glycosylase activity on these lesion types is initiated 
by Aag [286]. None the less the physiological relevance of the included Neil1/PNK sub-pathway 
has been demonstrated. Both Neil1 depleted mouse cells and PNK deficient A549 cells have been 
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shown to have increased sensitivity to MMS induced damage [48, 52, 53]. My simulation results 
do not show a significant sensitivity increase to MMS damage when the Neil1/PNK sub-pathway 
is removed. This suggests that the contribution of the Neil1/PNK sub-pathway was under-
estimated in the model although it is impossible to gauge to what extent in the absence of more 
quantitative pathway data. 
 Alternative model structure 3 (Alt3) was chosen for use in further data analysis because it 
fit both 293t and C4 data better than the other alternative model structures. Although Alt4 had 
equivalent predictive power Alt3 was chosen over Alt4 because it had the simpler structure. 
Fitting the C4 data with Alt3 required a reduction in Polβ expression between 95% and 97%, 
much more than the 59% Polβ reduction measured with the western blots. This demonstrates an 
important point for future work and model validation. Full validation of a quantitative BER 
model will require robust, precise measurements of protein expression and changes to protein 
expression. At the current state of technology this means that model validation will require mass 
spectrometry for accurate, quantitative protein detection. 
6.3 Sensitivity analysis 
 Single parameter sensitivity analysis was performed for the full model structure as well 
as Alt3. The metric used for sensitivity was the fold-change in the peak lesion concentration of 
the repair curve caused by a given fold-change in enzyme concentration. The results were the 
same for both analyses. 
Both model structures are most sensitive to Aag, the ligases (Lig1 and LigIII evaluated together), 
and Polβ in decreasing order. This means that peak damage of the repair curve is most sensitive 
to Aag concentration.  
An increase in Aag concentration results in a greater flux of lesions into the SCGE 
detectable pool and a higher peak damage concentration. This result agrees with previous 
experimental data [307]. Cellular sensitivity to alkylation induced cytotoxicity results from an 
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over-expression of Aag [285, 308, 309]. Rinne et al. showed in human cells that the sensitivity-
increasing effects of Aag over-expression are not due to the repair of the mutagenic 3-meA 
lesions but to the increased excision rate of the benign 7-meG lesions. They assert that the 
hypersensitivity of Aag over-expressed cells to alkylation induced cytotoxicity is caused by the 
increase in lesion-intermediate concentrations which is effected by the disproportionate increase 
in base-excision compared to the other enzymatic reactions in the pathway [308]. My modeling 
predictions agree with these results and conclusions.  
6.4 Rate-limiting step in the model 
It has been reported that Polβ 5’dRp lyase activity is the rate limiting step in BER 
downstream to the glycosylase [55, 56, 310]. More recently Wilson et al. have found evidence 
that ligation of nicked sites is rate limiting for BER [8]. Our model predictions agree with the 
more recent findings of Wilson et al.; downstream to the glycosylase, ligation is the rate limiting 
step in the BER model.  
Correspondingly sensitivity analysis shows that the peak damage concentration of the 
repair curve is more drastically affected by fold-changes to the ligase concentration than by 
equivalent fold-changes to the Polβ and Ape1 concentration. However, as ligase concentration is 
increased the magnitude of the effect on the peak damage concentration asymptotically 
approaches a maximum. The difference between the effect of a 100 fold increase versus a 1000 
fold increase in ligase concentration is negligible. As the rate of the ligation step is increased, 
Polβ becomes the rate-limiting step and further increase in the rate of ligation does not affect the 
concentration of lesions up-stream to the nicked sites.  
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6.5 BER proteins not explicitly represented in the model 
 Xrcc1 and Parp1 are important BER proteins which lack enzymatic function in the 
pathway. For this reason they are not included in the model. However the potential contributions 
of both proteins to the results of this study warrant discussion. 
6.5.1 PARP binding SSBs in 5 min repair time comet data 
 When modeling the PARP-1 binding function I used the simplest model that I could 
devise. An option that was rejected was to set thresholds for each repair intermediate. In that way 
PARP-1 binding would be triggered when the concentration of a particular intermediate exceeded 
its individual threshold. However, MATLAB does not accept conditional statements on variables 
being evaluated by the ODE solver. This limitation would significantly complicate the creation of 
a threshold based PARP-1 binding model and furthermore there is no available data regarding the 
setpoints of the individual threhsolds. Instead I modeled the PARP-1 binding by introducing a 
spike of PARP-1 and subtracted the concentration of PARP-1 from the concentration of repair 
intermediates. 
 AP sites are alkali labile and therefore detectable as strand breaks in the comet assay [63]. 
But PARP-1 binding would happen before alkali unwinding in the comet assay protocols and so 
AP sites were assumed to be excluded from the lesions bound by PARP-1. Only the intermediates 
in which a strand break is present were considered PARP-1 binding substrates. In the current  
implementation of the model this would not affect the output because PARP-1 concentration was 
subtracted from the total pool of comet detectable lesions. Also the concentration of AP sites 
predicted by the model is at least an order of magnitude less than the concentration of any other 
lesion state over the full timespan of the model run. 
 The PARP-1 binding model as I implemented it implies several assumptions about the 
PARP-1 binding process. 1) The model assumes that the rate of binding and dissociation of 
PARP-1 is the same for all lesions. 2) The proportion of each intermediate that is bound by 
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PARP-1 is equivalent to the fraction of total SSBs accounted for by that intermediate. In other 
words if 30% of the strand breaks in the model at t = 35 minutes are nicked sites, then 30% of the 
PARP-1 bound intermediates at that time are nicked sites. 3) All PARP-1 bound lesions still 
contribute to the total concentration of that particular lesion. Therefore the reaction rates for all 
enzymes in the model remain unaffected by PARP-1 binding. 
6.5.2 Xrcc1 and the Pass-the-Baton mechanism of BER 
The concept of BER enzymes ‘passing the baton’ was first described by Wilson and 
Kunkel for the Ape1 enzyme [311]. It refers to one enzyme being exchanged for another during 
the repair process while scaffolding proteins keep the potentially toxic lesion site secure. More 
recently Prasad et al. have shown that an entire BER event from the initial excision step by the 
glycosylase to the final nick sealing by a ligase can be coordinated in the same ‘passing the 
baton’ fashion with Xrcc1 acting to coordinate the process [158]. The effects of this process on 
enzyme kinetics have not yet been investigated. It can certainly be conceived that repair would be 
faster if each repair enzyme was recruited and already in place to act when its substrate became 
available at a damage site than if all repair reactions were carried out when the free enzyme 
encountered its substrate via Brownian motion. The second scenario, random molecular 
interaction, is assumed under the current model construction. This assumption was necessary in 
the model construction. While kinetic parameters for human BER proteins are scarce in the 
literature, kinetic parameters for each enzyme under baton-passing conditions are non-existent.  
Considering the pass-the-baton mechanism in the context of this study, if it increases the 
rate of BER, then a model incorporating the pass-the-baton mechanism would predict faster repair 
than the current BER model. But a seven-fold reduction in kcat values was necessary to fit this 
model to the experimental data. Incorporation of the pass-the-baton mechanism would then 
further increase the discrepancy between model predictions and experimental data. Perhaps 
though, the advantage a cell gains by this method of repair is stability for dangerous intermediate 
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lesions, and the rate of repair is actually decreased. It is possible that even if the repair sequence 
for an individual lesion is faster the overall repair rate could be restricted by the concentration of 
fully assembled pass-the-baton units. Also, pass-the-baton has only been demonstrated in sub-
pathway C. Fen1 does not associate with Xrcc1 and is limited by Brownian motion in locating its 
substrate [157, 158]. Whether the pass-the-baton mechanism functions in sub-pathway A, the 
Neil1/PNK sub-pathway, has not been determined. 
As quantitative data become available on the pass-the baton-mechanism, future BER 
models may be able to incorporate its effects. One potential approach to modeling the pass-the-
baton mechanism would be to treat the entire scaffolding structure as a single enzyme with 
multiple intermediate steps. Under the assumptions of Michaelis-Menten kinetics, no matter how 
many intermediate steps an enzyme-substrate complex go through, as long as they do not 
dissociate until the final product is formed, the equation describing the kinetics of the enzyme can 
be algebraically reduced to the standard Michaelis-Menten form. If the entire pass-the-baton 
structure was modeled in this fashion it could be treated as a single enzyme with its own rate 
constants derived from those of each component BER enzyme. Such a model may be inhibited by 
lack of knowledge of the reverse rate constants for each individual reaction. However, it may be a 
valid assumption to treat all reactions as favoring the forward reaction strongly enough that the 
rate constants for the reverse reaction could be considered negligible.  
6.6 Novelty and Contributions 
The work presented in this study contributes to the field by taking the first steps towards 
validation of a quantitative pathway model of the BER system. This has potential ramifications 
for the understanding of the underlying mechanisms leading to the onset of many disease 
processes, namely cancer.  
Novel components of this work include the following: 1) The establishment of protocols 
for measurement of quantitative data which can be integrated with the BER model for analysis. 
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This is critical for the useful application of the quantitative model to the analysis of experimental 
biological data. 2) The development of novel software for quantitative analysis of raw SCGE 
data. 3) The first quantitative BER model to include the Neil1/PNK dependent sub-pathway. This 
sub-pathway is notable for being the only known Ape1 independent BER pathway. 4) If my 
interpretation of the data is correct, the first quantitative measurements of the effects of Parp1 
binding to SSBs following an influx of DNA lesions. 
6.7 Future work 
 Future work in this area should focus on model validation. To achieve this it is necessary 
to use mass spectrometry to measure protein expression. This should be done for each pathway 
protein in a single human cell line. RNAi is still the most effective and targeted method for 
perturbation of pathway parameters in vivo. Future knockdown experiments should focus on the 
enzymes to which the repair curve is most sensitive, the glycosylase and the ligases. The comet 
assay is still the best choice for the measurement of DNA damage and repair but future studies 
should focus on the development of high throughput techniques and automated comet scoring. 
Increasing the statistical robustness of the comet data will be critical to thorough model 
validation. 
6.8 Conclusions 
 Prediction of the effects of intracellular protein variations on the base excision repair 
capacity of human cells can be achieved using modern experimental and computational 
techniques. The BER model created in this study has predictive capability for the effects of 
variation of Polβ expression under certain parameter settings and assumptions. The predictive 
power of the BER model is expected to improve as the volume of available model-compatible 
quantitative data increases. 
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Appendix A Full size diagrams of alternative model structures 
 
 
 
 
 
Figure 7.1: Alternative model structure 1. Sub-pathway A has been deactivated. To create this alternative 
model the reaction rates v3, v27, and v28 were all set and held equal to zero. Under these conditions Neil1 is 
inactive and Ape1 does not perform 3’-dRp lyase activity. Inactive portions of the BER pathway are shown 
in gray. 
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Figure 7.2: Alternative model stucture 2. Sub-pathway B has been deactivated. In this alternative model, 
reaction rates v10 and v20 were set and held at zero. Under these conditions Ogg1 does not perform its AP 
lyase activity and polδ does not perform its gap-filling activity. Inactive portions of the BER pathway are 
shown in gray. 
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Figure 7.3: Alternative model structure 3 is a combination of alternative models 1and 2. Sub-pathways A 
and B have been deactivated. To create this alternative model reaction rates v3, v10, and v20 were all set and 
held at zero. Under these conditions Neil1 does not function, Ogg1 does not perform its AP lyase activity, 
and polδ does not perform its gap-filling activity. Inactive portions of the BER pathway are shown in gray. 
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Figure 7.4: Alternative model structure 4. Sub-pathway C has been deactivated. To create this alternative 
model reaction rate v6 was set and held constant at zero. Under these conditions Ape1 does not perform AP 
endonuclease activity. The inactive portions of the pathway are shown in gray. 
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Figure 7.5: Alternative model structure 5. Sub-pathways A and C have been deactivated. To create this 
alternative model reaction rates v3, v6, v27, v28 were set and held constant at zero. Under these conditions 
Ape1 and Neil1 are inactive. The inactive portions of the pathway are shown in gray. 
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Figure 7.6: Alternative model structure 6. Sub-pathways B and C have been deactivated. To create this 
alternative model reaction rates v6 and v10 were set and held constant at zero. Under these only Neil1 can 
act on an abasic site. The inactive portions of the pathway are shown in gray. 
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Appendix B Matlab (2010a) code for base excision repair model 
 
Matlab script run_code.m 
 
%This script controls the model. Running this script will run a BER 
%simulation and plot the results against experimental data. 
  
%Model input 
MeG7 = 4.43e3;   %damage input dose; nM concentration of 7-
methylguanine 
time = 100;     %total repair time (not counting damage induction 
period) 
%alt=0 sets all model reaction on. 
%alt values 1-9 select alternative model structures 
alt = 0; 
  
%enzyme concentrations for easy changes 
polB = 419;   %polymerase beta concentration: enz(6), y(20) 
aag = 38;     %aag concentration: enz(13),y(27) 
runn = 1; 
  
[tt,yy,ii,intermeds301] = alt_9(polB,aag,time,alt,MeG7,runn); %runs 
model 
  
%shifts time (necessary because of the damage induction phase) 
t = (0:max(tt) - 30)'; 
%gets data from spreadsheet and calibrates to model 
[t1,data_293t] = get_data(intermeds301); 
  
figure(1) 
hold on 
%subplot(1,2,runn) 
plot(t1,data_293t,'rv')  %plots data 
plot(t(1:66),ii(31:96))  %plots model output corresponding with data 
xlabel('Repair Time(min)') 
ylabel('SCGE Detectable Lesions(nM)') 
 
 
Matlab function alt_9.m 
 
function [tt,yy,ii,intermeds301] = alt_9(polB,aag,time,alt,MeG7,runn) 
%alt_9.m runs the BER model 
  
[t30,t,y30,y] = repair(polB,aag,MeG7,time,alt,runn); 
  
% comet-contributing intermediates 
intermeds1   = y(:,2)   + y(:,6)   + y(:,7)   + y(:,9)   + y(:,10)... 
    + y(:,11)   + y(:,12)   + y(:,13)   + y(:,14); 
intermeds301 = y30(:,2) + y30(:,6) + y30(:,7) + y30(:,9) + y30(:,10)... 
    + y30(:,11) + y30(:,12) + y30(:,13) + y30(:,14); 
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t = t + 30; 
ii = [intermeds301(1:30);intermeds1]; 
tt = [t30(1:30);t]; 
yy = [y30(1:30,:);y]; 
 
 
Matlab function ber_initial_conditions.m 
 
function [t,y30] = ber_initial_conditions(polB,aag,kA,kG,alt,runn) 
% ber_initial_conditions.m runs the ber_model.m function using 
% ber_parameters. MeA3 and MeG7 damage types are generated at a 
constant 
% rate: 1/30 of the total damage per minute. It runs for 30 min and 
then 
% returns the values for all y at t=30. Those y values are then used as 
% initial conditions for a new run of the model. This method is used to 
% simulate the continuous damage formation which occurs during 30min 
MMS 
% treatments during experiments. A method using a damage creation 
function 
% which is not constant may be more realistic but requires modeling the 
MMS 
% damage creation in the cell and is beyond the scope of this project. 
A 
% bolus dose is the simplest method but less realistic because damage 
% induction is done over 30min. This method necessary because if a 
constant 
% damage induction rate is used and the simulation not restarted, there 
is 
% no way to tell the odesolver to stop creating damage at t = 30. 
  
[kcat,Km,enz] = ber_parameters_2(polB,aag); 
tspan = 0:30; 
  
[kcat,Km,enz] = k_changer(kcat,Km,enz,runn); 
  
% all intermediates, un-used damage types, and un-used enzymes = 0 
yi = zeros(53,1); 
% enzyme concentrations are specified in ber_parameters.m 
yi(15:27) = enz(1:13); 
  
%ic = 2 makes 3-MeA(dy(29)) and 7-MeG (dy(30)) form at a constant rates 
ic = 2; 
[t,y30] = ode15s(@ber_model_alt, tspan, yi, '', kcat,Km,ic,kA,kG,alt); 
 
 
Matlab function ber_model_alt.m 
 
function [dy] = ber_model_alt(t,y,kcat,Km,ic,kA,kG,alt) %#ok<INUSL> 
%This function contains a set of equations modeling the base excision 
%repair pathway. Enzyme concentrations are 
%assigned to y(15) through y(24).Reaction velocities V(n) are defined. 
%Derivatives dy/dt(n) are defined in terms of v(n). 
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%Definitions of reactions velocities. 
  
% v3 = Neil1 Bd elimination on spontaneously generated abasic sites 
% v6 = Ape1 AP endonuclease activity on spontaneous abasic sites 
% v10 = ogg1 AP lyase activity on spontaneous abasic sites 
% v12 = polB gap filling on gapped 
% v13 = lig1 ligation on nicked 
% v14 = lig3 ligation on nicked 
% v15 = polB gap filling on 5’dRP-flap, gapped 
% v16 = polB dRP lyase on 5’dRP-flap, gapped 
% v17 = polB dRP lyase on polB gapped intermediate 
% v18 = polB gap filling on polB intermediate 
% v20 = pold activity on 5’dRP 
% v21 = Fen1 5’endo 
% v25 = Ape1 3'phosphodiesterase activity on Neil excision product 
(abasic) 
% v26 = PNK activity on Neil1 excision product (abasic) 
% v27 = Neil1 Bd elimination on 3’dRP 
% v28 = Apel 3’phosphodiesterase 
% v29 = pold activity on 3’dRP 
% v32 = Aag excision of 3-MeA 
% v33 = Aag excision of 7-MeG 
  
v3 = (y(2) * y(17) * kcat(3)) / (y(2) + Km(3)); 
v6 = (y(2) * y(18) * kcat(6)) / (y(2) + Km(6)); 
v10 = (y(2) * y(15) * kcat(10)) / (y(2) + Km(10)); 
v12 = (y(6) * y(20) * kcat(12)) / (y(6) + Km(12)); 
v13 = (y(7) * y(23) * kcat(13)) / (y(7) + Km(13)); 
v14 = (y(7) * y(24) * kcat(14)) / (y(7) + Km(14)); 
v15 = (y(9) * y(20) * kcat(15)) / (y(9) + Km(15)); 
v16 = (y(9) * y(20) * kcat(16)) / (y(9) + Km(16)); 
v17 = (y(10) * kcat(17)); 
v18 = (y(11) * kcat(18)); 
v20 = (y(9) * y(21) * kcat(20)) / (y(9) + Km(20)); 
v21 = (y(12) * y(22) * kcat(21)) / (y(12) + Km(21)); 
v25 = (y(13) * y(18) * kcat(25)) / (y(13) + Km(25)); 
v26 = (y(13) * y(19) * kcat(26)) / (y(13) + Km(26)); 
v27 = (y(14) * y(17) * kcat(27)) / (y(14) + Km(27)); 
v28 = (y(14) * y(18) * kcat(28)) / (y(14) + Km(28)); 
v29 = (y(14) * y(21) * kcat(29)) / (y(14) + Km(29)); 
v32 = (y(29) * y(27) * kcat(32)) / (y(29) + Km(32)); 
v33 = (y(30) * y(27) * kcat(33)) / (y(30) + Km(33)); 
  
if alt == 1 
    v20 = 0; 
    v29 = 0; 
elseif alt == 2 
    v3 = 0; 
    v27 = 0; 
    v28 = 0; 
elseif alt == 3 
    v10 = 0; 
    v20 = 0; 
elseif alt == 4 
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    v3 = 0; 
    v10 = 0; 
    v20 = 0; 
elseif alt == 5 
    v6 = 0; 
elseif alt == 6 
    v6 = 0; 
    v3 = 0; 
    v27 = 0; 
    v28 = 0; 
elseif alt == 7 
    v10 = 0; 
    v6 = 0; 
elseif alt == 8 
    v3 = 0; 
    v10 = 0; 
    v20 = 0; 
    v15 = 0; 
elseif alt == 9 
    v3 = 0; 
    v10 = 0; 
    v20 = 0; 
    v16 = 0; 
end 
  
%Definitions of derivatives dy/dy(n) 
dy = zeros(53,1); 
  
dy(2) = -v3 - v6 - v10 + v32 + v33;          % abasic sites 
dy(6) = v25 + v26 + v28 - v12;               % gapped (pathway A) 
dy(7) = v12 + v17 + v18 + v21 - v13 - v14;   % nicked 
dy(8) = v13 + v14;                           % repaired 
dy(9) =  v6 - v15 - v16 - v20;               % 5'-dRp 
dy(10) = v15 - v17;                          % 5'-dRp nicked (polB 
intermediate) 
dy(11) = v16 - v18;                          % gapped (polB 
intermediate) 
dy(12) = v20 + v29 - v21;                    % flap (2-7 nt) 
dy(13) = v27 + v3 - v25 - v26;               % Bd elimination product 
dy(14) =  v10 - v27 - v28 - v29;             % 3'-dRp 
  
%conditional damage induction 
if ic == 1     %normal repair simulation repair only 
    dy(29) = -v32;        % 3-MeA 
    dy(30) = -v33;        % 7-MeG 
    %repair and damage induction. kA and kG are damage induction rates 
elseif ic == 2 
    dy(29) = -v32 + kA;   % 3-MeA 
    dy(30) = -v33 + kG;   % 7-MeG 
     
    dy(32) = kA; 
    dy(33) = kG; 
    dy(34) = kG + kA; 
end 
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%Enzyme concentrations are held constant during simulation. 
dy(15) = 0;     % Ogg1 
dy(16) = 0;     % Nth1 
dy(17) = 0;     % Neil1 
dy(18) = 0;     % Ape1 
dy(19) = 0;     % PNK 
dy(20) = 0;     % PolB 
dy(21) = 0;     % Pold 
dy(22) = 0;     % Fen1 
dy(23) = 0;     % lig1 
dy(24) = 0;     % lig3 
dy(27) = 0;     % Aag/MPG 
  
%these dy's are not in use right now. They are used by taking 
diff(y(35)) 
%to get plots of each v over time 
  
dy(35) = (y(2) * y(17) * kcat(3)) / (y(2) + Km(3));        % v3 
dy(36) = (y(2) * y(18) * kcat(6)) / (y(2) + Km(6));        % v6 
dy(37) = (y(2) * y(15) * kcat(10)) / (y(2) + Km(10));      % v10 
dy(38) = (y(6) * y(20) * kcat(12)) / (y(6) + Km(12));      % v12 
dy(39) = (y(7) * y(23) * kcat(13)) / (y(7) + Km(13));      % v13 
dy(40) = (y(7) * y(24) * kcat(14)) / (y(7) + Km(14));      % v14 
dy(41) = (y(9) * y(20) * kcat(15)) / (y(9) + Km(15));      % v15 
dy(42) = (y(9) * y(20) * kcat(16)) / (y(9) + Km(16));      % v16 
dy(43) = (y(10) * kcat(17));                               % v17 
dy(44) = (y(11) * kcat(18));                               % v18 
dy(45) = (y(9) * y(21) * kcat(20)) / (y(9) + Km(20));      % v20 
dy(46) = (y(12) * y(22) * kcat(21)) / (y(12) + Km(21));    % v21 
dy(47) = (y(13) * y(18) * kcat(25)) / (y(13) + Km(25));    % v25 
dy(48) = (y(13) * y(19) * kcat(26)) / (y(13) + Km(26));    % v26 
dy(49) = (y(14) * y(17) * kcat(27)) / (y(14) + Km(27));    % v27 
dy(50) = (y(14) * y(18) * kcat(28)) / (y(14) + Km(28));    % v28 
dy(51) = (y(14) * y(21) * kcat(29)) / (y(14) + Km(29));    % v29 
dy(52) = (y(29) * y(27) * kcat(32)) / (y(29) + Km(32));    % v32 
dy(53) = (y(30) * y(27) * kcat(33)) / (y(30) + Km(33));    % v33 
  
 
Matlab function ber_parameters_2.m 
 
function [kcat,Km,enz] = ber_parameters_2(polB,aag) 
%This function sets the parameters kcat, Km and enz for the function 
%ber_model_alt. kcat, Km, and enz stand for catalytic constant, 
%Michaelis-Menten constant, and enzyme concentration respectively. 
  
kcat = zeros(34,1); Km = zeros(34,1); enz = zeros(13,1); 
  
% kcats (1/min) -updated 11-20-9 
  
kcat(3) = 0.066;     % v3 = Neil1 Bd elimination 
kcat(6) = 158;       % v6 = Ape1 AP endonuclease 
kcat(10) = 0.053;    % v10 = ogg1 AP lyase activity 
kcat(12) = 27;       % v12 = polB gap filling  
kcat(13) = 0.156;    % v13 = lig1 ligation  
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kcat(14) = 0.156;    % v14 = lig3 ligation  
kcat(15) = 27;       % v15 = polB gap filling  
kcat(16) = 4.5;      % v16 = polB dRP lyase  
kcat(17) = 4.5;      % v17 = polB dRP lyase 
kcat(18) = 27;       % v18 = polB gap filling 
kcat(20) = 0.29;     % v20 = pold activity 
kcat(21) = 23.4;     % v21 = Fen1 5'endo 
kcat(25) = 0.03;     % v25 = Ape1 3'phosphodiesterase 
kcat(26) = 28;       % v26 = PNK 3' phosphatase 
kcat(27) = 0.066;    % v27 = Neil1 Bd elimination  
kcat(28) = 3;        % v28 = Apel 3’deoxyrobose phosphate lyase  
kcat(29) = 0.29;     % v29 = pold activity  
kcat(32) = 9.9;      % v32 = Aag excision of 3-MeA 
kcat(33) = 0.4;      % v33= Aag excision of 7-MeG 
  
%Km values (nM) -updated 11-20-9 
  
Km(3) = 12.8;       % v3 = Neil1 Bd elimination  
Km(6) = 35.6;       % v6 = Ape1 AP endonuclease  
Km(10) = 7.2;       % v10 = ogg1 AP lyase  
Km(12) = 300;       % v12 = polB gap filling  
Km(13) = 3.4;       % v13 = lig1 ligation  
Km(14) = 3.4;       % v14 = lig3 ligation  
Km(15) = 300;       % v15 = polB gap filling  
Km(16) = 500;       % v16 = polB dRP lyase 
Km(20) = 67;        % v20 = pold activity  
Km(21) = 39;        % v21 = Fen1 5’endo 
Km(25) = 27;        % v25 = Ape1 3'phosphodiesterase  
Km(26) = 16;        % v26 = PNK 3' phosphatase 
Km(27) = 12.8;      % v27 = Neil1 Bd elimination o 
Km(28) = 130;       % v28 = Apel 3’deoxyrobose phosphate lyase  
Km(29) = 67;        % v29 = pold activity  
Km(32) = 11;        % v32 = Aag excision of 3-MeA 
Km(33) = 32;        % v33= Aag excision of 7-MeG 
  
%enzyme concentrations (nM) -updated 11-20-9 
  
enz(1) = 406;          % Ogg1     y15 
enz(3) = 830;          % Neil1    y17 
enz(4) = 2000;         % Ape1     y18 
enz(5) = 4061;         % PNK      y19 
enz(6) = polB;         % PolB     y20    
enz(7) = 600;          % Pold     y21 
enz(8) = 450;          % Fen1     y22 
enz(9) = 254;          % lig1     y23 
enz(10) = 254;         % lig3     y24 
enz(13) = aag;         % Aag      y27    
enz(2) = 0;            % Nth1     y16 
enz(11) = 0;           % UDG      y25 
enz(12) = 0;           % SMUG1    y26 
  
 
Matlab function calibration.m 
 
function [c_data] = calibration(intermeds30,data) 
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%this function calibrates the data to the model. 
%it takes the %tail data, subtracts the untreated scores from each 
column 
%respectively (assuming row 1 is untreated and the last row is 0min 
repair. 
%and sets the 0min repair sample equal to the comet 
%contributing fraction of intermeds predicted by the model. 
%ZERO MIN REPAIR DATA MUST BE IN THE BOTTOM ROW OF THE MATRIX: data 
  
s = size(data); 
  
% i31 = the conc of all comet contributing intermeds after 30min dose 
time 
i31 = intermeds30(31); 
  
%SWITCHED TO DATA(1,1) SO THAT THE ALL THE QUARTILES SHIFT THE SAME 
AMOUNT 
u = data(1,:);              % u = the first row of data 
data1 = data(2:s(1),:);     % data1 = data without the first row 
data2 = zeros(size(data1)); % data2 = zeros the same size as data1 
%c_data = zeros(size(data2)); 
  
% normalize scores to untreated 
for k = 1:(s(1)-1) 
    %data2(k,:) = data1(k,:) - uq; 
    data2(k,:) = data1(k,:) - u; 
end 
  
%for converting multiple data sets all with the same factor 
cf = i31/data2((s(1)-1),1); %cf = convert factors for each column of 
data 
%c_data is the converted data which is now damage concentration 
c_data = data2 * cf; 
 
 
Matlab function get_data.m 
 
function [t1,data_293t] = get_data(intermeds301) 
%this function gets the data from the spreadsheet: cooked_data9.2.xlsx 
%it calls calibration and calibrates the 0min repair data point to the 
%model prediction. Initial value damage predictions come from 
%Pachkowski(2009) 
  
%gets the raw median %tail comet data from a spreadsheet and 
data_range = 'J63:L70'; 
d = xlsread('cooked_data 9.2.xlsx',1,data_range); 
dz = size(d); 
  
%take the first column which is repair times and separate it from the 
data 
rt1 = d(:,1); 
z = size(rt1); 
rt = rt1(2:z(1));   %this just removes the NaN from the first time row 
data = d(:,2:dz(2)); 
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[c_data1] = calibration(intermeds301,data); 
  
%remove the undesireable time points. 
t1 = [rt(2:5);rt(7)]; 
c_data_e = [c_data1(2:5,:);c_data1(7,:)]; 
  
data_293t= c_data_e(:,1); 
 
 
Matlab function k_changer.m 
 
function [kcat,Km,enz] = k_changer(kcat,Km,enz,runn) 
%function used to change parameters while testing the BER model 
  
%this parameter change for all Km's is justified in the literature 
%to account for slower diffusion in the crowded nucleus 
Km = Km * 10; 
  
%adjustment to default parameters to fit model to 293t comet data 
kcat = kcat * 1/7; 
  
%The code below is from ber_parameters_2.m  it is for reference when 
%adjusting enz concentrations in k_changer 
  
 
%     enz(1) = 406;          % Ogg1     y15 
%     enz(3) = 830;          % Neil1    y17 
%     enz(4) = 2000;         % Ape1     y18 
%     enz(5) = 4061;         % PNK      y19 
%     enz(6) = polB;         % PolB     y20   (419nM is the number from 
refs) 
%     enz(7) = 600;          % Pold     y21 
%     enz(8) = 450;          % Fen1     y22 
%     enz(9) = 254;          % lig1     y23 
%     enz(10) = 254;         % lig3     y24 
%     enz(13) = aag;         % Aag      y27   (38 is the number from 
refs) 
 
 
Matlab function repair.m 
 
function [t30,t,y30,y] = repair(polB,aag,MeG7,time,alt,runn) 
%This function uses ber_model.m and ber_parameters_2.m and returns 
repair 
%curves for the Base Excision Repair pathway. 
%default values should be:   polB = 419;  aag = 38; 
%80% of methylation adducts are 7-MeG (Beraneck 1990) 
%MeG7 = 4*MeA3; % the ratio of damage types induced by MMS (Beraneck 
1990) 
  
MeA3 = 0.25 * MeG7; 
kA = MeA3/30;   % rate of induction of 3-meA over 30min. (lesions/min) 
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kG = MeG7/30;   % rate of induction of 7-meG over 30min. (lesions/min) 
  
[t30,y30] = ber_initial_conditions(polB,aag,kA,kG,alt,runn); 
  
[kcat,Km,enz] = ber_parameters_2(polB,aag); 
tspan = 0:time; 
%y30 is the vector of all y values at t=30 after running model 
%with a constant damage induction rate 
yi = y30(31,:)'; 
ic = 1; 
  
% this function is used just to change parameters for model testing 
[kcat,Km,enz] = k_changer(kcat,Km,enz,runn); 
% enzyme concentrations are specified in ber_parameters.m 
yi(15:27) = enz(1:13); 
  
[t,y] = ode15s(@ber_model_alt, tspan, yi, '', kcat,Km,ic,kA,kG,alt); 
 
 
 
Median % tail DNA scores for comet assay samples. For use with the base excision repair 
model. 
 
Comet assay data must read from a Microsoft Excel 2010 spreadsheet to use with functions 
above. 
 
 
293t #1 C2 C3 C4 
     untreated 0.009321 0.004703 0.002378 0.004963 
90 0.19469 0.10476 0.186775 0.22017 
60 0.10263 0.065597 0.107625 0.075299 
45 0.16317 0.099306 0.15691 0.17793 
30 0.191195 0.12315 0.10931 0.24573 
15 0.2443 0.146945 0.16168 0.27695 
5 0.134765 0.08753 0.108675 0.216125 
0 0.21067 0.12576 0.179065 0.32837 
 
 
 
rep time median q1 q3 
293t  untreated 0.009321 0.00068 0.063692 
 
90 0.19469 0.13508 0.303735 
 
60 0.10263 0.053145 0.179435 
 
45 0.16317 0.091802 0.30395 
 
30 0.191195 0.12851 0.28252 
 
15 0.2443 0.181435 0.32131 
 
5 0.134765 0.089305 0.20399 
 
0 0.21067 0.163263 0.316733 
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rep time median q1 q3 
C2 untreated 0.004703 0.000307 0.056064 
 
90 0.10476 0.064361 0.177475 
 
60 0.065597 0.024541 0.186645 
 
45 0.099306 0.030567 0.22444 
 
30 0.12315 0.073605 0.191275 
 
15 0.146945 0.082733 0.22252 
 
5 0.08753 0.047428 0.129655 
 
0 0.12576 0.079344 0.1824 
 
 
 
rep time median q1 q3 
C3 untreated 0.002378 0 0.060706 
 
90 0.186775 0.076718 0.558185 
 
60 0.107625 0.031805 0.23527 
 
45 0.15691 0.083675 0.36293 
 
30 0.10931 0.056908 0.27489 
 
15 0.16168 0.070878 0.310868 
 
5 0.108675 0.05988 0.24572 
 
0 0.179065 0.097628 0.34991 
 
 
 
rep time median q1 q3 
C4 untreated 0.004963 0.000291 0.094036 
 
90 0.22017 0.130668 0.340438 
 
60 0.075299 0.036933 0.131048 
 
45 0.17793 0.092745 0.26927 
 
30 0.24573 0.144145 0.364733 
 
15 0.27695 0.17662 0.402155 
 
5 0.216125 0.11642 0.33063 
 
0 0.32837 0.227653 0.526733 
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Appendix C Matlab (2010a) code for Ascore comet assay scoring software 
 
 
Matlab function  a_score.m 
 
function [allscores,data] = a_score(imageH,imageL,file,bckgrndcheck,... 
    thresh,threshL,userdefhead) 
%function [atkinscore] = a_score(imageH,imageL,file,thresh,threshL) 
%a_score returns the vector atkinscore calculated from 2 measurements. 
%atkinscore = (distance btwn head-centroid and tail-centroid)*(%tail 
DNA) 
%inputs are strings for (high gain image.bmp),(low gain 
%image.bmp),(outputfilename), (background threshold for 
%high-gain),(background threshold for low-gain) respectively. thresh 
and 
%threshL are optional inputs with default values of 0.05 and 0.01 
%respectively. Negative atkinscore values indicate that no DNA was in 
the 
%low gain tail image. userdefhead = 0 chooses automatic head finding; 
%userdefhead = 1 chooses manual imput for each comet; userderhead = 2 
is 
%set during manual background threshold by typing 'f' and it allows one 
at 
%a time head center choosing 
  
if nargin < 5 
    thresh = 0.05; 
    threshL = 0.01; 
    userdefhead = 2; 
elseif nargin < 6 
    threshL = 0.01; 
    userdefhead = 2; 
elseif nargin < 7 
    userdefhead = 2; 
end 
  
%load image pair 
[H] = imread(imageH,'BMP'); 
[L] = imread(imageL,'BMP'); 
  
figure(4) 
hold on 
image(L) 
hold off 
  
k=0; 
n=1; 
bb=0; 
prevent_error = 0; 
  
ascore = zeros(50,1); 
cancelscr = zeros(50,1); 
tc = zeros(50,2); 
tda = zeros(50,1); 
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distancea = zeros(50,1); 
radiusa = zeros(50,1); 
tail_lena = zeros(50,1); 
tail_momenta = zeros(50,1); 
olive_momenta = zeros(50,1); 
low_dista = zeros(50,1); 
tail_lengthLa = zeros(50,1); 
tail_momentLa = zeros(50,1); 
radiusLa = zeros(50,1); 
  
disp('Click on two corner points to define a rectangle.') 
  
while n==1 %it will always be 1. you must right click to exit 
     
    k = k + 1; 
     
    %plot sub_images with x's to mark centroids and head edge 
    if k > 1 
        run subplots 
    end 
     
    %define sub_image: 1 comet 
    [I_sub,pL,pH,cancel,cs] = selectpolygon_image(H,k,tc); 
     
    %sets values for the canceled scores matrix 
    if cs == 1 
        %cs == 1 and cancelscr = 1 default settings for keeping a score 
        cancelscr(k) = 1; 
    elseif cs == 0 
        %cs == 0 and cancelscr = 0 score cancelation in score_cancel 
        cancelscr(k) = 0; 
    end 
     
    %if cancel==1  ends the program following right click on orig image 
    if cancel == 1 
        hold off 
        break 
    end 
     
    isubH = I_sub; 
    szisub = size(I_sub); 
     
    %select matching sub_image 
    [isubL] = equivalent_section(pL,pH,L); 
     
    %zero background in both sub images 
    [isubHz,isubLz,userdefhead] = 
zero_background(isubH,isubL,thresh,... 
        threshL,bckgrndcheck,userdefhead); 
     
    % NOW FORM THE HEAD 
    [radius,head_edge,head_centroid,userdefhead,bb,prevent_error] =... 
        define_head(bb,isubHz,userdefhead,isubLz); 
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    %additional score cancelling for comets improperly scored (prevents 
    %error message when the comet head or tail runs off the edge of the 
    %sub-image 
    if prevent_error == 1 
        %score cancelled. don't set cancelscr(k) to 1 because that 
means 
        %cancel the previos score 
        %(due to the timing of the button2 click for cancel) 
        cancelscr(k) = 2; 
    end 
     
    %find and zero head in isubHz and locate tail centroid 
    [tail_centroid,tail] = define_tail(isubHz,head_centroid,... 
        szisub,radius); 
     
    %calculate the %tail DNA 
    [td,lowtail] = tail_dna(isubLz,head_centroid,szisub,radius); 
     
    %determine total tail length 
    [tail_length,tail_edge,prevent_error] = length_of_tail... 
        (isubHz,head_centroid,radius,prevent_error); 
     
    %additional score cancelling for comets improperly scored (prevents 
    %error message when the comet head or tail runs off the edge of the 
    %sub-image 
    if prevent_error == 1 
        %score cancelled. don't set cancelscr(k) to 1 because that 
        %means cancel the previos score 
        %(due to the timing of the button2 click for cancel) 
        cancelscr(k) = 2; 
    end 
    %find centroid migration with low_gain image 
    [low_dist,radiusL,tail_lengthL,bb] = low_distance(bb,... 
        isubLz,szisub,head_centroid,radius,head_edge,... 
        userdefhead,prevent_error); 
     
    %distance between head and tail centroids 
    %dist = dist between centroids minus radius. Otherwise a 
    % 2x increase in dna migration won't be a 2x distance score. 
    distance = (sqrt((tail_centroid(2)-head_centroid(2))^2 +... 
        (tail_centroid(1)-head_centroid(1))^2)-radius); 
     
     
    %Couldn't determine why the NaNs show up as distance values but it 
    %seems to happen exclusively on comets with no tail so the quickfix 
    %seems to be to just set them to zero right here. 
    NaNfixer = isnan(distance); 
    if NaNfixer == 1 
        distance = 0; 
    end 
     
    %calculate ascore and tail moment 
    ascore(k) = td * distance; 
    tail_momenta(k) = td * tail_length; 
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    olive_momenta(k) = td * low_dist; 
    tail_momentLa(k) = td * tail_lengthL; 
     
    %tail_moment can be negative when the tail is faint and spotty 
    %and the distance found by tail_edge is less than the radius 
    %which may be off-center. Then tail_moment is just set to zero 
    if tail_momenta(k) < 0 
        tail_momenta(k) = 0; 
    end 
     
    if tail_momentLa(k) < 0 
        tail_momentLa(k) = 0; 
    end 
     
    %adjustment for marking scored comets on the main image 
    tc(k,1) = head_centroid(2) + pL(1); 
    tc(k,2) = head_centroid(1) + pL(2); 
     
    %collect all of the variables of interest in vectors 
    tda(k) = td; 
    distancea(k) = distance; 
    radiusa(k) = radius; 
    tail_lena(k) = tail_length; 
     
    %plus collect the same scores for Low gain image only 
    low_dista(k) = low_dist; 
    tail_lengthLa(k) = tail_lengthL; 
    radiusLa(k) = radiusL; 
     
end 
  
cancelator = cell(1,13); 
cancelator{1} = ascore; 
cancelator{2} = cancelscr; 
cancelator{3} = k; 
cancelator{4} = tda; 
cancelator{5} = distancea; 
cancelator{6} = radiusa; 
cancelator{7} = tail_lena; 
cancelator{8} = tail_momenta; 
cancelator{9} = olive_momenta; 
cancelator{10} = tail_lengthLa; 
cancelator{11} = low_dista; 
cancelator{12} = tail_momentLa; 
cancelator{13} = radiusLa; 
  
%removal of the canceled scores 
[atkinscore,tdc,distancec,radiusc,tail_lenc,tail_momentc,... 
    olive_momentc,tail_lengthLc,low_distc,tail_momentLc,... 
    radiusLc] = score_cancel(cancelator); 
  
d=size(atkinscore); 
data = zeros(d(1),11); 
data(:,1) = atkinscore; % synthetic moment 
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data(:,2) = tdc;        % %tail DNA 
data(:,3) = tail_lenc;   % tail length 
data(:,4) = distancec;  % centroid migration distance 
data(:,5) = tail_momentc; %tail moment 
data(:,6) = olive_momentc; %olive_moment 
data(:,7) = tail_lengthLc; %tail length LOW gain 
data(:,8) = low_distc; %centroid migration distance LOW gain 
data(:,9) = tail_momentLc; %tail moment LOW gain 
data(:,10) = radiusc;    % radius of the head HIGH gain 
data(:,11) = radiusLc; % radius of head LOW gain 
  
csvwrite(file,data) 
  
allscores = cell(1,11); 
  
allscores{1} = atkinscore; 
allscores{2} = tdc; 
allscores{3} = tail_lenc; 
allscores{4} = distancec; 
allscores{5} = tail_momentc; 
allscores{6} = olive_momentc; 
allscores{7} = tail_lengthLc; 
allscores{8} = low_distc; 
allscores{9} = tail_momentLc; 
allscores{10} = radiusc; 
allscores{11} = radiusLc; 
 
 
Matlab function centroid.m 
 
function [cent] = centroid(isub) 
%takes an image isub and returns the coordiantes 
%of its centroid in the vector cent 
  
sz = size(isub); 
  
ti = sum(sum(isub)); %total intensity 
  
My = zeros(sz(1),sz(2)); 
Mx = zeros(sz(1),sz(2)); 
  
  
%assign a moment to each point 
for j = 1:sz(1) 
    for i = 1:sz(2) 
        My(j,i) = i * double(isub(j,i));  Mx(j,i) = j * 
double(isub(j,i)); 
    end 
end 
  
%divide by total intensity to find x and y coord of centroid 
Mytotal = sum(sum(My)); 
xbar = Mytotal/ti; 
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Mxtotal = sum(sum(Mx)); 
ybar = Mxtotal/ti; 
  
xbar = ceil(xbar); ybar = ceil(ybar); 
cent = [ybar,xbar]; %the centroid of the image 
 
 
Matlab function define_head.m 
 
function[radius,head_edge,head_centroid,userdefhead,bb,... 
    prevent_error] = define_head(bb,isubHz,userdefhead,isubLz) 
%takes highgain background zeroed subimage 
%gives head centroid, head radius, and the edge of the head 
  
prevent_error = 0; 
isi = size(isubHz);  
isize = isi(2);  %prevents error if head is off the edge of the image 
  
if userdefhead == 1 
     
    %user defined head centroid is chosen here 
    figure(5) 
    clf(5) 
    hold on 
    image(isubLz) 
    [x5,y5] = ginput(1); 
    %x6 = ceil(x5); y6 = ceil(y6); 
    cent = [ceil(y5),ceil(x5)]; 
    hold off 
     
   %find the edge of the head 
    x=1; i=1; 
  
    while x==1 
        if isubHz(floor(cent(1)),floor(cent(2)-1+i)) > 0 
            i = i+1; 
            x=1; 
             
            moops = floor(cent(2)-1+i); 
            if moops == isize 
                x=0; 
                head_edge = [floor(cent(1)), floor(cent(2)-1+i)];  
                prevent_error = 1; 
            end 
               
        else 
          x=0; 
         head_edge = [floor(cent(1)), floor(cent(2)-1+i)]; 
        end 
    end 
  
    head_centroid = cent; 
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    radius = i-1; 
  
%userdefhead=2  gets set when 'f' is input during manual background 
%threshold adjustment 
%userdefhead=2 lets head_cent be chosen manually 
%for one comet at a time 
elseif userdefhead == 2    
                           
 %user defined head centroid is chosen here 
    figure(5) 
    clf(5) 
    hold on 
    image(isubLz) 
    [x5,y5] = ginput(1); 
    %x6 = ceil(x5); y6 = ceil(y6); 
    cent = [ceil(y5),ceil(x5)]; 
    hold off 
     
     %find the edge of the head 
    x=1; i=1; 
  
    while x==1 
        if isubHz(floor(cent(1)),floor(cent(2)-1+i)) > 0 
            i = i+1; 
            x=1; 
              
            moops = floor(cent(2)-1+i); 
            if moops == isize 
                x=0; 
                head_edge = [floor(cent(1)), floor(cent(2)-1+i)];  
                prevent_error = 1; 
            end 
  
        else 
          x=0; 
         head_edge = [floor(cent(1)), floor(cent(2)-1+i)]; 
        end 
    end 
  
    head_centroid = cent; 
    radius = i-1; 
userdefhead = 0; 
bb = 1; 
  
else 
    high = isubHz >= (0.85 * max(max(isubHz))); 
    low = isubHz < (0.85 * max(max(isubHz))); 
  
    %removes all of the high gain sub-image  
    head_cent = isubHz; 
    head_cent(low) = 0; 
  
    %get the centroid of the head 
    [cent] = centroid(head_cent);    
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    %find the edge of the head 
    x=1; i=1; 
  
    while x==1 
        if isubHz(floor(cent(1)),floor(cent(2)-1+i)) > 0 
            i = i+1; 
            x=1; 
          
            moops = floor(cent(2)-1+i); 
            if moops == isize 
                x = 0;   
                head_edge = [floor(cent(1)), floor(cent(2)-1+i)]; 
                prevent_error = 1; 
            end 
  
        else 
          x=0;                      
          head_edge = [floor(cent(1)), floor(cent(2)-1+i)];      
        end 
    end 
  
    head_centroid = cent; 
    radius = i-1; 
end 
 
 
 
Matlab function define_headL.m 
 
function[radiusL,head_edgeL,head_centroidL,bb] = define_headL... 
    
(isubLz,head_centroid,radius,head_edge,userdefhead,bb,prevent_error) 
%takes low-gain background zeroed subimage 
%gives head centroid, head radius, and the edge of the head 
  
if prevent_error == 1 
    bb = 0; 
    radiusL = radius; 
    head_edgeL = head_edge; 
    head_centroidL = head_centroid; 
else 
  
    if userdefhead == 1 
        head_centroidL = head_centroid; 
        cent = head_centroid; 
  
        %find the edge of the head 
        x=1; i=1; 
  
  
        while x==1 
            if isubLz(floor(cent(1)),floor(cent(2)-1+i)) > 0 
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                i = i+1; 
                x=1; 
            else 
                x=0; 
                head_edgeL = [floor(cent(1)), floor(cent(2)-1+i)]; 
            end 
        end 
        radiusL = i-1; 
  
    elseif bb == 1 
  
        head_centroidL = head_centroid; 
        cent = head_centroid; 
  
        %find the edge of the head 
        x=1; i=1; 
  
  
        while x==1 
            if isubLz(floor(cent(1)),floor(cent(2)-1+i)) > 0 
                i = i+1; 
                x=1; 
            else 
                x=0; 
                head_edgeL = [floor(cent(1)), floor(cent(2)-1+i)]; 
            end 
        end 
        radiusL = i-1; 
        bb = 0; 
  
    else 
        high = isubLz >= (0.85 * max(max(isubLz))); 
        low = isubLz < (0.85 * max(max(isubLz))); 
  
        %removes all of the high gain sub-image 
        head_cent = isubLz; 
        head_cent(low) = 0; 
  
        %get the centroid of the head 
        [cent] = centroid(head_cent); 
  
        %find the edge of the head 
        x=1; i=1; 
  
  
        while x==1 
            if isubLz(floor(cent(1)),floor(cent(2)-1+i)) > 0 
                i = i+1; 
                x=1; 
            else 
                x=0; 
                head_edgeL = [floor(cent(1)), floor(cent(2)-1+i)]; 
            end 
        end 
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        head_centroidL = cent; 
        radiusL = i-1; 
    end 
end 
 
 
 
Matlab function define_tail.m 
 
function [tail_centroidL,tailL] = define_tail(isubLz,... 
    head_centroidL,szisub,radiusL) 
%this function takes a high-gain comet sub_image and its head 
parameters  
%and returns a the centroid of the tail as a vector 
%Also handles NaNs that come up when there is no tail in high gain 
image  
  
tailL = isubLz; 
tailL(:,head_centroidL(2)-radiusL:szisub(2)) = 0; 
  
[tail_centroidL] = centroid(tailL); 
 
 
 
Matlab function equivalent_section.m 
 
function [isubL] = equivalent_section(pL,pH,L) 
%this function takes pL and pH from a high gain sub_image and  
%uses them to define a sub_image from the low gain matching image 
%isubL is the low gain sub image 
  
sp(1) = pL(1); sp(2) = pL(2); sp(3) = pH(1); sp(4) = pH(2); 
  
isubL = L([sp(2):sp(4)],[sp(1):sp(3)],:); 
 
 
 
Matlab function length_of_tail.m 
 
function [tail_length,tail_edge,prevent_error] = length_of_tail... 
    (isubHz,head_centroid,radius,prevent_error) 
%The length_of_tail function finds the tail length of the comet by 
loading 
%the Highgain sub-image with zeroed background, isubHz. It begins at 
the 
%head_centroid point, counts pixels to the left until it hits a zero 
valued 
%pixel. The distance in pixels from head_centroid to tail_tail edge 
minus 
%the radius equal taillength which is the function output. tail_edge is 
the 
%coordinates of the tail's edge. 
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%find the edge of the tail 
x=1; i=0; 
  
while x==1 
    if isubHz(floor(head_centroid(1)),floor(head_centroid(2)+i)) > 0 
        i = i-1; 
        x=1; 
  
        if floor(head_centroid(2)+i) == 1 
            x=0; 
            tail_edge = [floor(head_centroid(1)), ... 
                floor(head_centroid(2)+i)]; 
            prevent_error = 1; 
        end 
    else 
        x=0; 
        tail_edge = [floor(head_centroid(1)), 
floor(head_centroid(2)+i)]; 
    end 
end 
  
tail_length = head_centroid(2) - (floor(head_centroid(2)+i)) - radius; 
 
 
Matlab function low_distance.m 
 
function [low_dist,radiusL,tail_lengthL,bb] = low_distance(bb,isubLz... 
    ,szisub,head_centroid,radius,head_edge,userdefhead,prevent_error) 
%low_distance takes makes use of define_head and define_tail functions 
%to find the tail migration distance using the low gain image so that 
an 
%Old Fashioned Olive moment can be calculated. 
  
 % NOW FORM THE HEAD 
    [radiusL,head_edgeL,head_centroidL,bb] = define_headL... 
        (isubLz,head_centroid,radius,head_edge,userdefhead... 
        ,bb,prevent_error); 
     
    if userdefhead == 1 
        head_centroidL = head_centroid; 
    end  
     
    if bb == 1 
        head_centroidL = head_centroid; 
    end 
    bb = 0; 
     
    %find and zero head in isubHz and locate tail centroid 
    [tail_centroidL,tailL] = define_tail(isubLz,... 
        head_centroidL,szisub,radiusL); 
     
    %distance between head and tail centroids 
    %dist = dist between centroids minus radius. Otherwise a 2x  
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    %increase in dna migration won't be a 2x distance score. 
    low_dist = (sqrt((tail_centroidL(2)-head_centroidL(2))^2 + ... 
        (tail_centroidL(1)-head_centroidL(1))^2)-radiusL); 
     
    %Couldn't determine why the NaNs show up as distance values but it 
    %seems to happen exclusively on comets with no tail so the quickfix 
    %seems to be to just set them to zero right here. 
     NaNfixer = isnan(low_dist);  
    if NaNfixer == 1             
        low_dist = 0;            
    end 
     
    [tail_lengthL,tail_edge] = length_of_tail(isubLz,... 
        head_centroidL,radiusL); 
 
 
Matlab function score_cancel.m 
 
function [atkinscore,tdc,distancec,radiusc,tail_lenc,... 
    tail_momentc,olive_momentc,tail_lengthLc,low_distc,... 
    tail_momentLc,radiusLc] = score_cancel(cancelator) 
%this function takes all the ascore data from one original comet image 
as 
%well as cancelscr which has the same dimensions as ascore with zeros 
where 
%ascore was canceled by the user. It returns atkinscore which is a 
vector 
%containing all the non-canceled points 
  
%2 ways to remove the zeros from a vector 
%X(X==0) = []; 
%or you could type X = nonzeros(X); 
  
ascore = cancelator{1}; 
cancelscr = cancelator{2};  
k = cancelator{3}; 
tda = cancelator{4};  
distancea = cancelator{5};  
radiusa = cancelator{6}; 
tail_lena = cancelator{7}; 
tail_momenta = cancelator{8}; 
olive_momenta = cancelator{9}; 
tail_lengthLa = cancelator{10}; 
low_dista = cancelator{11}; 
tail_momentLa = cancelator{12};  
radiusLa = cancelator{13}; 
  
scores = ascore(1:k-1,1); 
tdb = tda(1:k-1,1); 
distanceb = distancea(1:k-1,1); 
radiusb = radiusa(1:k-1,1); 
tail_lenb = tail_lena(1:k-1,1); 
tail_momentb = tail_momenta(1:k-1,1); 
olive_momentb = olive_momenta(1:k-1,1); 
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tail_lengthLb = tail_lengthLa(1:k-1,1); 
low_distb = low_dista(1:k-1,1); 
tail_momentLb = tail_momentLa(1:k-1,1); 
radiusLb = radiusLa(1:k-1,1); 
  
  
  
%Cancelation of the canceled scores 
for i = 1:k-1 
    if cancelscr(i) == 0 
        radiusb(i-1) = 0;   
    elseif cancelscr(i) == 2 
        radiusb(i) = 0; 
    end 
end 
%the radius will never be zero unless  
%set to zero by the score canceller above 
q = radiusb ~= 0;           
atkinscore = scores(q);              %ZERO when %dna = 0  
tdc = tdb(q);                        %ZERO when %dna = 0  
tail_momentc = tail_momentb(q);      %ZERO when %dna = 0  
olive_momentc = olive_momentb(q);    %ZERO when %dna = 0  
distancec = distanceb(q);   %NOT zero when %dna is 
tail_lenc = tail_lenb(q);   %NOT zero when %dna is 
radiusc = radiusb(q);       %NOT zero when %dna is 
tail_lengthLc = tail_lengthLb(q);  %ZERO when %dna = 0 
low_distc = low_distb(q);    %ZERO when %dna = 0 
tail_momentLc = tail_momentLb(q); %ZERO when %dna = 0 
radiusLc = radiusLb(q); %Not zero when %DNA is 
  
  
%scores that should be zero when %tail_dna is zero are set to zero here 
qq = tdc == -1; 
atkinscore(qq) = 0;  
tdc(qq) = 0; 
tail_momentc(qq) = 0; 
olive_momentc(qq) = 0; 
  
tail_lengthLc(qq) = 0; 
low_distc(qq) = 0;     
tail_momentLc(qq)= 0; 
  
%distances that can show negative scores when they should be zero (DUE 
to 
%lopsided comets with heads that stick out farther on the right from 
the 
%centroid than they do on the left) are set to zero here 
e1 = distancec < 0; 
distancec(e1) = 0; 
e2 = tail_lenc < 0; 
tail_lenc(e2) = 0; 
e3 = tail_lengthLc < 0; 
tail_lengthLc(e3) = 0; 
e4 = low_distc < 0; 
low_distc(e4) = 0; 
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% Removed Nan removal part because it may make unbalnced sized  
%matrices and Why should there be NaNs? If there are I 
% must locate the source of the NaNs. 
  
%NaNs are removed 
% ww = atkinscore == atkinscore; 
% atkinscore = atkinscore(ww); 
%  
% w = olive_momentc == olive_momentc;  
% olive_momentc = olive_momentc(w); 
%  
% www = distancec == distancec; 
% distancec = distancec(www); 
%  
% uu = low_distc == low_distc; 
% low_distc = low_distc(uu); 
  
  
% atkinscore = zeros(k-1,1); 
% scores = zeros(k-1,1); 
% tdb = zeros(k-1,1); 
% distanceb = zeros(k-1,1); 
% radiusb = zeros(k-1,1); 
% tail_lenb = zeros(k-1,1); 
% tail_momentb = zeros(k-1,1); 
% olive_momentb = zeros(k-1,1); 
 
 
Matlab function select_polygon_image.m 
 
function [I_sub,pL,pH,cancel,cs] = selectpolygon_image(I,k,tc) 
  
% function [I_sub,pL,pH,cancel] = selectpolygon_image(I) 
% 
% Given an image (I), allows interactive plotting to select the corners 
of 
% a rectangle (with two mouse clicks at positions pL and pH) and then 
% outputs the resulting subimage I_sub. The image I is assumed to be 
the 
% output of a previous I = imread(FILENAME,FMT) function call. If the 
right 
% button is depressed (control-button on a Mac), then the function 
sends 
% out a signal to cancel the image capture. 
  
figure(1) 
hold on 
image(I); 
  
%this is where #s are added to the main image to prevent rescoring. 
% XX = zeros(k,1); 
% yy = zeros(k,1); 
XX = nonzeros(tc(1:k,1)); 
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YY = nonzeros(tc(1:k,2)); 
  
%plot(XX,YY,'rx') 
  
for v = 1:length(XX) 
   text(XX(v),YY(v),num2str(v), 'color',[1 1 1]); 
end 
  
% pick the points 
cancel = 0; 
cs = 1; 
  
[x1,y1,but] = ginput(1); 
if but == 3 
    cancel = 1; 
    I_sub=0;pL=0;pH=0; 
    figure(1); clf; figure(2); clf; figure(4); clf; 
    return 
%if the middle mouse button is pressed, it will set cs = 0 to cancel 
the 
%previous score and ask again for the first x,y point 
elseif but == 2 
    cs = 0; 
    disp('score #'),k,('omitted') %#ok<NOPRT> 
    [x1,y1,but] = ginput(1); 
end     
    if but == 3 
        cancel = 1; 
        I_sub=0;pL=0;pH=0; 
        figure(1); clf; figure(2); clf; figure(4); clf; 
        clf 
        return 
    end 
  
plot(x1,y1,'rx') 
  
[x2,y2,but] = ginput(1); 
if but == 3 
    cancel = 1; 
    I_sub=0;pL=0;pH=0; 
    figure(1); clf; figure(2); clf; figure(4); clf; 
    clf 
    return 
end 
  
%mark_scored = [x1,y2];  
% keeps track of how much to shift each 'rx' 
% marker of previously scored comets 
  
plot(x2,y2,'rx') 
  
% Get the x and y corner coordinates as integers 
sp(1) = min(floor(x1), floor(x2)); %xmin 
sp(2) = min(floor(y1), floor(y2)); %ymin 
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sp(3) = max(ceil(x1), ceil(x2));   %xmax 
sp(4) = max(ceil(y1), ceil(y2));   %ymax 
  
rectangle('Position',[sp(1) sp(2) sp(3)-sp(1)... 
    sp(4)-sp(2)],'EdgeColor','r'); 
hold off 
  
% Index into the original image to create the new image 
% Note that we selected x and y coords, corresponding to columns and 
rows 
I_sub = I([sp(2):sp(4)],[sp(1):sp(3)],:); 
  
pL = [sp(1),sp(2)]; pH = [sp(3),sp(4)]; 
 
 
Matlab function tail_dna.m 
 
function [td,lowtail] = tail_dna(isubLz,head_centroid,szisub,radius) 
%using the low-gain sub_image this function sets all pixels to the 
right of 
%the left edge of the head to zero. It then calculates %tail_dna as a 
%fraction of the total image intensity. 
  
lowtail = isubLz; 
lowtail(:,head_centroid(2)-radius:szisub(2)) = 0; 
  
%Setting comets with no tail in low gain to ascore = -1 
if max(max(lowtail)) == 0 
    td = -1; 
else 
toti = sum(sum(isubLz)); 
taili = sum(sum(lowtail)); 
  
td = taili/toti; 
end 
 
 
Matlab function zero_background.m 
 
function [isubHz,isubLz,userdefhead] = zero_background... 
    (isubH,isubL,thresh,threshL,bckgrndcheck,userdefhead) 
%takes sub images isubH and isubL and sets anything below a 
%threshold of 5% of the maximum intensity to zero. 
  
isubmaxH = max(max(isubH)); 
isubmaxL = max(max(isubL)); 
  
 r = 1; 
 if userdefhead == 1 
    r = 2; 
 end 
  
%bckgrndcheck is assigned in the a_score function call and indicates 
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%whether or not to prompt user for background adjustment 
if bckgrndcheck == 0 
  
    backgroundH = isubH <= thresh*isubmaxH; 
    isubH(backgroundH) = 0; 
    backgroundL = isubL <= threshL*isubmaxL; 
    isubL(backgroundL) = 0; 
  
isubHz = isubH; 
isubLz = isubL; 
  
elseif bckgrndcheck == 1 
  
while true 
    isubH2 = isubH; 
    backgroundH = isubH2 <= thresh*isubmaxH; 
    isubH2(backgroundH) = 0; 
    figure(3) 
    image(isubH2) 
    key_press = input('change background', 's'); 
    switch key_press 
        case 'a' 
            thresh = thresh - 0.01 
        case 'd' 
            thresh = thresh + 0.01 
        case 'q' 
            thresh = thresh - 0.04 
        case 'e' 
            thresh = thresh + 0.04 
        case 'z'  
            thresh = thresh - 0.02 
        case 'c' 
            thresh = thresh + 0.02 
        case 'f' 
            userdefhead = 2; 
            r = 0; 
        otherwise 
            break 
    end 
end 
isubHz = isubH2; 
isubLz = isubL; 
  
elseif bckgrndcheck == 2 
     
    while true 
    isubH2 = isubH; 
    backgroundH = isubH2 <= thresh*isubmaxH; 
    isubH2(backgroundH) = 0; 
    figure(3) 
    image(isubH2) 
    key_press = input('change background', 's'); 
    switch key_press 
        case 'a' 
            thresh = thresh - 0.01 
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        case 'd' 
            thresh = thresh + 0.01 
        case 'q' 
            thresh = thresh - 0.04 
        case 'e' 
            thresh = thresh + 0.04 
        case 'z'  
            thresh = thresh - 0.02 
        case 'c' 
            thresh = thresh + 0.02 
        case 'f' 
            userdefhead = 2;     
            r = 0; 
        otherwise 
            break 
    end 
end 
isubHz = isubH2; 
  
while true 
    isubL2 = isubL; 
    backgroundL = isubL2 <= threshL*isubmaxL; 
    isubL2(backgroundL) = 0; 
    figure(3) 
    image(isubL2) 
    key_press = input('change background', 's'); 
    switch key_press 
        case 'a' 
            threshL = threshL - 0.01 
        case 'd' 
            threshL = threshL + 0.01 
        case 'q' 
            threshL = threshL - 0.04 
        case 'e' 
            threshL = threshL + 0.04 
        case 'z'  
            threshL = threshL - 0.02 
        case 'c' 
            threshL = threshL + 0.02     
        case 'f' 
            userdefhead = 2;     
            r = 0; 
        otherwise 
            break 
    end 
end 
isubLz = isubL2; 
  
end 
  
if r == 1 
    userdefhead = 0; 
elseif r == 2 
    userdefhead = 1; 
end 
213 
 
Sample pair of bitmap images to load for scoring in Ascore 
 
 
 
 
Figure 7.7: High gain bitmap image. 
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Figure 7.8: Low gain bitmap image. 
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